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ABSTRACT
Phytoestrogens are plant compounds that possess estrogenic and biological properties that
have been postulated to protect against chronic diseases. Isoflavonoids and lignans are two
main classes of phytoestrogen that have been investigated for their estrogenic efficacy and
occurrence in the human diet. Isoflavonoids are found in soy and related products, whereas
lignans are found in a wider range of plant-based foods, such as cereals, vegetables, fruits,
legumes, nuts and seeds; and in beverages such as tea, coffee and wine. In Western
populations with low dietary intake of soy products, compared to the Asian counterparts,
lignans could be a more important and consistent source of phytoestrogens from the diet. Data
for the phytoestrogen content in foods are now available, as more recent research has been
conducted to quantify content in commonly consumed food choices in Western populations.
The collation of these published values has led to the desire to adequately assess lignan
intake.
The aims of the research were to evaluate the validity and reliability of a phytoestrogen food
frequency questionnaire (FFQ) tool, with a reference method, the weighed food record
(WFR), and urinary biomarkers, to measure phytoestrogen intake in the Australian context.
The phytoestrogen FFQ was updated and refined to align with food groups and dietary
patterns in the current Australian Dietary Guidelines, in particular to optimise measurement of
lignans from the FFQ, and utilise current databases of lignan content available from direct
measurement of lignans in foods. Intake level and contributing food sources of each class of
phytoestrogen, and the associations between social and lifestyle characteristics and
phytoestrogen intake and urinary biomarker were also explored.
This was a cross-sectional study that recruited 59 Australian men and women aged 18 to 67
years at Joondalup campus, Edith Cowan University. Intake of lignans, isoflavonoids and
enterolignans from foods was assessed using the 277-item phytoestrogen FFQ and 3-day
WFR, and excretion was assessed with urinary biomarkers. Published values of phytoestrogen
content in foods were utilised to measure the intakes. Subjects collected three 24-hour urine

samples and phytoestrogen concentration was analysed using a liquid chromatography-mass
spectrometry (LC-MS) technique for four lignan subclasses, five isoflavonoids and two
enterolignans.
Statistical analyses were conducted using IBM SPSS for Windows (SPSS Inc., Version 22
Chicago, IL). Median intake comparisons were assessed with the Wilcoxon signed rank test.
Associations between the intake and excretion measurements of two dietary assessment
methods were assessed using Spearman’s Rho correlations. Level of agreement between
methods was assessed with cross-classification analysis and Bland Altman plots. A triangular
comparison between the three methods was conducted with the Method of Triads (MOT)
using the software R. The Mann-Whitney U test and Kruskal-Wallis one-way ANOVA were
used to compare the median intakes and excretion across categories of social and lifestyle
factors.
The FFQ had acceptable convergent validity for intake of total lignans and enterolignans
when compared to a WFR, in terms of median intakes (lignans: 3914 versus 4302 µg/day,
p=0.09; enterolignans: 54 versus 65 µg/day, p=0.81, respectively); and associations between
the two methods (lignans ρ=0.42, p<0.001 and enterolignans ρ=0.62, p<0.001). Median
intakes of total isoflavonoids from the FFQ and WFR were also comparable (3851 versus
2287 µg/day, p=0.67) with a significant association between the two tools (ρ=0.36, p<0.001).
A 7% to 17% of subjects were misclassified into opposite quartiles for different phytoestrogen
classes. The FFQ also had acceptable reliability when compared to a repeat FFQ, for all
classes of phytoestrogens, with strong correlations between intakes (ρ=0.78 to ρ=0.85,
p<0.001 for all) and minor misclassifications into opposite quartiles, between 2% to 5%. The
FFQ had poor validity in relation to biomarkers of phytoestrogen excretion. The median
intake and excretion of combined lignans and enterolignans were not significantly different
(4051 versus 3104 µg/day, p=0.22, respectively), but there was no significant correlation
between intake and excretion (ρ=0.16, NS). For total isoflavonoids, excretion was 10-fold
lower than intake from the FFQ (268 versus 3851µg/day, respectively p<0.001) and there was
no significant correlation between the two tools (ρ=0.10, NS). Misclassification into the

opposite quartile was also relatively high for both phytoestrogen classes (21% to 23%). Visual
inspection of the Bland Altman graphs showed trends towards greater inconsistency at higher
median intakes and urinary excretion. Higher validity coefficients (VCs) were observed for
the FFQ in measuring total lignans (VC=0.57) or the FFQ and WFR for measuring combined
lignans plus enterolignans (VC=0.79, 0.78, respectively).
Top contributing food sources of lignans were from the nuts and seeds group (30%),
nonalcoholic beverages (19%), and breads and cereals (19%); for enterolignans, from dairy
products (86%) followed by nonalcoholic beverages (11%). Soy and related food products
were the major contributors (78%) to total isoflavones, followed by breads and cereal
products (17%).
Female subjects who were Caucasian, were at, or had achieved university education level and
took regular commercial dietary supplements, were more likely to have a higher lignan and
enterolignan intake and excretion level than subjects with different characteristics.

Based on these findings, we conclude that the modified phytoestrogen FFQ is highly reliable.
It would be a useful assessment tool for example to rank usual intake of phytoestrogen classes
for individuals within a group, or quantify mean intakes between different population groups.
It is not acceptably valid or accurate for estimation of individual phytoestrogen status, for
example for use in experimental studies or to investigate associations with chronic diseases.
The lack of associations between measurement of the FFQ and biomarkers could partly be
due to limitations of the FFQ tool, such as recall bias or inaccuracies in the estimation of
frequency of intake or portion sizes. They also suggest that urinary biomarkers alone are not
sufficient for estimation of phytoestrogen status and that additional biomarkers obtained from
faecal and plasma samples should be considered for a more complete picture of phytoestrogen
status.
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CHAPTER ONE: INTRODUCTION

1.1 Background and conceptual framework
The consumption of plant-based diets, including a variety of vegetables, fruits, grains,
legumes, and nuts and seeds, has been inversely associated with the progression of chronic
diseases (World Cancer Research Fund/American

Institute for Cancer Research

(WCRF/AICR), 2007; National Health and Medical Research Council (NHMRC), 2013a;
Mann, 2000). Optimising plant-based diets may increase the potential health benefits, which
are attributed to vitamins, minerals, and more recently, a diverse array of bioactive
constituents in plant foods (NHMRC, 2013a). Of these constituents, phytoestrogens have
been thought to protect against chronic diseases, particularly certain types of cancer, due to
their estrogenic properties and other biological activities (Adlercreutz, 2007; NHMRC, 2013a;
WCRF/AICR, 2007).
The Australian Dietary Guidelines (the Guidelines) and the Australian Guide to Health Eating
(AGHE) were developed to provide guidance on the types and amounts of foods from the five
food groups to inform dietary patterns that promote health and wellbeing (NHMRC, 2013a,
2013b). The Guidelines encourage Australians to consume a variety of items from the five
food groups, with emphasis on the consumption of plant-based foods, such as vegetables and
legumes; fruits; grains, especially whole grains and high fibre cereals; and nuts and seeds. It is
important to measure the dietary consumption of phytoestrogens in Australia, as the
population is likely to follow dietary patterns that include variable amounts of plant-based
foods in which phytoestrogens contribute to the perceived health benefits.
The current research focuses on the capability of a modified food frequency questionnaire
(FFQ) to measure intake of two major classes of phytoestrogen, the lignans and isoflavonoids,
in a sample of the Australian population. The validation of the food frequency questionnaire is
the basis of this applied research. The conceptual framework that depicts the relationship
1

between the development and evaluation of the FFQ is shown in Figure 1. Central to the
framework is the FFQ and the estimation of phytoestrogen status in relation to dietary intake
and urinary excretion.

The FFQ food list was reviewed and modified with respect to the

content of lignans and isoflavones from published databases, to include a range of
commonly-consumed foods based on dietary patterns described in the Australian Dietary
Guidelines. Individual differences in colonic microflora could influence the bioavailability
and hence metabolism and urinary excretion of phytoestrogens.

Demographic, social and

lifestyle characteristics such as gender, BMI, bowel habits, and supplements use are also
associated determinants of status (Hanna, O'Neill, & Lyons-Wall, 2010). The repeatability of
the FFQ was evaluated by administering the FFQ to subjects on two occasions one to two
weeks apart; and the validity was evaluated by comparing intake from the FFQ with intake
derived from a 3-day weighed food record (WFR) reference method, and with excretion of
urinary biomarkers. Phytoestrogen status determined by both the dietary assessment tools and
urinary biomarkers, is the outcome of this research that informs the bioavailability and
metabolomics profiles of lignans and isoflavonoids. The Method of Triads was applied for a
triangular comparison between the FFQ, the 3-day WFR and the urinary excretion of
metabolites for estimating phytoestrogen status. The implication of the research is to
investigate the potential applicability of phytoestrogen status as a biomarker of health and
wellbeing.

2

Figure 1. Conceptual framework for the evaluation of a modified FFQ, dietary phytoestrogen
intake and status, and associated factors and variables.
The validation of a dietary assessment tool for estimating phytoestrogen status is the basis of this
applied research. Methods are shown in green, tools are in red and phytoestrogen status is in blue.
Phytoestrogen status determined by both the dietary assessment tools and urinary biomarker is the
outcome of this research that informs the bioavailability and metabolomics profiles. If the FFQ is
shown to a valid and reliable tool, it could be used to further investigate the role of dietary
phytoestrogens in health and prevention of disease

3

1.2 Aims and hypotheses
This research was conducted in a sample of the Australian population. The aims were:
1. To modify and refine a FFQ to estimate phytoestrogen intake based on a previous
questionnaire for use in an Australian population;
2. To estimate the validity of the FFQ by comparison with intake obtained from a 3-day
WFR reference method and biomarkers of urinary phytoestrogen excretion;
3. To estimate the reliability of the FFQ by comparison with intake obtained from pre FFQ
and post FFQ;
4. To estimate dietary phytoestrogen intake using the FFQ and WFR and evaluate the major
contributing food sources;
5. To determine the social and lifestyle characteristics and variables associated with
phytoestrogen intake and biomarkers.

The hypotheses being tested are:
1. There is no significant difference between average phytoestrogen intakes derived from the
FFQ versus the 3-day WFR reference method.
2. There is no significant difference between the average phytoestrogen intake derived from
the pre FFQ versus the post FFQ, administered one week apart.
3. There are significant positive associations between phytoestrogen intake derived from the
pre FFQ and post FFQ, and FFQ and WFR; and between phytoestrogen intake estimated
from the FFQ or WFR and urinary excretion of phytoestrogen metabolites.
4. There is acceptable agreement observed in Bland Altman plots between individual values
for phytoestrogen intake derived from the FFQ and WFR, and pre FFQ and post FFQ; and
between phytoestrogen intake estimated from the FFQ and urinary biomarkers.
5. Of the measures of assessment of phytoestrogen status, the FFQ has a higher validity
coefficient (VC), calculated with the method of triads, than the WFR or biomarkers; the
VCs are within the accepted theoretical range of 0 to 1.
4

1.3 Significance
There is a need for dietary tools to adequately assess phytoestrogen intake of different
populations living in Western locations, including multiethnic groups such as those living in
Australia today.

Data for the phytoestrogen content in foods are now available, as more

recent research has been conducted to quantify content in commonly consumed food choices
in Western populations. The collation of these published values has led to the desire to
adequately assess lignan and isoflavonoid intake.

The public interest in following dietary

patterns that promote health and wellbeing has driven the need to know more about the
current intake level, and food sources and dietary patterns related to these bioactive
compounds such as phytoestrogens. These compounds may play a role in the mechanism and
physiological changes that lead to health benefits and wellbeing.

This study evaluates the validity and reliability of a modified FFQ tool to measure
phytoestrogen intake in the Australian context. The contribution of these compounds and their
association with chronic diseases has not been completely elucidated, indicating the
importance of having valid and reliable tools with low burden for assessment of
phytoestrogen intake and status. Once validated, the FFQ could be used as the tool to measure
phytoestrogen intake in nutritional epidemiological studies to investigate the relationship
between dietary phytoestrogen intake and chronic diseases in Australia. As there is currently
no optimal intake level established for phytoestrogen, the findings of the research could also
contribute to development of an optimal intake level for these bioactive constituents in dietary
guidelines.
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CHAPTER TWO: LITERATURE REVIEW

2.1 Phytoestrogens
Phytoestrogens are non-steroidal plant compounds that possess estrogenic properties due to
structural similarity to mammalian estrogens (Adlercreutz, 2007; Dixon, 2004; Mostrom &
Evans, 2011; Wiseman, 2012). The structural features of phytoestrogens, including the
diphenolic ring and the position of the hydroxyl groups, are crucial for binding to the estrogen
receptor (ER) to elicit estrogenic activity (Miksicek, 1995; Turner, Agatonovic-Kustrin, &
Glass, 2007) (Figure 2). Phytoestrogens act like selective estrogen receptor modulators
(SERMS) to inhibit or stimulate estrogen-like actions that include modulation of enzyme
activities, induction of gene expression and regulation of cell growth (Cassidy, Hanley, &
Lamuela-Raventos, 2000; Kurzer & Xu, 1997; Mostrom & Evans, 2011). Scientific attention
has focused on the two main classes of phytoestrogens, isoflavonoids and lignans for their
estrogenic efficacy and occurrence in the human diet (Cassidy et al., 2000; Landete, 2012;
Wang, 2002).

Isoflavonoids are found in soy and related products, and the legume and bean

family. Lignans are found in a wider range of plant-based foods, such as cereals, vegetables,
fruits, legumes, nuts and seeds; and in beverages such as tea, coffee and wine (Adlercreutz,
2007; Cassidy et al., 2000; Dixon, 2004; Landete, 2012).

In Western populations with low

dietary intake of soy products, lignans could be a more important and consistent source of
phytoestrogens from the diet (Hanna, 2006).

2.2 Subclasses of phytoestrogens– lignans and isoflavonoids
Secoisolariciresinol (SECO), matairesinol (MAT), pinoresinol (PINO), and lariciresinol
(LARI) are the four major dietary plant lignans or lignan precursors, of particular interest in
relation to their bioavailability for human absorption and degree of conversion into two major
lignan metabolites or enterolignans, enterodiol (END) and enterolactone (ENL) (Heinonen et
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al., 2001).

Two other lignan precursors from rye, syringaresinol (SYR) and medioresinol

(MED), have also been identified as major dietary determinants of urinary lignan
concentrations in the Finnish population (Heinonen et al., 2001; Peñalvo, Haajanen, Botting,
& Adlercreutz, 2005). The chemical structures of lignans are illustrated in Figure 2b, c.
Genistin, daidzin and glycitin are the major dietary isoflavonoids. They are hydrolysed and
converted by colonic bacteria into metabolites, in particular genistein, daidzein and glycitein,
that can be absorbed and excreted into the urine (King & Bursill, 1998; Watanabe et al.,
1998).

2.3 Absorption and metabolism of lignans and isoflavonoids
Lignans and isoflavonoids show similar patterns of absorption and metabolism with
production of their unique metabolites (Heinonen, Hoikkala, Wähälä, & Adlercreutz, 2003;
Landete, 2012).

Lignans are diphenolic compounds that occur in plants as inactive

conjugated glycosides or glycones with sugar moieties attached (Dixon, 2004).

The active

aglycone is formed through the removal of the sugar moiety by intestinal microbial enzymes,
β-glucosidases

(Mostrom

&

Evans,

2011).

The

unconjugated

lignans

undergo

biotransformation through a further series of metabolic reactions to form two metabolites,
enterodiol (END) and enterolactone (ENL) (Landete, 2012).

The active lignan aglycones

and their metabolites possess estrogenic properties and can act either as an estrogen agonist or
an antagonist (Dixon, 2004; Kurzer & Xu, 1997; Mostrom & Evans, 2011; Thompson & Ward,
2002).
Dietary lignans undergo metabolic transformations in the colon. Metabolites are absorbed
from the gastrointestinal tract into the portal vein and transported to the liver where they are
conjugated with glucuronate or sulphate. They may be secreted with bile into the
gastrointestinal tract and undergo hepatic recirculation or distributed in the body and finally
excreted into urine or faeces; lignans are also secreted into bodily fluids such as breast milk.
The absorption and metabolism of lignan precursors is summarised in Figure 3 (Cassidy et al.,
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2000; Duncan, Phipps, & Kurzer, 2003; Heinonen et al., 2001; Landete, 2012; Mostrom &
Evans, 2011; Wang, 2002). In brief, SECO diglucoside (SDG) is deglycosylated by intestinal
glucosidases to form the aglycone SECO, which can be further metabolised to END through a
series of demethylation and dehydroxylation reactions, or dehydrogenated to form ENL as the
end product. Both END and ENL can be detected in urine and reflect dietary intake of SECO.
In a study of lignan metabolism using an in-vitro incubation model, Heinonen et al. (2001)
measured the degree of conversion of lignan precursor to enterolignans in a 24 hour
incubation period and observed that 72% of added SECO, 55% of PINO, 100% of LARI and
4% of SYR were converted to both ENL and END, and 62% of MAT to ENL only (Bowey,
Adlercreutz, & Rowland, 2003; Wang, 2002; Wang, Meselhy, Li, Qin, & Hattori, 2000).
The conjugated isoflavone glycosides, genistin, daidzin and glycitin, and methylated
precusors formononetin and biochanin A, form the main sources of dietary isoflavonoids
(Setchell, Brown, Desai, Zimmer-Nechemias, & et al., 2001). Similarly to lignans, the
isoflavonoid glycosides require the hydrolysis of the sugar moiety by intestinal
β-glucosidases to release the aglycones, genistein, daidzein and glycitein (Setchell et al.,
2002). The aglycones can be absorbed into the portal vein or undergone further
transformation to different metabolites. For example, daidzein can be metabolised to
dihydrodaidzein, O-desmethylangolensin and equol; genistein can be metabolised to
dihydrogenistein and 6’-hydroxy-O-desmethylangolensin (Heinonen et al., 2003); glycitein
can

be

metabolised

to

dihydroglycitein,

dihydro-6,7,4’-trihydroxyisoflavone

and

5’-O-methyl-O-desmethylangolensin (Simons, Renouf, Hendrich, & Murphy, 2005)
8-hydroxyl-glycitein and 6-hydroxyl-daidzein (Rüfer, Maul, Donauer, Fabian, & Kulling,
2007) (Figure 4). The methylated precursors, formononetin and biochanin A can be
metabolised to daidzein and genistein, respectively (Reinli & Block, 1996).

2.4 Biological activities of lignan metabolites
END and ENL possess biological functions and weak estrogenic properties like other
8

phytoestrogenic compounds (Figure 2c). It has been postulated that high production of these
metabolites results from a high dietary exposure and provides subsequent protection against
hormonal-dependent cancers, particularly breast and prostate cancer (Adlercreutz, 2007;
Wang, 2002).

Structural differences amongst phytoestrogen compounds exhibit different

selective binding affinity for variants of the estrogen receptor (ER). While certain
phytoestrogens, like the soy isoflavonoids, genistein and coumestrol, have a higher binding
affinity for ER beta (β) than ER alpha (α), ENL preferentially binds to ER (α) (Kuiper et al.,
1997; Mueller, Simon, Chae, Metzler, & Korach, 2004).

This implies that selective binding

affinity may be an attribute that enables phytoestrogenic compounds, particularly END and
ENL, to have biphasic estrogenic or antiestrogenic characteristics, that is, the phytoestrogens
exhibit estrogenic activity at low concentration (0.1-10µM) but antiestrogenic at high
concentration (>10µM) (Wang & Kurzer, 1997). The biphasic effect allows END and ENL to
potentially regulate biological functions that are related to health. Upon binding to the ER,
END and ENL might modulate ER protein metabolism and influence hormonal status of
tissues, modify gene expression and the activity of enzymes. For instance, Adlercreutz et al.
(1993) showed that ENL at high concentration can inhibit aromatase, which could reduce
concentration of circulating estrogen; Chen et al. (2009) demonstrated that ENL inhibits
cyclin D1 expression, which is responsible for proliferation and migration of prostate cancer
cells. In addition to the discussed activities, END and ENL possess antioxidant activities as
described by Hu, Yuan, and Kitts (2007), which could protect cells against DNA damage and
lipid peroxidation.
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Figure 2. Chemical structures of a) mammalian estrogen, oestradiol; b) plant lignan precursors; and c) lignan metabolites and
enterolignans.
(Images adapted and modified from Landete (2012) Hydroxyl groups and the diphenolic ring are structural features required for binding to the estrogen receptor.
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Figure 3. Metabolism of plant lignans and their metabolites.
(Adapted and modified from Cassidy et al. (2000); Duncan et al. (2003); Heinonen et al. (2001);
Landete (2012); Mostrom and Evans (2011); Wang (2002))

Inactive plant lignans, or glycone, are obtained through the diet and are deglycosylated by
intestinal bacterial enzymes to the active form or aglycone. Aglycone plant lignans can be
readily absorbed but the majority are further metabolised into lignan metabolites, which are
absorbed into bloodstream. Lignan metabolites circulate through the body and are secreted
into body fluids or enter enterohepatic recirculation. They are finally excreted in urine.
11

Figure 4. Metabolism of isoflavonoids.
(Adapted and modified from Cassidy et al. (2000); Duncan et al. (2003); Mostrom and Evans (2011)

Isoflavonoids and lignans share similar metabolic pathways. Isoflavonoids in the glycone
form, are obtained through diet and are deglycosylated by intestinal bacterial enzymes to the
active form or aglycone. The aglycones can be readily absorbed or further transformed into
metabolites, which are absorbed into bloodstream. Metabolites circulate through the body and
are secreted into body fluids or undergo enterohepatic recirculation, and finally excreted in
urine
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2.5 Epidemiological studies of lignans and isoflavones and risk of chronic diseases
Lignans and isoflavones are recognised as natural bioactive compounds with a spectrum of
biological activities that could potentially influence progression of chronic diseases (Cunha, e
Silva, Veneziani, Ambrosio, & Bastos, 2012; Vitale, Piazza, Melilli, Drago, & Salomone,
2013). Interest in lignans and isoflavones has been fueled by epidemiological research
investigating

the

association

between

lignans

and

chronic

diseases;

particularly

hormone-dependent cancers due to structural features of phytoestrogens being able to the bind
to the estrogen receptor (ER) to elicit estrogenic activity (Turner et al., 2007)
Epidemiological evidence for the effect of lignans and isoflavones on chronic diseases is
briefly presented in this section of the literature.

Breast cancer
A case-control study conducted by McCann et al. (2004) examining lignan intake and breast
cancer risk in pre- and post-menopausal women concluded that there was a significant 34%
reduction of breast cancer risk in premenopausal women (OR: 0.66 95% CI 0.44 – 0.98) with
the highest quartile intake of lignans of at least 673μg/d. Further, higher lignan intakes were
found associated with improved survival among postmenopausal women with breast cancer
(HR: 0.29, 95%CI 0.11-0.76) (McCann et al., 2010). However one limitation of these studies
was that the results were not controlled for dietary confounding variables, for example, diets
high in lignans and isoflavonoids are also high in other food components that have been
investigated for potential disease prevention benefits.

In a meta-analysis on epidemiological

studies of lignans in relation to breast cancer risk, Buck, Zaineddin, Vrieling, Linseisen, and
Chang-Claude (2010) found high lignan exposure was associated with a reduced risk of breast
cancer in postmenopausal women (pooled RE:0.86, 0.77-0.94). These studies suggest that the
protective effect may be more prominent in women with post-menopausal status, with
reduction of estrogen production by the ovaries.
Isoflavone intake was inversely associated with risk of breast cancer for Japanese Brazilians
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(OR: 0.25, 0.09-0.68), p<0.01) and non-Japanese Brazilians (OR: 0.56, 0.35-0.90) but these
effects were not significantly associated with menopausal status (Iwasaki et al., 2009). In
contrast, a study conducted by Morimoto, Maskarinec, et al. (2014) observed no significant
associations between isoflavone intake and overall breast cancer risk in a multiethnic cohort
(HR: 0.96, 0.85-1.08, p=0.40) although a trend of decreasing risk was observed with
increasing intake in Latina, African American and Japanese American women. Similarly in
Canadian women no associations were found between isoflavone intake and breast cancer risk
among all women (OR: 1.06, 0.87-2.30), pre- (OR: 0.96, 0.69-1.33) or post- menopausal (OR:
1.09, 0.83-1.41) women (Cotterchio, Boucher, Kreiger, Mills, & Thompson, 2008). In a
meta-analysis by Chen et al. (2014) isoflavone intake had a protective effect on both pre- (OR:
0.59, 0.48-0.69) and post- (OR: 0.59, 0.44-0.74) menopausal women in Asian countries but a
marginal protective effect in Western countries (OR: 0.92, 0.83-1.00). These studies suggest
that the protective effect of isoflavone intake does not differ by menopausal status. Living
environment, location or a background diet traditionally high in soy intakes was a more
important potential influence in the relationship between isoflavone intake and breast cancer
risk, with the protective effect observed in Asian but not in Western women. Notably, these
studies did not report intake of lignans, which are found broadly in plant-based foods, and in
Western cultures could provide a more important source of phytoestrogens than isoflavones,
which are mainly derived from soy and soy products.

Prostate cancer
A case-control study conducted by Heald, Ritchie, Bolton-Smith, Morton, and Alexander
(2007) investigated serum phytoestrogens and risk of prostate cancer in a group of 916
Scottish men, and found a significant reduction of prostate cancer risk with increased level of
serum ENL >28.9 nmol/l (OR: 0.40, 0.22-0.71), and with soy food consumption (OR: 0.52,
0.30-0.91), but not with serum daidzein, genistein and equol. However, conflicting evidence
was observed in other case-control studies with no significant associations between risk of
prostate cancer and circulating serum enterolactone (Kilkkinen et al., 2003; Stattin et al., 2002;
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Ward et al., 2008), isoflavone intake (Hedelin, Klint, Chang, Bellocco, Johansson, Andersson,
Heinonen, Adlercreutz, Adami, Grönberg, et al., 2006), or urinary isoflavonoids (Jackson,
McFarlane-anderson, Simon, Bennett, & Walker, 2010); or an increased risk of prostate
cancer associated with higher concentrations of urinary enterolactone (OR: 1.85, 1.01-3.44)
and intake of phytoestrogens (OR: 1.41, 1.12-1.76) (Jackson et al., 2010; Ward & Kuhnle,
2010).

Other cancers and chronic diseases
The associations between lignans and isoflavones and other cancers and chronic diseases have
also being investigated. Lignan and isoflavone intakes have been associated with decreased
risks of adenocarcinoma of the oesophagus and gastroesophageal junction in Swedish women
(Lin, Yngve, Lagergren, & Lu, 2012), endometrial and ovarian cancer in American and
Australian women (Horn-Ross, John, Canchola, Stewart, & Lee, 2003; Neill et al., 2014),
lung cancer (Schabath, Hernandez, Wu, Pillow, & Spitz, 2005) and oesophageal cancer in
Chinese subjects (Tang et al., 2014).
A cross-sectional study conducted by Franco et al. (2005) investigated lignan intake and
cognitive function in postmenopausal women and found that high intakes were associated
with intact cognitive function in the older postmenopausal women. Another cross-sectional
study exploring the phytoestrogen intake and cardiovascular disease risks conducted by Van
der Schouw et al. (2005) concluded that the risk of coronary heart disease was lower with
increasing lignan and isoflavone intake in Western women, particularly in current or past
smokers. In contrast Talaei, Koh, van Dam, Yuan, and Pan (2014) found that intake of soy and
isoflavones were not associated with the risk of cardiovascular disease mortality in Chinese
Singaporean adults.
The studies presented in this section demonstrate epidemiological evidence to support an
inverse association between lignan and/or isoflavones, and risk of chronic diseases, although
some studies have found conflicting results. There were no systematic reviews or
meta-analyses found on epidemiological studies on prostate and other cancers or chronic
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diseases in relation to phytoestrogen intake. The potential health benefits and high prevalence
of lignans in Western diets cannot be ignored and to our knowledge there are limited
epidemiological studies in the Australian population. This highlights the need to develop a
dietary assessment tool specifically to quantify intake of lignans and isoflavones in Australian
context.
2.6 Food frequency questionnaire
The food frequency questionnaire (FFQ) is a dietary assessment tool used to assess habitual
dietary intake by determining the frequency of consumption of a list of foods that are dietary
contributors to that particular nutrient or dietary component, over a specified period of weeks,
months or years (Willett, 1998).

There are usually three components of a FFQ, a food list, a

frequency, and a portion size response section, where the responders indicate how often and
how much of each food is consumed.
The FFQ is a common method used in epidemiological studies with large population size
because it can be self-administered, thus allowing the investigators to collect a substantial
amount of dietary data in a relatively inexpensive manner.

In addition, FFQs allow

investigators to identify food patterns associated with certain nutrient intakes, to rank
individuals by quantile of food or nutrient intakes and to examine the intake in relation to risk
of chronic diseases (Bingham, 2007; Willett & Lenart, 1998).

The ability of the FFQ to

correctly reflect the intake of the population is determined by the discrimination between the
variation in dietary patterns in different groups (Willett, 1998). Therefore, identifying dietary
patterns and inclusion of commonly consumed food sources in the study population is
fundamental to the design of a FFQ to successfully capture the dietary component from the
appropriate food sources.
There are seven approaches used to evaluate a FFQ, as stated by Willett and Lenart (1998): (1)
comparison of means, (2) proportion of total intake accounted for by foods included on the
questionnaire, (3) reproducibility, (4) validity, (5) comparison with biochemical markers, (6)
correlation with a physiological response and (7) the ability to predict disease. Of these, the
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common methods used in validation studies of phytoestrogen FFQs in this literature review
were the comparison of means or medians, and comparison of biochemical markers (Bhakta
et al., 2005; French, Thompson, & Hawker, 2007; Hanna et al., 2005; Heald, Bolton-Smith,
Ritchie, Morton, & Alexander, 2005; Horn-Ross et al., 2006; Huang et al., 2000; Lin, Wolk, et
al., 2012; Tseng et al., 2008; Yamamoto, Sobue, Sasaki, Kobayashi, & et al., 2001),
convergent validity in comparison with an independent reference method (Bhakta et al., 2005;
Chan et al., 2008; Fernandez, Omar, & Husain, 2013; Hanna et al., 2005; Horn-Ross et al.,
2006; Huang et al., 2000; Yamamoto et al., 2001), and reproducibility with the FFQ in
repeated measures (Frankenfeld et al., 2003; Frankenfeld et al., 2002; French et al., 2007;
Hanna et al., 2005; Horn-Ross et al., 2006). Four of the above approaches were implemented
in this study to evaluate a specific FFQ in the Australian context; and the other three
approaches in relation to measurement of total intake, physiological response and disease risk
were not utilised, as they were not relevant for the current research.

2.7 Evaluation of food frequency questionnaires
2.7.1 Validity
2.7.1.1 Weighed food record – convergent validity
Food records are records of weighed or estimated amounts of food and beverages at the time
of consumption for a specified number of days (Bingham, 2007). Multiple food records are
often conducted to consider the daily variation in intake of individual subjects.

Three to ten

days of food records, with weekend days included, are usually required to represent individual
usual intake of energy and macronutrients (Buzzard, 1998; Lee & Nieman, 2010).
Choosing an appropriate reference method is important for assessing the convergent validity
of the FFQ, to compare the newly established instrument with other related instruments and
verify that it measures the same construct (Thorkildsen, 2010). Since there is no perfect
reference method in validation studies, the associated errors of the FFQ and the reference
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method should be as independent and uncorrelated as possible (Nelson, 1997; Willett &
Lenart, 1998). The FFQ and the diet history interview are both retrospective dietary tools and
therefore share similar sources of errors that may lead to the underestimation of the
correlation between the two methods (Willett and Lenart 1998). The ‘ideal’ reference method
for validating a FFQ is a food record because the sources of errors of food records are
reasonably uncorrelated to those of the FFQ (Willett & Lenart, 1998).

The bias related to

these errors impacts on the accuracy, completeness and representativeness of the dietary data
collected, and therefore on the validity assessment of the two dietary tools. Since the bias
associated with these sources of error cannot be eliminated, a good reference method should
ideally share different sources of error. Therefore, the proposed reference method for
validating the phytoestrogen FFQ in the current study was a weighed food record (WFR).
Food scales and household measuring tools were provided to assist in portion size estimation
to ensure accuracy and consistency of the dietary data obtained.
Subjects may subconsciously modify their usual food intake for ease of recording a food
record, which will lead to inaccurate assessment, potentially undermining a correlation
between the intake derived from the FFQ and the food record (Lee & Nieman, 2010; Willett
& Lenart, 1998). Other sources of error are attributed to the food composition data used to
measure the nutrient intakes (Willett & Lenart, 1998). Both FFQ and food record methods
could under- or over-estimate the intake due to the natural variability of the dietary
components in food, for instance, phytoestrogen content in plant foods can vary because of
genetics, growth and environmental factors, and effects of harvesting and processing (Kuhnle,
Dell'Aquila, Runswick, & Bingham, 2009; Lyons-Wall, 2007). Due to the natural variability
of phytoestrogen content in foods and incompleteness of databases, especially for lignan
intake, it is challenging to measure the exact ‘true’ dietary intake, even with a valid and
reliable dietary assessment tool. For the current study, lignan and isoflavonoid intakes were
estimated from the content currently available from published international databases.
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2.7.1.2 Urinary biomarkers – the criterion validity
Willett and Lenart (1998) stated that biochemical indices could be an informative and
objective comparison method when there is uncertainty regarding the estimated intakes and
validity between the questionnaire and a reference dietary assessment method. The associated
errors of biomedical indices are likely to be independent to those of the two dietary
assessment methods, and are mainly attributed to subject variation in absorption and
metabolism of the nutrients, and external errors related to laboratory measurement and
bioavailability of the nutrient or constituent from food (Willett & Lenart, 1998).
Biological markers or biomarkers, in blood and urine are collected as a criterion to compare
with the estimated intake derived from the dietary tool in validation and epidemiological
studies (Borneman, 2010; Hunter, 1998). The biomarker must be sensitive to intake of the
nutrient (Willett & Lenart, 1998). The time interval of biomarker collection is dependent on
the pharmacokinetics of the target nutrient, the subjects’ variability of the nutrient intake, and
the research design (Bates, Thurnham, Bingham, Margetts, & Nelson, 1997; Kelemen, 2007;
Samet & Alberg, 1998).

2.7.1.3 Strengths and limitations of the food frequency questionnaire, food record and
urinary biomarker tools
The strengths and limitations of the food frequency questionnaire, food record and biomarker
tools are summarised in Table 1. The sources of errors of a FFQ, WFR and urinary
biomarkers are relatively unrelated to each other.

For example, completion of a FFQ relies

on the subject’s memory to recall the correct food consumption and frequency of intake,
whereas when completing a food record, the process of recording is open-ended and does not
depend on the subject’s memory because details about the food and drinks are recorded at the
time of consumption. In addition, a food record does not restrict subject’s choice on a fixed
list of foods from a FFQ.
However, given that details about the subject’s dietary intake are required to complete food
records, the subject burden is relatively high and literacy and numeracy are required to
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understand the process to accurately complete food records. Biomarkers can reflect true status
assessed by the diet assessment method; nevertheless biomarkers are prone to be affected by
systematic errors related to work in laboratory measurement.
For the current study the modified FFQ was administered for the previous month to capture
usual intake over a feasible retrospective time period. The weighed food record was
administered over a relatively short period of 3 days, to minimise the subject burden, and
included 2 weekdays and 1 weekend day to optimise the chance of capturing usual intake.
Data for urinary biomarkers were collected over a 3-day period to coincide with the intake
from the food record and provide an estimate of usual excretion. Laboratory measurements of
urinary biomarkers were based on standardised methods from the published literature.
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Table 1. Limitations (sources of errors) and strengths of food frequency questionnaire (FFQ), weighed food record (WFR), and biomarker
(Buzzard, 1998; Hunter, 1998; Willett, 1998; Willett & Lenart, 1998)

FFQ

WFR

Biomarker

Limitation

Strength

Limitation

Strength

Limitation

Strength

Reliance on subjects’

Relative low

High subject’s numeracy and literacy requirement

Open-ended, do not depend

External

memory on food

subject’s burden

and burden to complete the recording - to record

on subjects’ memory or

subject variation in metabolism

time

consumed over the

compared to weighed

the weighed food consumptions and details like

restrict subject’s choice on a

of the nutrient, bioavailability

nutrient intake during the period

period of time

record

specific types/brands, amount, preparation

fixed list of foods

of nutrient from food

evaluated by the diet assessment

sources

of

errors:

method, ingredients used in recipe and dishes
Restrictions imposed

Potential to reflect

by a fixed list of

long-term habitual

foods

intake

Systematic

Poor response rate* resulted from low subject

size by measuring the weight

with laboratory and analytical,

motivation

and size of the food and

techniques, contamination and

drinks consumed

stability of biomarker

errors

associated

Interpretation of the

Can be

Day-to-day dietary variation, require multiple days

questions and

self-administered or

of intake to account the variability of the subject’s

More detailed dietary

Stress or inconvenience brought

perception of serve

completed with

intake.

information can be recorded

to subjects when collecting

sizes

assistance of trained

and more accurate dietary

samples for the biomarkers

personnel

analysis and assessment
Error associated with the measuring and recording

choosing the

process which leads to change in eating behaviour

correct/appropriate

– the food record may not be representative of

category of

what subject normally eat (change in eating

frequency of the

behavior)

integrated

to

reflect

methods being tested
Direct assessment of portion

Difficulty in

Reflect true intake when it is

Specific and sensitive to the
intake of the nutrient

food is consumed
*Cole (1997) stated that “In nutritional studies involving the measurement of food intake over several days, the degree of non-response can be 30% or more” (p.67). A study conducted by Kolar et al. (2005) indicated
that the response rate of a self-administrated 3-day food record is 68% (32% non-response rate) in one hundred 50-76 years men and women. Another study conducted by Dietrich et al. (2003) showed that the response
rate of a 24-hour food record, which was designed to measure fruit and vegetable intake of primary school children, is 76% (24% non-response rate).
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2.7.1.4 Method of Triads
The Method of Triads is a statistical model for a triangular comparison developed by Kaaks
(1997) to assess the interrelationship between the dietary questionnaire or test method (Q), a
detailed dietary assessment or reference method (R) and biochemical measurements or
biomarkers (M) to the ‘true’ (T) intake of nutrients. The assumptions for this method to be
valid are that the errors associated with the questionnaire, reference method and biomarker
measurements are uncorrelated or independent, and the measurements Q, R and M are
linearly related to the ‘true’ intake (T) (Kaaks, 1997; Willett & Lenart, 1998; Yokota,
Miyazaki, & Ito, 2010). Ocké and Kaaks (1997) described this method as an approach to
assess the agreement between the questionnaire (Q), reference method (R) and biomarker (M)
measurements in relation to a nutrient status. Validity coefficients (VC) are calculated for the
correlation between the measurement intakes of the methods and the hypothetical ‘true’ intake
status. The VC is readily influenced by the strength of the correlation coefficient (r) because
the VC is mathematically derived from the associations between the two individual
assessment methods. The theoretically acceptable range of VC is between 0 and 1, although
VC exceeding 1 is acceptable if the assumptions were not violated. A VC exceeding 1 is
called Heywood case.
Several validation studies have applied the method of triads to assess three or more
measurement methods for different nutrients (Andersen et al., 2005; Bhakta et al., 2005;
Daures et al., 2000; Kabagambe et al., 2001; McNaughton, Marks, Gaffney, Williams, &
Green, 2004; Ocké & Kaaks, 1997; Shai et al., 2005; Tan, Charlton, Tan, Ma, & Batterham,
2013). Studies conducted by Kabagambe et al. (2001), Daures et al. (2000), Shai et al. (2005)
and Andersen et al. (2005) assessed more than three measurement methods. The four other
studies by Ocké and Kaaks (1997), McNaughton et al. (2004) and Bhakta et al. (2005) Tan et
al. (2013) assessed two dietary and one biochemical assessment method. Bhakta et al. (2005)
was the first and only study to apply the method of triads to evaluate phytoestrogen status,
using a specific FFQ, 24-hour recalls and plasma phytoestrogens.
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2.7.2 Reliability
The reliability of the FFQ is the consistency of the measurement of the tool for the same
subject at different occasions of administration (Cade, Burley, Warm, Thompson, & Margetts,
2004; Willett & Lenart, 1998). The reliability assessment is often a component of the
evaluation of FFQ in validation studies (Cade, Thompson, Burley, & Warm, 2002; Willett &
Lenart, 1998). Correlation coefficients are frequently used in assessing the reliability of the
FFQ (Cade et al., 2002). Acceptable correlation coefficients commonly range from 0.5 to 0.7
and the correlation tends to be higher for administration of the FFQ with shorter periods of
time, one month or less apart, when compared to longer periods, six months to one year apart,
due to possible recall bias with shorter timeframe, or time or seasonal change in food intake
with longer time periods (Cade et al., 2004; Cade et al., 2002; McLennan & Podger, 1995).
Although correlation coefficients can be used to assess the validity and reliability of the FFQ,
the Bland-Altman plot is a more robust method to assess the level of agreement between the
intake estimated with two assessment methods or with the same method at different occasions
(Altman & Bland, 1983; Bland & Altman, 1986). The plot is constructed by plotting the
differences in intake against the mean intakes derived from the two points of measure. In the
current study, reliability of the FFQ was tested by administering a repeat FFQ after a short
period of time, 1 to 2 weeks, to minimise the possibility of seasonal changes in food intake.

2.8 Validation studies on phytoestrogen food frequency questionnaires
Of previous studies that have evaluated phytoestrogen food frequency questionnaires, ten
studies measured isoflavones only, one study measured lignans only, and four studies
measured both isoflavones and lignans (Table 2). This section addresses the research,
published in 2000 and onwards, in the evaluation of these food frequency questionnaires in
relation to convergent and/or criterion validity.
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Convergent validity
Studies conducted by Bhakta et al. (2005) and Horn-Ross et al. (2006) assessed convergent
validity of the phytoestrogen FFQ and demonstrated that their FFQs were moderately to
highly correlated to the reference methods, with correlation coefficients ranging from r=0.50
to 0.79. For Bhakta et al. (2005); the correlations were significant for both lignans (r=0.70,
p<0.001) and isoflavones (r=0.57, p<0.001), with higher correlations observed for lignans
suggesting that the FFQ was valid for phytoestrogen intake, particularly lignans, when
compared to the reference method.

Criterion validity
Criterion validity of the phytoestrogen FFQs was assessed in five studies, with Hanna et al.
(2005), Horn-Ross et al. (2006) and French et al. (2007) using urinary phytoestrogen
excretion, Bhakta et al. (2005) using plasma phytoestrogen levels, and Lin, Wolk, et al. (2012)
using serum ENL levels. The associations between intake from the FFQ and excretion for
lignans were weaker than those for isoflavones for Hanna et al. (2005) (lignans: r=0.138,
p>0.05; isoflavones: r=0.207, p<0.05), and French et al. (2007) (lignans: r=0.46, p=0.02;
isoflavones: r=0.64, p<0.001). Further comparison between lignan and isoflavone intakes and
urinary excretion conducted by Horn-Ross et al. (2006) suggested that the both 24h dietary
records (DR) and FFQ had a stronger correlation with measurement of urinary isoflavones
(ρ=0.43-0.50) than lignans (ρ=0.16-0.21). Similar findings were observed by Bhakta et al.
(2005) who compared intake from a FFQ with 24h dietary records (DRs), and with plasma
concentrations, and found stronger correlations for isoflavones (r=0.21-0.43) than lignans
(r=0.08-0.10). The study conducted by Lin, Wolk, et al. (2012) compared lignan intake from
two different FFQs with serum ENL levels; tLin, Wolk, et al. (2012)Lin, Wolk, et al.
(2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al.
(2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. (2012)hey found that the FFQ-97, with
open-ended responses allowed more dietary information to be recorded in addition to the
closed-ended frequency category response, was significantly correlated with serum ENL
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levels (ρ=0.22, p=0.01) and concluded that FFQ-97 was a better tool for assessing lignan
intake.
Notably, two studies have estimated phytoestrogen intake in Australian populations (Hanna et
al., 2005; Lahmann et al., 2012). In one study, the FFQ was valid for measurement of
isoflavonoids when tested against urinary biomarker excretion but had poor validity for
measurement of lignans, possibly due to the inability of the FFQ to capture the range of food
items consumed in varied diets; or due to use of an indirect method for estimating the lignan
content in food items, which may not have accurately estimated intake (Hanna et al., 2005).
The second study used a FFQ that was validated for energy and nutrient intake but not
specifically for phytoestrogens (Lahmann et al., 2012).

This section informs the key results and study design from earlier research in the evaluation
of the current FFQ for measuring phytoestrogen intake. While all studies provided
comparisons of average intakes and correlations between tools at the group level, three studies
further conducted Bland-Altman analyses to evaluate agreement at the individual level (Chan
et al., 2008; Fernandez et al., 2013; Frankenfeld et al., 2003).

Five studies conducted

cross-classification analyses for level of agreement by calculating the percentage of subjects
categorised into the same and opposite quantiles of isoflavone intake and biomarker
concentration (Bhakta et al., 2005; Chan et al., 2008; Fernandez et al., 2013; French et al.,
2007; Heald et al., 2005). Bhakta et al. (2005) additionally used the Method of Triads to
evaluate the FFQ for phytoestrogen intake in a triangular comparison of the measurements
from an FFQ, 24hDRs, and plasma phytoestrogens. These statistical analyses were employed
to evaluate the modified FFQ in the current research. Open-ended questions were also
incorporated into the modified FFQ in addition to the closed frequency questions, to elicit any
further information on subjects’ food intake.

Estimation of lignans
Earlier studies only measured two lignans, SECO and MAT, as more recently quantified
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lignan precursors, LARI and PINO, were not available at the time. Lin, Wolk, et al. (2012)
estimated intakes of LARI, PINO, MED and SYR in addition to SECO and MAT. For the
current research, four primary lignan precursors, SECO, MAT, LARI and PINO were
measured, as they are present in a wide range of food sources commonly consumed in the
Australian population.

From the validation studies conducted to evaluate isoflavone intake,

two to eight isoflavone-rich food items listed in the FFQ were reported to be sufficient to
capture variability in intake (Frankenfeld et al., 2003; Frankenfeld et al., 2002; Tseng et al.,
2008; Verkasalo et al., 2001). As lignans are present in a wider range of food sources than
isoflavones, the FFQ for the current research was modified to focus on enhancing lignan
measurement by including a range of food sources for which lignan content were available.
Subjects from the majority of validation studies were females, but male subjects and subjects
of both gender were recruited by Heald et al. (2005) and Frankenfeld et al. (2002). Lignans
are found ubiquitously in Western and non-Western dietary patterns and lignans are
considered to be nutritionally important to the Australian community with diverse
demographic backgrounds. Therefore both male and female subjects from various cultural
backgrounds were recruited for the current research to reflect the diversity in dietary intake.

Verkasalo et al. (2001) recognised the importance of the timing of biomarker collection with
respect to the administration of the dietary assessment tool, hence understanding the
pharmacokinetics of phytoestrogens is essential for the study design. Huang et al. (2000) and
Tseng et al. (2008) collected the first morning/overnight sample separately from the rest of the
24-hour sample and found that phytoestrogen concentrations in the first morning or overnight
urine were highly correlated to concentrations in the 24-hour sample.

In the current study,

three consecutive 24 hour urine samples including one weekend and two weekdays, were
collected in an attempt to capture usual intake of lignans and isoflavonoids for comparison
with usual intake from the modified FFQ.
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2.9 Phytoestrogen databases
Much of the pioneering work on direct analysis of lignans in foods has been done by Mazur
and colleagues (Adlercreutz & Mazur, 1997; Mazur, 1998b; Mazur & Adlercreutz, 2000;
Mazur & Adlercreutz, 1998; Mazur, Duke, Wähälä, Rasku, & Adlercreutz, 1998; Mazur et al.,
1996; Mazur, Uehara, Wähälä, & Adlercreutz, 2000; Mazur et al., 1999; Mazur, Wähälä,
Rasku, et al., 1998; Mazur, Wähälä, Wang, & Adlercreutz, 1998; Nilsson et al., 1997a, 1997b;
Nurmi et al., 2003). In these studies, SECO and MAT were the only two lignans analysed. In
the past decade, other researchers have discovered additional lignan precursors that are major
determinants of dietary lignan intake and metabolism, including LARI, PINO, SYR and MED
(Bonzanini, Bruni, Palla, Serlataite, & Caligiani, 2009; Durazzo, Zaccaria, Polito, Maiani, &
Carcea, 2013; Milder, Arts, Putte, Venema, & Hollman, 2005; Moreno-Franco et al., 2011;
Peñalvo, Adlercreutz, Uehara, Ristimaki, & Watanabe, 2008; Smeds et al., 2007; Smeds,
Jauhiainen, Tuomola, & Peltonen-Sainio, 2009; Thompson, Boucher, Cotterchio, Kreiger, &
Liu, 2007; Thompson, Boucher, Liu, Cotterchio, & Kreiger, 2006). SYR and MED have been
analysed in cereals, such as rye, wheat, and in seeds like sesame seeds but have not yet been
comprehensively quantified in other foods (Peñalvo et al., 2005; Smeds et al., 2007).

The prominent isoflavones in foods are daidzein, genistein and glycitein, however, the latter
contributes only approximately 10% to the total isoflavones in soy (Rüfer et al., 2007; Simons
et al., 2005). The U.S. Department of Agriculture has compiled a comprehensive database for
isoflavone content in 557 foods from various articles containing analytical data for the two
major isoflavones, daidzein and genistein, and their methylated precursors formononetin and
biochanin A, and also glycitein (Bhagwat, Haytowitz, & Holden, 2008).

Lignans are present in a wide range of plant-based foods, including breads and cereals,
vegetables, nuts, seeds and legumes, fruits, and beverages like tea, coffee and wine (Mazur,
1998b; Mazur & Adlercreutz, 1998; Mazur, Duke, et al., 1998; Mazur, Wähälä, Rasku, et al.,
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1998; Milder, Arts, et al., 2005; Moreno-Franco et al., 2011; Nurmi et al., 2003; Peñalvo et al.,
2008; Thompson et al., 2006).

Oil seeds and nuts contain high amounts of lignans, with

linseed (or flaxseed) being the richest source with approximately 3.4 mg/g (Horn-Ross et al.,
2000; Meagher & Beecher, 2000; Pillow et al., 1999; Smeds et al., 2007; Thompson et al.,
2006).

Small but significant concentrations of lignan metabolites, especially ENL, have

been detected in dairy products like cheese, milk and yoghurt (Antignac, Cariou, Le Bizec, &
Andre, 2004; Kuhnle et al., 2008b).

There are negligible quantities of lignan metabolites in

meat and seafood (Kuhnle et al., 2008b).

Isoflavones are concentrated in soybeans, with approximately 2-4 mg isoflavones/g, and
foods derived from soy, such as soymilk beverages, and foods fortified with and/or containing
soy as an ingredient (Adlercreutz & Mazur, 1997; Bhagwat et al., 2008; Mazur, 1998b).
Moderate amounts are present in other legumes such as beans and peas (0.03-0.08mg
isoflavones/g), and small amounts in bread (0.02-0.03mg/g) and other food sources (<0.01mg
isoflavones/g) namely fruits and vegetables, nuts and seeds, beverages, meat and dairy
(Bhagwat et al., 2008; Kuhnle, Dell'Aquila, Aspinall, Runswick, Joosen, et al., 2009; Kuhnle
et al., 2008a, 2008b; Kuhnle, Dell'Aquila, Aspinall, Runswick, Mulligan, et al., 2009; Mazur,
Duke, et al., 1998; Mazur, Wähälä, Rasku, et al., 1998).

As no culturally-specific database is available for Australian foods, data on the lignan and
isoflavone content of foods was sourced from published international values. Examining
different lignan databases provided information on the range of lignan content from different
food sources. This assisted in selecting appropriate food items to be included in the food list
to ensure the design of the FFQ to be relevant to the target population. Foods rich in lignans,
for example, linseed and related food items, soy and linseed bread were included. A range of
commonly consumed items in Australia with moderate lignan content, including vegetables,
fruits, nuts, seeds and legumes, grains and cereals, and beverages like tea, coffee and wine,
and soy and related food products were also included.
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2.10 Cross-sectional studies on phytoestrogen intake and food sources

Intake of phytoestrogens and contributing food sources
Previous studies have quantified intake of dietary phytoestrogens in different populations
from various countries and regions with 24 cross-sectional studies conducted from 2005 to
2014. Five studies have estimated intakes of lignans, isoflavones and enterolignans; five
estimated lignans and isoflavones; two estimated lignans and enterolignans; six studies have
estimated only lignans and six studies estimated only isoflavones. The intakes and
contributing food sources varied across different studies due to a number of factors such as
dietary diversity and demographic differences in the population, and different phytoestrogen
databases and dietary tools for assessment of intake (Table 3).

Dietary lignan intake varies with different dietary patterns. For instance, Milder, Feskens, et al.
(2005) found that beverages like tea, coffee and wine, Brassica vegetables like cabbage, nuts
and seeds, wheat bread and fruits were major lignan-contributing foods in the Dutch
population, whereas in the Finnish population, the main contributors were rye products,
berries, coffee, tea and whole grains (Nurmi, Mursu, Peñalvo, Poulsen, & Voutilainen, 2010).
Similarly in Latvia, rye and seed bread, nuts and seeds and coffee and tea beverages were
major contributing foods for lignans (Meija et al., 2013). Despite differences in dietary
patterns, the average lignan intakes were comparable in the three studies, between 1.22 mg/d
and 1.26 mg/d.

Differences in phytoestrogen intakes and food sources were reflected in regional dietary
preference in The EPIC cohort study (Zamora-Ros, Knaze, et al., 2012; Zamora-Ros, Not, et
al., 2012). Major food sources of lignans were fruits, vegetables and alcoholic beverages such
as wine in Mediterranean (MED) countries, Greece, Spain, Italy and South of France; and
non-alcoholic beverages like tea and coffee, vegetables, cereals in Non-Mediterranean
(non-MED) countries, North-East and North-West of France, Germany, the Netherlands,
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Denmark, Sweden and Norway, and U.K.. Major food sources of isoflavones were soy
products, legumes and vegetables in MED countries and soy products, and non-alcoholic
beverages such as soy beverages in non-MED countries. Dairy products contributed more
than 90% of enterolignan intake in both MED and non-MED countries. Population groups of
different ethnic backgrounds and dietary habits had different intake levels and contributing
food sources of phytoestrogens. In the EPIC study, the Health conscious group in U.K. had
the highest intake of lignans (2.15 mg/d) and isoflavones (12.1 mg/d) as the group was
characterised by higher consumption of fruit, vegetables, legumes, nuts and seeds, cereal and
soy products than other cohorts in the EPIC study (Zamora-Ros, Knaze, et al., 2012);
corresponding intakes from Greece were 1.04 mg/d for lignans and 0.24 mg/d for isoflavones.
Vegetables dishes, milk beverages and bread products were main food sources of
phytoestrogens in the soya-consuming groups and bread products, breakfast cereals, and tea
and coffee in the non soya-consuming groups from the EPIC-Norfolk cohort study (Mulligan
et al., 2013).

Chinese and Japanese American women had relatively high intake of isoflavones (9.71 mg/d
and 12.59 mg/d) compared to Caucasian and African American women (0.32 mg/d and 0.28
mg/d) although intakes of lignans were comparable (0.20 to 0.40 mg/d) (Huang et al., 2012).
Main food sources for lignans were coffee, black tea, Chinese herbs in soup or tea and green
tea amongst the multiethnic women. The main food sources for isoflavones were soymilk
beverages in Caucasian, African American and Chinese Americans but soybean and related
products for Japanese Americans. In contrast, Chinese living in China consumed vegetables
namely soybean sprouts, Chinese lettuce, tofu and taro as their main sources of isoflavones,
and carrot, Chinese lettuce, taro and white gourd as main sources for SECO (Hu et al., 2014).

The intake of lignans (0.14 mg/d, 0.18 mg/d) and isoflavones (0.32 mg/d, 0.37 mg/d) of South
Asian residents and native British residents, respectively, living in U.K. were similar but with
different contributing food sources (Bhakta et al., 2006). The South Asians had more
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vegetables and vegetable dishes (38%) for isoflavones than the native British, who had only
2% contribution from vegetables. Breads provided the main source of lignans in both groups.

2.11 Pharmacokinetics of lignans and isoflavones
Based on pharmacokinetic studies, enterolignans, END and ENL appeared in blood 7-10
hours after a lignan supplement from flaxseed, and daidzein and genistein appeared 2 hours
after an isoflavone supplement from soy meal, with the majority excreted in urine within 24
hours of the supplement (King & Bursill, 1998; Kuijsten, Arts, Vree, & Hollman, 2005;
Watanabe et al., 1998). The delay of appearance reflected the time required for the bacterial
conversion to metabolites in the colon prior to absorption. Plasma END reached its peak at 15
hours and ENL at 20 hours in Dutch subjects; daidzein and genistein reached at 6 hours in
Japanese subjects and at 7-8 hours in Australian subjects.

In some subjects, a second peak of

enterolignans, predominantly ENL, and genistein were observed in plasma. This peak could
be explained by the reabsorption via the gastrointestinal tract into bloodstream and
redistribution of enterolignans and isoflavones through the enterohepatic circulation. Both
enterolignans and isoflavones were continually excreted for the first two days before they
declined on the third day. In pharmacokinetic studies conducted in human subjects,
approximately 40% of enterolignans, 62% of daidzein and 22% of genistein in Australian
subjects (King & Bursill, 1998), and 36% daidzein and 18% genistein in Japanese subjects
(Watanabe et al., 1998) were accumulatively excreted through urine over the two to three days
after intake of the flaxseed or soy supplement.
A positive dose-dependent relationship has been established between supplement
consumption and urinary excretion in humans for both isoflavonoids (Morimoto, Beckford,
Franke, & Maskarinec, 2014) and lignans (Hutchins, Martini, Olson, Thomas, & Slavin,
2000); and similarly in animal models (King, Broadbent, & Head, 1996; Rickard et al., 1996).
Dietary lignan precursors, SECO, MAT and LARI have been detected in human urine as a
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result of incomplete metabolism to enterolignans by intestinal microbes (Adlercreutz et al.,
1995; Bannwart, Adlercreutz, Wähälä, Brunow, & Hase, 1989). Isoflavonoid metabolites,
glycitein, formononetin, biochanin A and equol have also been reported in urine (Hanna et al.,
2005).
These studies, demonstrate a positive dose-dependent relationship between intake and
excretion, and justify the choice of urinary excretion of isoflavonoid and lignan metabolites as
appropriate biomarkers of dietary intake for the current study. They further indicate that a
variable proportion, between 18% to 62% for different metabolites, is excreted in urine within
1 to 3 days after ingestion of precursors in the diet.
2.12 Phytoestrogen status and demographic, social and lifestyle characteristics
Epidemiological studies have shown that higher intakes of phytoestrogens and phytoestrogen
rich foods were associated with lower risks of breast and prostate cancers (Heald et al., 2007;
Iwasaki et al., 2009; McCann et al., 2004; McCann et al., 2010). Demographic, social and
lifestyle characteristics associated with the intake of phytoestrogen rich diets could contribute
to these health outcomes. Factors related to the demographic, social and lifestyle status, for
instance, age, gender, occupation, education, participation in physical activity and smoking,
influence food choices and could therefore impact the observed relationships between
phytoestrogen intake and risk of chronic diseases. This section is briefly presented with
results from correlation, regression and quantile analysis of population-based cross-sectional,
prospective cohort and case-control studies.
Milder et al. (2007) in a cross-sectional analysis of a Dutch population identified several
factors, namely age, weight, current smoking status and frequency of defecation (all p<0.001),
that explained 12.7% of the differences in plasma ENL, and age and use of antibiotics
explained 2.1% of the difference in plasma END. Kilkkinen et al. (2001) found that
constipation contributed to a 2.7% variance in serum ENL of Finnish men (R2=0.0268),
whereas BMI, smoking, age and constipation together contributed to a 14% variance in serum
ENL in Finnish women. Rybak, Sternberg, and Pfeiffer (2013) observed that smoking
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compared

to

non-smoking

was

associated

with

a

25%

reduction

in

urinary

O-desmethylangolensin (DMA) and ENL; a 25% increase in BMI was associated with a 21%
decrease in urinary ENL; and increasing physical activity was associated with a greater than
6% increase in urinary ENL. The relationship between urinary phytoestrogens and
socio-demographic and lifestyle variables was metabolite-specific, which further complicated
the situation.
Johnsen et al. (2004) in a case-control study, found that smoking, more frequent bowel
movements, and higher BMI were inversely correlated with concentrations of plasma ENL
(p<0.001), while in a prospective cohort study, significant determinants of urinary lignan and
isoflavone excretion for Chinese women were BMI, menopausal status, participation in
exercise, and vitamin supplement use (p<0.05)(Wu et al., 2012). Morisset et al. (2009) in a
cross-sectional analysis found that older Canadian women who consumed higher lignan
intake and had higher plasma ENL tended to have lower BMI and total body fat mass
(p<0.05). Older Australian women, who consumed soy and linseed, had higher levels of
physical activity level, socio-economic position and education, were more likely to use
supplements (all p<0.001) (Hanna et al., 2010). Using regression analysis, these determinants
were inversely associated with urinary phytoestrogen metabolites, which suggested that older
women with higher body weight and body fat composition may have lower dietary
phytoestrogen intake, or different metabolism and distribution in body tissues, compared to
women with the opposite characteristics.
Lampe (2003) and Lampe, Atkinson, and Hullar (2006) in a review of experimental studies in
human subjects, suggested that gender-specific physiological differences in phytoestrogen
absorption and metabolism i.e. gut transit time, and composition of intestinal microbiota may
have influenced the bioavailability of phytoestrogen and consequently the level of biomarkers,
i.e. women tend to have more phytoestrogen metabolite-producing bacterial communities than
men (Clavel et al., 2005).

The formation of lignan and isoflavone metabolites is facilitated

by intestinal microbiota, and use of antibiotics that disrupt the composition and balance of
intestinal microbiota have impacted on the bioavailability and metabolism of phytoestrogens.
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For example, Kilkkinen et al. (2002) found that subjects who had used antibiotics up to 12-16
months prior to serum sampling had significantly lower serum ENL concentrations.
Sutherland et al. (2012) found that the antimicrobial agent tetracycline inhibited the
daidzein-metabolising bacteria; thus less daidzein metabolites were produced.
In summary demographic, social and lifestyle variables, such as BMI, bowel movement,
smoking status, physical activity level, age and gender, supplement and antibiotics use are
important determinants in dietary phytoestrogen intake and consequently biomarker levels.
Information on these sociodemographic variables was obtained for the current study to
explore possibly associations with phytoestrogen status, and recent intake of antibiotics was
an exclusion criterion. In Australia, the population consists of different cultural and ethnic
groups (Australian Bureau of Statistics, 2014). This would enrich the cultural diversity as
different ethnic groups have distinctive dietary preferences. Therefore cultural background
and ethnicity was also explored in relation to phytoestrogen intake and metabolites in the
current research.
2.13 Concluding remarks
The literature review of the current thesis firstly covered the background knowledge of
phytoestrogen absorption and metabolism, and epidemiological health outcomes of
phytoestrogen consumption. Secondly it discussed the use of dietary tools and evaluation of
the dietary tool with a reference method and biomarkers. Thirdly, it reviewed recent research
conducted on validation and evaluation of FFQ to measure phytoestrogen, and pioneering and
recent work on analysing phytoestrogen content in foods and establishment of phytoestrogen
databases. Then it critically appraised studies that quantified intake of phytoestrogens and
identified contributing food sources in different populations from various countries and
background, with the use of different methodologies, dietary tools and phytoestrogen
databases. Lastly, it described the pharmacokinetics of phytoestrogen metabolism and the
influence of demographic, social and lifestyle factors associated with phytoestrogen status.
Much of the early research had focused on isoflavones, being one of the two main classes of
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phytoestrogen. More recent research work has focused on lignans because they are more
prevalent in dietary patterns followed by Western populations. Lignans and isoflavones being
structurally alike, their pathway of absorption and metabolism is similar. The metabolism of
phytoestrogens indicates that dietary precursors are actively converted to metabolites and
excreted in urine in a dose-dependent manner. Measurement of metabolites in urine therefore
provides a feasible method to assess phytoestrogen status and evaluate the validity of the
dietary assessment tool. A range of sociodemographic and lifestyle factors can influence this
association and therefore need to be considered.
Epidemiological research has demonstrated that phytoestrogens are positively associated with
reduced risk of hormone dependent cancers, although not all studies are supportive and more
evidence is required to draw conclusions regarding the relationship between phytoestrogens
and risk of chronic diseases.
Results from validation studies showed that the FFQs were not consistently valid or reliable
in measuring phytoestrogen intake, especially for lignans, possibly due to lack of specificity
of the FFQ for measuring the range of lignan sources in a varied diet; or limitations of
available databases for estimation of lignans. Most studies have been restricted to female
subjects, therefore, in the current research, subjects of both genders from diverse backgrounds
were recruited.
Previous cross-sectional studies have focused on phytoestrogen intake of populations from
Scandinavian, European, American and Asian countries, with isoflavones being the focus in
Asian countries and lignans and enterolignans being the focus in Western countries.
Contributing food sources to phytoestrogens varied amongst countries, as populations had
different food choices and cultural preferences. Limited data are available on phytoestrogen
intake in the Australian multicultural context.

This review of the literature mapped the ground of knowledge on phytoestrogens, critically
reviewed what has been done in this field of research, and informed the knowledge gap that
should be addressed. For the current study an original phytoestrogen FFQ needs to be updated
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and refined to align with food groups and dietary patterns in the current Australian Dietary
Guidelines, in particular to optimise measurement of lignans from the FFQ, and utilising
current databases of lignan content available from direct measurement of lignans in foods.
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Table 2. Results of the evaluation of food frequency questionnaires in measuring phytoestrogen intake
Author

FFQ: PEs

Study

Convergent validity,

Criterion validity, Excretion by

Reliability, Intake

(country)

measured, # of

sample

Intake by reference

biomarker

by FFQ2

food items

Results and comments

method

Validation studies that evaluate for both lignan and isoflavone phytoestrogen
Hanna

IFs (daidzein,

141F

The questionnaire was

√ FFQ and 3x24h urine over 1week

√ FFQ1 and FFQ2

FFQ intake: IFs median 0.00mg/d, LGs

(Australia)

genistein,

(40-59y)

previously validated with

Total IFs (r=0.207, P≤0.05), Total LGs

after 6-10months

1.61mg/d

2005

glycitein);

7dWFRs, adopted and

(r=0.138, P>0.05), Total PEs intake and

IFs Intake (r=0.60,

Conclusion: FFQ appeared more reliable for

LGs (SECO,

modified for PEs

urine IFs in (r=0.245, P≤0.01), Total

CI95% 0.23-0.81)

IFs than LGs. FFQ was not valid with urine

MAT)

measurement

PEs intake and urine LGs (r=0.199,

LGs intake (r=0.36,

LGs

PEs (IFs+LGs),

P≤0.05), Total PEs intake and urine

CI95% 0.07-0.68)

Strength: Australian population

112 items

PEs(r=0.283, P≤0.01)

Intake not reported

Limitation: female subjects; LGs intake

Median excretion: IFs 0.418 (0.005-41),

measured based on LGs content from an

LGs 0.771 (0.004-11)

indirect method

Bhakta

IFs (genistein,

58F

√ FFQ and 12x24hDRs

√ FFQ and 4x2ml plasma every 3month

(U.K.)

daidzein),

(25-75y)

for 1year

for 1 year

327µg/d, LGs mean 208µg/d, median

2005

LGs (SECO,

IFs (r=0.57, P<0.001)

FFQ and plasma Genistein (r=0.21,

149µg/d

MAT), 277

LGs (r=0.70, P<0.001)

P=0.12), plasma Daidzein (r=0.32,

Conclusion: FFQ appeared valid for LGs.

items

IFs Mean: 405 µg/d,

P=0.02), and plasma ENL (r=0.10,

FFQ had highest VC for LGs

median:194µg/d

P=0.43)

Strength: method of triads.

LGs mean:141µg/d,

24hDRs and plasma Genistein (r=0.43,

Genistein,24hDrs(0.95),FFQ(0.46),Plasma(0

median:110µg/d

P<0.001), plasma Daidzein (r=0.40,

.45).Daidzein,24hDRs(0.83),FFQ

P<0.002), and plasma ENL (r=0.08,

(0.67),Plasma(0.45).LGs,24hDRs(0.73);FFQ

P=0.50)

(0.91),Plasma(0.11), cross classification

Mean excretion: genistein 18.3nmol/L,

Limitation: female subjects; no reliability

daidzein 7.8nmol/L, ENL 13.7nmol/L

was assessed.

×

FFQ intake: IFs mean 471µg/d, median
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Horn-Ross

IFs (daidzein,

175F

√ FFQ and 4x24DRs for

√ FFQ and 2x24h urine (no p-values

√ FFQ1 and FFQ2

FFQ intake: Median IFs 1.5mg/d, LGs

(U.S.)

genistein,

(≤85y)

10 months (no p-values)

reported)

10 month apart (no

138µg/d

2006

formononetin,

FFQ1, IFs (ρ=0.70), LGs

FFQ and urine IFs (ρ=0.50), urine LGs

p-values reported)

Conclusion: FFQ appeared more valid for

biochanin A),

(ρ=0.74)

(ρ=0.16)

IFs (ICC=0.77)

IFs than LGs when comparing with 24hDRs

LGs (SECO,

FFQ2, IFs (ρ=0.72), LGs

24hDRs and urine IFs (ρ=0.43), urine

LGs (ICC=0.80)

and urine PEs, but it appeared more reliable

MAT)

(ρ=0.76)

LGs (ρ=0.21)

SECO (ICC=0.81)

for LGs than IFs

Coumestant

IFs median1.6mg/d, LGs

Excretion not reported

MAT (ICC=0.67)

Strength: large sample size

(coumestrol),

161µg/d

IFs median

Limitation: female subjects, no p-values

Block95 FFQ

1.5mg/d, LGs

reported for the significance of results

plus 32 items

137µg/d

for PEs
√ FFQ and 1x24h urine

√ FFQ1 and FFQ2

FFQ intake: IFs mean 13.7mg/d, median

FFQ1 and urine IFs (r = 0.54, P =

one month apart

15mg/d, LGs mean 13.8mg/d, median

(SECO, MAT),

0.004), and urine LGs (r = 0.40, P =

IFs intake (r = 0.69,

3.8mg/d

53 items

0.045), FFQ2 and urine IFs (r = 0.64, P

P < 0.001), LGs

Conclusion: FFQ appeared valid for LGs

2007

<0.001), and urine LGs (r = 0.46, P =

intake (r = 0.69,

and IFs when compared to urine PEs and

:

0.019)

P<0.001)

equally reliable for LGs and IFs

IFs mean 17.4umol/d, median

IFs mean 10.8mg/d,

Strength: cross-classification

4.1umol/d, LGs mean 20.6umol/d,

median 0mg/d, LGs

Limitation: female subjects, no convergent

median 6.4umol/d

mean 8.8mg/d,

validity and reliability, small sample size

French,

IFs (daidzein,

26F

Thompson

genistein), LGs

(25-42y)

and Hawker
(Canada)

×

median 0.7mg/d
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Validation study that evaluate for lignans
Lin (Sweden)

LGs (SECO,

140F

2012

MAT, LARI,

(55-75y)

×

√ FFQs and 1x serum 3 months apart

×

FFQ intake: FFQ87 mean 1616µg/d,

FFQ-87 and serum ENL (ρ=0.09,

median 1552µg/d, FFQ97 mean 1516µg/d,

PINO, MED

P=0.47), FFQ-97 and serum ENL

median 1497µg/d (P=0.002)

and SYR), 67

(ρ=0.22, P=0.01)

Conclusion: FFQ-97 was a better tool to

items for

ENL Mean 23.2nmol/l, median

measure LG status than FFQ-87.

FFQ-87, 93

20.8nmol/l,

Strength: lignan specific, include more LG

items for

subclasses

FFQ-97

Limitation: not validation study because no
reference method. Only comparing two
FFQs with serum LGs to determine which
FFQ is a better tool for LGs
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Validation studies that evaluate for isoflavones
Huang (U.S.)

IFs (daidzein,

69F.

√ FFQ and 4x48hDRs

√ FFQ and 4x24h urine over 4 weeks

2000

genistein),

51

over 4weeks

Daidzein (r=0.49, p<0.0002,

daidzein 7580µg/d, 5680µg/d, genistein

Block 95 FFQ

Japanese

Daidzein (r=0.58,

unadjusted), Genistein (r=0.30,

11402µg/d, 8778µg/d, Caucasian, daidzein

plus additional

(48.4) and

P<0.0001), Genistein

p=0.0346, unadjusted)

736µg/d, 108µg/d, genistein, 1435µg/d,

58 items for PEs

18

(r=0.52, P<0.0004)

Average of 48hDRs and 4x24h urine)

210µg/d

Caucasian

(Mean, median) Japanese,

Daidzein (r=0.45, p<0.0027,

Conclusion: IFs Intake moderately

(45.8)

daidzein 7336µg/d,

unadjusted), Genistein (r=0.41,

correlated with that of 48DRs and excretion

4402µg/d, genistein

p=0.0057, unadjusted)

Strength: Intake by ethnicity.

11118µg/d,6887µg/d.

First morning and 24h urine

Limitation: female subjects; no reliability

Caucasian, daidzein

Daidzein (r=0.58), Genistein (r=0.50)

was assessed. Small sample size

1036µg/d, genistein

Excretion not reported

×

FFQ intake: (mean, median) Japanese,

2049µg/d
√ (FFQ and 1x plasma) (p<0.001)

Verkasalo

IFs (daidzein,

80F (20 in

(U.K.) 2001

genistein), Total

each 4

Daidzein (r=0.74), genistein (r=0.69),

Conclusion: IFs intake can be estimated

IFs (sum of

groups of

Total IFs intake and plasma daidzein

with either a FFQ or 7dFDs. Plasma can be

daidzein,

soy intake

(r=0.56), and plasma genistein (r=0.53)

biomarker of soy intake

genistein,

level)

7dFDs and 1x plasma

Strength: Small number of soy items

glycitein), FFQ

(20-39y)

Daidzein (r=0.79), Genistein (r=0.80),

sufficient to estimate intake and have good

from UK arm of

Total IFs intake and plasma daidzein

correlation with biomarker

EPID study plus

(r=0.79) and plasma genistein (r=0.80)

Limitation: no convergent validity and

3 questions of

No overall excretion reported

reliability assessed.

×

×

No overall FFQ intake reported

soya intake
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Yamamoto

IFs (daidzein,

247

√FFQ and 4x7dDRs over

√ FFQ and 1x serum, and 2x 24h urine

√ FFQ1 and FFQ2

FFQ intake: mean daidzein 18.3mg/d,

(Japan) 2001

genistein), 8

subjects,

1 year

serum daidzein (r=0.26, CI:0.13-0.39),

one year apart

genistein 31.4mg/d

items

125F

Daidzein (r=0.60,

genistein (r=0.22, CI: 0.08, 0.35), urine

r=0.75, CI: 0.68-

Conclusion: FFQ appeared to be a valid and

(55y) and

CI:0.5-0.69), Genistein

daidzein (r=0.40, CI:0.21-0.60),

0.82

reproducible in estimating IFs intake

122M

(r=0.59, CI:0.5-0.68)

genistein (r=0.30, CI:0.08-0.51)

r=0.72, CI: 0.61-

Strength: female and male subjects, large

(56y)

Mean daidzein 14.5mg/d,

7dDRs and 1x serum, and 2x 24h urine

0.83

sample size, account for seasonal difference

genistein 23.4mg/d

serum daidzein (r=0.37, CI:0.25-0.49),

(repeated DRs for each season and repeated

genistein (r=0.36, CI:0.18, 0.55), urine

FFQ one year apart)

daidzein (r=0.48, CI:0.31-0.64),

Limitation: single urine and serum samples

genistein (r=0.36, CI:0.18-0.55)
1x serum and 2x 24h urine
serum and urine daidzein (r=0.22,
CI:0.01-0.42), genistein (r=0.32,
CI:0.12-0.52)
Mean serum daidzein 119.9nmol/l,
genistein 475.3nmol/l, Mean urine
daidzein 17µmol/d, genistein
14.2µmol/d
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√ FFQs and 1x plasma

√ Soy FFQ and

FFQ intake: daidzein mean 9.7mg/wk,

M

Soy FFQ daidzein (r=0.45, CI:0.

WHI FFQ,

median 7.6mg/wk, genistein mean

(20-40y)

25,0.61), genistein (r=0.53, CI:0. 35,

completed at the

11.9mg/wk, median 11.1mg/wk

FFQ, 122 items

0.67)

same time

Conclusion: Soy FFQ appeared to be a valid

(2 for IFs) for

WHI FFQ daidzein intake (r=0.45,

-compare 2 different

estimate of soy intake

WHI FFQ

CI:0. 25,0.61), genistein intake (r=0.46,

FFQs) (p<0.001)

Strength: female and male subjects

CI:0. 26, 0.62)

Daidzein (r=0.82),

Limitation: convenience sample, only

Daidzein plasma concentration mean

Genistein (r=0.83)

compare the intake from two different FFQs

8.8mmol/dl, median 4.7mmol/dl,

WHI FFQ daidzein

(no reliability of one FFQ was assessed)

genistein mean 16.9mmol/dl, median

mean 5.6mg/wk

12.8mmol/dl

median 2.1mg/wk,

Frankenfeld

IFs (daidzein,

77F and

(U.S.) 2002

genistein), 40
items for Soy

×

genistein mean
6.5mg/wk median
3mg/wk
√ FFQs and 2x plasma one at each visit

√ FFQs one week

FFQ intake: daidzein mean 6.2mg/wk,

postmeno

(p<0.001)

apart

median 3.7mg/wk, genistein mean

items for soy

pausal,

Soy FFQ daidzein (r=37), genistein

Diadzein and

8.1mg/wk, median 7.5mg/wk

FFQ, 122 items

(50-79y)

(r=0.43)

genistein (r=0.67,

Conclusion: Soy FFQ and comprehensive

(2 for IFs) for

Comprehensive FFQ daidzein (r=0.35),

p<0.001)

FFQ appeared to be reliable and valid

comprehensive

genistein intake (r=0.38)

Comprehensive

Strength: Bland Altman analysis (no plots)

FFQ

Daidzein plasma concentration (mean,

FFQ daidzein mean

between the two FFQs

median) 6.9mmol/dl,5mmol/dl,

2.2mg/wk, genistein

Limitation: female subjects. No convergent

genistein12.2mmol/dl, 10.9mmol/dl

mean 2.5mg/wk

validity assessed

Frankenfeld

IFs (daidzein,

96F

(U.S.) 2003

genistein), 20

×
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Frankenfeld

IFs (daidzein,

1823F

(China) 2004

genistein), 107

(30-64y)

×

√ FFQ and 2x serum

×

No overall FFQ intake reported

Significant trend of increasing serum

Conclusion: FFQ provided ranking of IFs

items (6 soy

daidzein and genistein level across

consumption and exposure

items)

increasing quartiles of isoflavone intake

Strength: rank intake for large sample size

(p<0.01)

Limitation: Population not representative

No overall excretion reported

(female textile workers). No convergent
validity, reliability and correlation were
assessed.

Heald

IFs (daidzein,

203M

Previously validated

√ SCG-FFQ and 1x serum 4-9 weeks

(Scotland)

genistein), 155

(50-74y)

against with 4dWDRs for

apart

Conclusion: FFQ appeared to be valid for

2006

items

nutrients intake, but for

daidzein (r=0.24, CI:0.11,0.36,

ranking intakes

PEs

p=0.001)

Strength: level of agreement (cross

genistein (r=0.26, CI:0.12,0.38,

classification) analysis (categorised into

p<0.001)

same and opposite tertile of intake and serum

Total IFs (r=0.27, CI:0.13,0.39,

concentration)

p<0.001)

Limitation: male subjects, no convergent

Median daidzein 18nmol/l, genistein

validity and reliability were assessed

×

FFQ intake: median IFs 1mg/d

33.79nmol/l, IFs 51.49nmol/l
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Tseng (U.S.)

IFs (daidzein,

27F

2008

genistein), 26

(30-50y)

×

√ Soy FFQ, DAF and 4x24h urine (no

×

FFQ intake: SFQ daidzein mean 2.9mg/d,

p-values reported)

median 0.015mg/d, genistein mean 3.9mg/d,

items for soy

Soy FFQ daidzein (r=0.49), genistein

median 0.013mg/d, DAF daidzein mean

FFQ, 126 items

(r=0.54)

2.1mg/d, median 0.032mg/d, genistein mean

for DAF

Diet assessment form (DAF) daidzein

2.2mg/d median 0.129mg/d

(r=0.54), genistein (r=0.33)

Conclusion: Soy FFQ and DAF valid in

24h urines and overnight urine daidzein

ranking intake; overnight urine correlate well

(r=0.84), genistein (r=0.93), glycitein

with 24h urine

(r=0.76), ODMA (r=0.94), equol

Strength: Comparison of excretion between

(r=0.61)

first-morning and 24h urine (similar to

24h excretion daidzein mean

Huang et al. 2000).

323ng/mgC, median 110ng/mgC,

Limitation: female subjects, small sample

genistein mean 136ng/mgC, median

size, no p-values reported

67ng/mgC
Fernandez

If (genistein),

64

√ FFQ and 7dFDs

√ FFQ and serum

√ FFQ1 and FFQ2

FFQ intake: mean 13.7mg/d

(Malaysia)

19 items

pregnant F

Genistein (r=72, p<0.001)

No coefficient and p-values presented

three to four weeks

Conclusion: 33 items FFQ is valid in

FD mean=9.9mg/d

Dose-response relation (p<0.01)

apart

measuring genistein.

between intake and serum level across

No coefficient and

Strength: Bland Altman plot and percentage

quintile of intake: mean of serum level

p-values presented

agreement (cross-classification)

increases as quintile of intake increases

FFQ2 intake mean

Limitation: female subjects, small sample

Mean serum 55.9nmol/l

13.3mg/d

size, measure only genistein

2013
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√ (FFQ1 and FFQ2

FFQ intake: IFs mean 6.6mg/d

DRs throughout 1-year)

thirteen month

Conclusion: soy FFQ is valid and reliable in

mid-life

IFs (ρ=0.53, p<0.001)

apart)

measuring IFs.

women

Median intake 6.3mg/d

ICC=0.68

Strength: Bland Altman plot and percentage

(p<0.0057)

FFQ2 median

agreement (cross-classification)

7.7mg/d (P=0.83)

Limitation: female subjects

Chan (Hong

IF (combined

145

√ FFQ and 23 day x 24h

Kong) 2008

total IFs), 47

Chinese

items

×

Key: FFQ = food frequency questionnaire, 24h-, 48h-,7d-DRs = 24-hour, 48-hour, 7-day dietary recalls/records, 7dWFRs = 7-day weighed food records, 4dWDRs=4-day weighed diet record, 7dFDs=7-day food diaries, DAF =Diet assessment form, LGs
= lignans, IFs = isoflavones, PEs = phytoestrogens, ENL = enterolactone, VCs= validity coefficients, r = Spearman correlation coefficient, ρ = Pearson correlation coefficient, ICC = intraclass correlation coefficient, F=female, M=male
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Table 3. Cross-sectional studies of lignan and isoflavone intake and food sources
Author

Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Country
Studies that measure lignan, isoflavone and enterolignan phytoestrogens
Hedelin (2006)

1,130 male

261-items

Mean (range), Median

LGs: SECO, MAT, PINO, LARI, SYR, MED; Enterolignan; END,

Sweden

control,

validated FFQ for

Control

ENL; IFs: daidzein, genistein, formononetin, biochanin A, equol;

1,499 case of

phytoestrogens

Total LGs 4,855 (292-106,958), 3,045

Finnish, Swedish;

prostate cancer,

Total enterolignans 16.06 (0-167), 13.05

N/A

35-65y

Total IFs 343 (1-18,975), 15
Case
Total LGs 4,929 (310-73,754), 3,044
Total enterolignans 16.06 (0-102), 13.05
Total IFs 491 (0-37,760), 16

Hedelin (2008)

45,448 female

80-items

Mean±SD (range), Median

LGs: SECO, MAT, PINO, LARI, SYR, MED; Enterolignan: END,

Sweden

control,

self-administered

Control

ENL; IFs: daidzein, genistein, formononetin, biochanin A, equol;

1,014 case of

validated FFQ

Total plant LGs 1,763±886 (15-14,473), 1,632

Finnish, Swedish;

breast cancer,

Total enterolignans 11±9 (0-110), 9

N/A

30-49y,

Total IFs 73±166 (0-5,023), 7
Case
Total plant LGs 1,784±887 (31-7,435), 1,639
Total enterolignans 10±8 (0-67), 8
Total IFs 78±181 (0.2-1,979), 7
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Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Lahmann

2,078 female

135-items FFQ,

Mean±SD, Median (IQR)

LGs: SECO, MAT, PINO, LARI; Enterolignan: END, ENL; IFs:

(2012) Australia

control cohort

modified and

Total LGs 693±296, 639 (323),

Equol, daidzein, genistein, glycitein, formononetin, biochanin A;

from case-control

validated in

Total enterolignans 22±12, 21(15)

U.K. (for SECO, MAT, and total enterolignans and IFs), Canadian

gynaecological

Australia for

Total IFs 3,293±5,71, 1,286 (1,693)

(LARI, PINO);

cancer study,

energy and

Low intake (≤1286µg/d): non-soya bread (23%), vegetables (22.5%),

18-79y

nutrients intake

fruits (16%)

Author,
Country

High intake (≥1286µg/d): Soybean and linseed bread (22%), Soybean
milk (19%), non-soya bread (12%)
Zamora-Ros

36,037 adults

24 hour dietary

Mean±SE

LGs: SECO, MAT, PINO, LARI; Enterolignan: END, ENL; IFs: daidzein,

(2012)

from European

records

Total LGs 1,037±30 (Greece) to 2,145±90

genistein, glycitein, formononetin, biochanin A;

European

Prospective

(U.K.)

Dutch, U.K., Canadian;

countries

Investigation into

Total enterolignans 10±0 (Greece) to 18.5±0

Mediterranean countries Total LGs: Fruits (31%), vegetables (26%),

Cancer and

(Sweden)

alcoholic beverages (11%)

Nutrition (EPIC)

Total IFs 236±140 (Greece) to 12,133±360

Non-Mediterranean countries Total LGs: Non-alcoholic beverages (25%),

study, 35-74y

(U.K)

vegetables (23%), Cereals products (20%)
Mediterranean countries Total IFs: Soy products (49%), legumes (9%),
vegetables (7%)
Non-Mediterranean countries Total IFs: Soy products (32%), sugar and
confectionary (17%), non-alcoholic beverages (13%)
Mediterranean countries Total enterolignans: dairy (92%), sugar and
confectionary (2%), condiments and sauces (2%), meat (1%)
Non-Mediterranean countries total enterolignans: dairy (90%), condiments
and sauces (3%), sugar and confectionary (2.9%)
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Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Mulligan

20,437 adults

7 day food diaries

Mean±SD, Median (IQR)

LGs: SECO, MAT, Shonanin; Enterolignan: END, ENL; IFs: daidzein,

(2012) U.K.

from of EPIC

Total LGs, non soya-consuming (NSC) men

genistein, glycitein, formononetin, biochanin A;

Norfolk cohort,

311±178, 273 (209-364),

U.K.;

40-79y

Total LGs, soya-consuming (SC) men

NSC group (men and women); bread and bread rolls (43%), breakfast

361±230, 309 (237-422)

cereals (12%), tea and coffee (6%)

Total LGs, NSC women 251±141, 229

SC group (men and women): vegetables dishes (41%), milk,

(180-293)

soy/goat/sheep (25%), bread and bread rolls (11%)

Author,
Country

Total LGs, SC women 318±212, 276
(215-351)
Total enterolignan NSC men 19±9, 18 (13-24)
Total enterolignan SC men 18±9, 17 (12-24)
Total enterolignan NSC women 16±8, 16
(11-21)
Total enterolignan SC women 16±8, 15
(10-20)
Total IFs, NSC men 1,033±871, 858
(633-1,155)
Total IFs, SC men 4,664±4,973, 2,413
(998-6,845)
Total IFs, NSC women 734±597, 615
(457-819)
Total IFs, SC women 5,055±6,054, 2,830
(779-6,938)
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Author,

Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Country
Studies that measure lignans and isoflavones
Bhakta (2006)

221 South Asians

12 x 24-hour

Mean±SD, Median (IQR)

IFs: daidzein, genistein; LGs: SECO, MAT;

U.K.

residents in U.K.

recalls for 1 year

Total IFs South Asians 322±877, 184

U.K. (for IFs), Finnish (LGs)

and 49 Native

(121-278)

IFs - South Asians, breads (51%), vegetables/vegetable dishes (38%),

British residents,

Total LGs South Asians 137±82, 111 (77-182)

milk/milk products (8%), flours, grains & cereals (2%)

25-75y

Total IFs Native British 366±176, 334

Native British, breads (93%), milk/milk products (3%),

(227-449)

vegetables/vegetable dishes (2%), flours, grains. cereals (1%)

Total LGs Native British 183±132, 149

LGs - South Asians, breads (70%), vegetables/vegetable dishes (12%),

(87-229)

miscellaneous (7%), fruit and fruit juices (5%), flours, grains, cereals
(3%)
Native British, breads (60%), fruit and fruit juices (21%),
miscellaneous (9%), vegetables/vegetables dishes (6%), alcohol (2%)

Cotterchio

3,370 women

178-items FFQ

(2008) Canada

Median (IQR)

LGs: SECO, MAT, PINO, LARI; IFs: daidzein, genistein, glycitein,

Total LGs, 857 (305, 4,005),

formononetin;

Total IFs, 230 (93, 842)

Canadian;
IFs, soybean (37%), soy milk (18%), tofu (13%)
LGs, Flaxseed (88%), multigrain bread (6%), flax bread (3%)

Saleh (2011)

111

Bangladesh

7-day FFQ

Mean±SD, Median (range)

LGs: SECO, MAT; IFs: daidzein, genistein, formononetin, biochanin

postmenopausal

Total LGs, 7,320±3,280, 7,310 (5,530-9,830)

A;

women

Total IFs, 320±160, 320 (190-390)

Finnish (scoring PEs concentration);
IFs, soybean oil (96%), Beans and peas (4%), cabbage, cauliflower
LGs, beans and peas (6%), cabbage, cauliflower, carrot (5%), onion,
garlic, pepper (3%)

49

Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Huang (2012)

Multiethnic

137-items FFQ

Median (IQR)

LGs: SECO, MAT, PINO, LARI; IFs:daidzein, genistein, glycitein,

U.S.

women from The

Total LGs, 191 (146) African American

formononetin;

Study of

Total LGs, 250 (170) Caucasian

LGs - African American: coffee (12-13%), black tea (7-16%), green

Women’s Health

Total LGs, 291 (248), English speaking

salad (9-11%), Chinese herbs in soup/tea (5-12%)

Across the Nation

Chinese

Caucasian: coffee (13-23%), black tea (6-20%), green salad (10-12%),

(SWAN) midlife

Total LGs, 354 (232), Chinese speaking

broccoli (6-8%)

Chinese

English speaking Chinese: Chinese herbs in soup/tea (25%), black tea,

Total LGs, 233 (180), English speaking

(13%) green tea (8%), green leafy vegetables (6%). Chinese speaking

Japanese

Chinese: Chinese herbs in soup/tea (23%), black tea (16%), green

Total LGs, 371 (292), Japanese speaking

leafy vegetables (11%), green tea (9%)

Japanese

English speaking Japanese: coffee (15%), green tea (12%), green salad

Total IFs, 285 (545) African American

(10%), black tea (9%). Japanese’s speaking Japanese: green tea (20%),

Total IFs, 318 (699) Caucasian

Chinese herbs in soup/tea (13%), black tea (11%), coffee (9%)

Total IFs, 5,487 (13,545) English speaking

IFs - African American: soymilk (76-86%), tofu (4-11%), donut

Chinese

(2-9%), meat substitute (6%)

Total IFs, 9,714 (15,215) Chinese speaking

Caucasian: soymilk (54-86%), tofu (5-18%), meat substitute (5-8%),

Chinese

fresh green soybean (5-21%)

Total IFs, 6,743 (9,334) English speaking

English speaking Chinese: Soymilk(51%), tofu(21%), fresh green

Japanese

soybeans(10%), dry spiced tofu(9%). Chinese speaking Chinese:

Total IFs, 24,585 (21,704) Japanese speaking

Soymilk(52%), tofu(27%), dry spiced tofu(5%), fermented

Japanese

soybean(3%)

Author,
Country

Canadian;

English speaking Japanese: Fresh green soybean(36%), tofu(21%),
soymilk(15%), roasted soybean(13%). Japanese speaking Japanese:
fermented soybean(30%), fresh green soybean(26%), tofu(21%),
soymilk(8%)
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Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Hu (2014)

1,000 subjects

Modified

Mean±SD, Median

Total IFs daidzein, genistein, glycitein, LGs, SECO;

China

from 31

semi-quantitative

Total IFs 183.2±122.7μg/kg/day,

Chinese (on plant-derived foods)

provinces or

food frequency

149.9μg/kg/day

Total IFs

province-level

questionnaire

SECO 26.1±20.2μg/kg/day, 22.5μg/kg/day

Soy (22%), soybean sprouts (19%), Chinese lettuce (17%), silken

administrative

With average weight of Chinese population,

bean curd (13%), taro (6%)

regions

60kg

SECO

Estimated Total IFs, 10,992μg/day, SECO,

Carrot (40%), Chinese lettuce (10%), taro (9%), white gourd (6%)

Author,
Country

1,566μg/day
Studies that measure lignans and enterolignans
Touillaud

58,049 women,

208-items

Median (range)

Total LGs: SECO, MAT, PINO, LARI, Total enterolignans: END,

(2007) France

41-72y

self-administered

Total LGs 1,112 (0-5,702)

ENL;

validated diet

Total enterolignans 768 (0-2,538)

Finnish, Dutch, French, Canadian (indirect analysis for content of

history

lignan metabolites produced);

questionnaire

Fruit (35%), vegetables (30%), tea (11%)

Peñalvo (2012)

3,534 children

24 diet recalls

Mean, Median (IQR)

Total LGs: SECO, MAT, PINO, LARI, SYR, MED, Enterolignan:

Spain

and young

over the year

Total LGs, 1,080, 830 (0.49-1.33)

ENL;

ENL alone, 14, 13 (8-20)

Spanish;

Mean

White bread (17%), olive oil (16%), virgin olive oil (11%)

adults, 2-24y

SECO, MAT, PINO LARI, 786
Studies that measure lignans
Milder (2005)

4,660 adults,

2 day dietary

Mean±SD (range)

Total LGs SECO, MAT, PINO, LARI;

The

19-97y

record

Total LGs 1,241±2,052 (43-77,584)

Dutch;

Netherlands

Beverages (37%), vegetables (24%), nuts and seeds (14%)
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Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Galvan-Portillo

50 women,

54-items FFQ

Mean±SD

Total LGs, SECO, MAT, PINO, LARI;

(2007) Mexico

17-37y

104, plant lignan mean

Dutch, Finnish;

Author,
Country

Pinto bean (76% to SECO), broccoli (20% to LARI, 10% to
PINO), orange (55% to MAT)
Nurmi (2010)

100 men

Finland

4 day food

Mean±SD (range)

Total LGs SECO, MAT, PINO, LARI;

record

Total LGs 1,224±539 (250-989)

Dutch, Finnish;
Rye products, berries, coffee, tea, wholegrains

Sohrab (2013)

2,618 adults,

168-items

Median

Total LGs SECO, MAT, PINO, LARI;

Iran

19-84y

validated

Total LGs, 200

European Phenol-Explorer online database;

semi-quantitative

Nuts (r=0.28), wholegrain (r=0.26), meat poultry and fish (r=0.10)

FFQ
González

304

Specially

Mean±SD

Total LGs, SECO, MAT, PINO, LARI;

(2013) Iran

institutionalised

designed FFQ

Total LGs, 450±0.3

European Phenol-Explorer online database;

elderly adults

for each 14

Olive oil, white bread, red wine, wholemeal bread

institution
Meija (2013)

172 men and 97

147-item,

Mean±SD, Median (IQR)

Total LGs, SECO, MAT, PINO, LARI, SYR, MED;

Latvia

women, 40-75y

country specific

Total LGs

Canadian (for SECO, MAT, PINO, LARI), Latvian (all LGs,

food frequency

Men 5,151±6,364, 2,783 (1,266-6,815)

particular SYD and MED, for Latvian local breads);

questionnaire

Women 3,339±4,429, 1,823 (1,022-3,349)

Food sources (only SECO, MAT, PINO, LARI)

modified for

Men, cereals (rye and seed bread) (90%), nuts and seeds (flaxseed)

lignan

(7%), beverages (coffee and tea) (1%), vegetables (cabbage) (1%)
Women, cereals (rye and seed bread) (60%), nuts and seeds (35%),
vegetables (2%), fruit and berries (2%)
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Author,

Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Country
Studies that measure isoflavones
Wong (2007)

1,701 men with

Modified

Mean±SD, Median (IQR)

Total IFs daidzein, genistein, glycitein;

Hong Kong

lower urinary

285-item Block

Total IFs

U.S. (Dwyer et al. 1994, Anderson 1997);

(H.K.) SAR,

tract symptoms,

FFQ with 10

15,730±23,130, 11,470 (13,230)

N/A

China

≥65y

commonly
consumed soya
items in H.K.

Iwasaki (2009)

780 Japanese

136-item

Mean

Total IFs, daidzein, genistein

Japan and

in Japan, 162

semi-quantitative

Total IFs

Japanese (Kimira et al.1998, Arai et al. 2000);

Brazil

Japanese

FFQ for Japan,

Cases

N/A

Brazilian in

118-item version

Japanese in Japan 43,500

Brazil, 758

for Brazil

Japanese Brazilian in Brazil 16,500

non-Japanese

Non-Japanese Brazilian in Brazil 1,100

Brazilian in

Control

Brazil,

Japanese in Japan 46,100

case/control of

Japanese Brazilian in Brazil 24,900

breast cancer

Non-Japanese Brazilian in Brazil 4,400

study, 20-74y
Zamora-Ros

40,483 subjects,

Computerised

Mean±SD, Median

Total IFs, daidzein, genistein, glycitein;

(2010) Spain

15,446 men and

diet history

Total IFs

USDA isoflavone database;

25,237 women,

questionnaire

Men 110±440, 0

Soybean sprouts (72%), beans (17%), chickpeas (8%), legumes

35-64y

developed/

Women 40±160, 0

(2%) soy sauce (0.1%)

validated for

All 80±330, 0

EPIC Spain
cohort
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Population

Dietary tool

Intake µg/d, (mean and/or median)

Phytoestrogens measured; Database; Food sources (%)

Lee (2013)

8,502 subjects

24-hour dietary

Mean±SE

Total IFs daidzein, genistein, glycitein;

Korea

from 2008

recall

Total IFs, subjects meet *dietary

Korean (Food composition table supplied by Korea National

Korea National

recommendation 25,800±2,800

Academy of Agricultural Science);

Health and

Total IFs subjects do not meet *dietary

Mandarin (67%), soybean curd (15%), soybeans (11%), orange

Nutrition

recommendation 5,400±500

(3%), soybean sprout (2%);

Author,
Country

Examination

*Dietary recommendation: 1 to 3 servings of fruit and 5 to 7

Survey

servings of vegetables

(KNHANES)
2008, ≥2y
Tang (2013)

359 cases of

Validated

Mean±SD

Total IFs, daidzein, genistein, glycitein;

China

oesophageal

137-item

Total IFs

USDA isoflavone database;

(North-West)

cancer, 380

semi-quantitative

Cases 16,500±29,900

N/A

controls,

FFQ

Controls 27,100±36,500

(mean±SD age
61±11)
Bai (2014)

17,900 subjects

24-hour dietary

Mean±SE

Total IFs, daidzein, genistein, glycitein;

U.S.

from NHANES

recall

Total IFs, 2,350±270

USDA isoflavone database;

III

N/A
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CHAPTER THREE: METHODS

3.1. Research design
This is a cross-sectional study that evaluated the validity and reliability of a modified
phytoestrogen-specific dietary tool. The study was conducted to firstly, compare
phytoestrogen intake derived from the modified dietary tool with intake derived from a
reference dietary tool and with urinary excretion of phytoestrogen biomarkers; secondly,
assess the dietary intake and food sources of phytoestrogens in a group of 59 Australians
with the modified dietary tool, and thirdly explore the relationship between phytoestrogen
intake and excretion, and selected social and lifestyle characteristics. An overview of the
study design, including tools development, data collection and analysis is illustrated in
Figure 5.

3.2. Tools and method development for data collection
This section describes the development of the tools and methods used for data collection.
Databases for the lignan and isoflavone content from dietary sources were collated and
utilised to measure intake of phytoestrogens from foods and beverages consumed by the
research subjects.

Phytoestrogen intake status was assessed with a previously-developed

specific FFQ, which was reviewed, expanded and updated to measure phytoestrogen
intake in the current Australian context. A 3-day weighed food record (WFR) was used as
the reference method to collect details of foods and beverages consumed over three
consecutive days. Phytoestrogen excretion status was assessed with urinary biomarkers of
phytoestrogen metabolites. A questionnaire was designed to collect selected demographic
and lifestyle characteristics which were shown to be associated with phytoestrogen status
in previous research.
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Figure 5. Overview of the study design
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3.2.1. Dietary lignan and isoflavonoid database
There are no published data for the lignan content of Australian foods and therefore data
were sourced from international published studies from The Netherlands, Finland, the
U.S, and Canada (Blitz, Murphy, & Au, 2007; Mazur, 1998a; Mazur et al., 1999; Mazur,
Wähälä, Rasku, et al., 1998; Meagher & Beecher, 2000; Milder, Arts, et al., 2005;
Thompson et al., 2006).

The database was compiled by a previous Master of Nutrition

and Dietetics student at the University of Wollongong (2009) under the supervision of
Associate Professor Philippa Lyons-Wall, and used with permission for the current study.
This database was reviewed and updated by the candidate with more recently published
lignan values and was used in the current study to quantify intake of the four primary
dietary lignan precursors, SECO, MAT, LARI and PINO (Bonzanini et al., 2009; Clarke
et al., 2013; Durazzo, Azzini, et al., 2009; Durazzo, Azzini, et al., 2013; Durazzo,
Raguzzini, et al., 2009; Durazzo, Turfani, Azzini, Maiani, & Carcea, 2013; Durazzo,
Zaccaria, et al., 2013; Kuhnle, Dell'Aquila, Aspinall, Runswick, Joosen, et al., 2009;
Kuhnle et al., 2008a; Kuhnle, Dell'Aquila, Aspinall, Runswick, Mulligan, et al., 2009;
Moreno-Franco et al., 2011; Nurmi et al., 2003; Peñalvo et al., 2008; Peñalvo et al., 2005;
Smeds et al., 2007; Smeds et al., 2009).
Intake of two enterolignans, END and ENL was calculated using the one available
database from the UK for animal-based foods (Kuhnle et al., 2008b). No plant-based
foods contained END and ENL and no animal-based foods contained plant lignans.

Databases which provided the lignan content for all four dietary lignan precursors were
preferentially selected for assigning lignan content to items for the current study. To
account for the effect of the natural variability of phytoestrogens in foods, values for the
same food item across multiple databases were averaged.

The averaged values were

used to assign lignan content to the food items in the phytoestrogen specific food
frequency questionnaire and in the 3-day weighed food record. The final collated lignan
database contained a total of over 1000 food and beverages items and included individual
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foods, processed foods and mixed dishes from the major food groups: vegetables, fruits,
fruit and vegetable juices; nuts and seeds, breads and cereals; dairy products and
milk-like beverages; meats; also herbs and spices, tea and coffee, and alcoholic beverages.
The collated database is available on request.
Intakes of five isoflavones, daidzein, genistein, glycitein, formononetin and biochanin A
were quantified using the comprehensive United States Department of Agriculture
isoflavone database (Release 2.0) (Bhagwat et al., 2008). The phytoestrogen values of the
aglycone forms, based on wet weight, were used to quantify the dietary intake.

3.2.2. Phytoestrogen specific food frequency questionnaire
An existing 112 item phytoestrogen FFQ was developed by two Nutrition and Dietetics
students at the University of Sydney under the supervision of Associate Professor
Philippa Lyons-Wall.

This FFQ was adopted by Hanna et al. (2005) in her doctoral

research to measure phytoestrogens intake and is used with permission for the current
study.

The modification of this FFQ by the candidate for the current research was based

on updating the content of lignans and isoflavones of items from published databases and
increasing the number of items to include dietary patterns and typical serve sizes
described in the Australian Dietary Guidelines (NHMRC, 2013a). Food sources rich in
lignans and isoflavones i.e. flaxseed and soy and related food products, and commonlyconsumed food sources of lignans, such as broccoli, pumpkin, oranges and berries, were
included in the questionnaire. Food groups and common foods consumed in Australia
were identified from the 1995 National Nutrition Survey conducted in a broad sample of
13,800 adults (McLennan & Podger, 1995) and from a secondary data analysis in 2010 of
the baseline diet of 106 Australian men and women enrolled in a clinical trial, previously
conducted by the candidate under the supervision of Associate Professor Philippa
Lyons-Wall. The FFQ was designed to recall usual diet over the past month (4 weeks) and
contained five columns. The ‘Food Item’ column contained the list of 277 foods and
beverages in the FFQ. The ‘Brand’ and ‘Type’ column provided additional space for the
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subjects to state further details about the food item, for example, the brand, the type or the
colour. The ‘Standard serve size’ column stated the reference serve size of the food items
taken from The Australian Dietary Guidelines (NHMRC, 2013a).

Subjects used the

standard serve size as a comparison to respond how much they usually consumed for that
particular food item, which they entered in the ‘Portion size’ column. The ‘Frequency’
column allowed subjects to report how often they consumed each food item with
reference to their portion size over the previous month. The questionnaire comprised 14
frequency categories: never/<1 per month, 1 per month, 2 per month, 3 per month, 1 per
week, 2 per week, 3 per week, 4 per week, 5 per week, 6 per week, 1 per day, 2 per day, 3
per day and ≥4 per day (Appendix A).
3.2.2.1 Pilot study of food frequency questionnaire
A pilot study of the FFQ was conducted to pretest the feasibility of the research tool
(Persaud, 2010).

A group of 10 people, known to the candidate and mainly from a

nutrition and sport sciences background, were invited to complete the food frequency
questionnaire and provided feedback based on a list of pilot questions, including the time
it took to complete, the format and feasibility of the questionnaire, and improvement for
the questionnaire from the respondent’s perspective (Appendix B). On average,
approximately 35 minutes was spent to complete the questionnaire. Most respondents
believed that the format of the questionnaire was easy to understand and three suggested
changes were made to improve the response for portion size in comparison to standard
serve size or to answer portion size in exact amounts consumed or household measures.
Half of the respondents thought that having visual aids for standard serve size and
common household measures would be helpful in completing this questionnaire.
Respondents also nominated commonly consumed food items to be considered on the
questionnaire. Amendments were made to the FFQ according to this feedback. A food
model booklet (Stamatis, 2000) was made available as a visual aid on request. The
candidate embedded extra rows on the questionnaire for recruited subjects to record other
foods and beverages that they consumed regularly but were not listed.
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3.2.3. Demographic and lifestyle questionnaire
A questionnaire was designed to collect demographic and lifestyle information
(Appendix C). The questions were based on those from the Australian Health Survey
(ABS, 2013b), and previous published research (Hanna et al., 2010; Johnsen et al., 2004;
Milder et al., 2007). Several social characteristics were found to be associated with lignan
intake and/or biomarkers in the literature review. These variables included age, gender,
height, weight and BMI, occupation, level of education, physical activity level, smoking
status, bowel habits (frequency and movement) and commercial dietary supplemental use.
The associations between ancestry/ethnicity and cultural background (language spoken at
home, country of birth) and lignan status were also explored in the current study to
address the multicultural nature of the sample group.

3.2.4. Three-day weighed food record
A 3-day weighed food record was chosen as the reference method for validating the
phytoestrogen specific FFQ because the weighed food record has unrelated sources of
errors from those of a food frequency questionnaire (Willett & Lenart, 1998).

Subjects

were provided with the weighed food record booklet to record and describe their food and
beverages intake over 3 days. Subjects were required to record the amount, type and
brands of the food and beverages consumed, the meal type, preparation method, and place
of preparation and the time of consumption (Appendix D). Where subjects consumed a
dish they prepared from a range of ingredients, they were required to record the recipe in
the recipe section of booklet and to specify the amount consumed in the food booklet.
Details of the ingredients and the amounts used in the recipes were important to identify
ingredients that were rich in phytoestrogen content.

A set of digital kitchen scales,

which measured to the nearest 1g (Propert 5 kg capacity, slimline stainless steel, Propert
Houseware, NSW) and modular measuring cups and spoons (Décor Cook, The Décor
Corporation, VIC) were provided to each subject to standardise weighing and estimating
the amount of their food and beverages intake.
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3.2.5 Urine sample collection
A dose-dependent relationship between phytoestrogen consumption and urinary excretion
has been reported in human intervention studies for both lignans (Hutchins, Martini,
Olson, Thomas, & Slavin, 2000) and isoflavonoids (Morimoto, Beckford, Franke, &
Maskarinec, 2014). This relationship demonstrates that the use of urinary biomarkers of
phytoestrogen metabolites is an informative and objective method to test the criterion
validity of the phytoestrogen questionnaire.
Subjects were asked to collect 24-h urine samples for three consecutive days. Each
subject was provided with three 3 L bottles (SteriHealth, VIC) with ascorbic acid (1g per
bottle) added as preservative (Sigma Aldrich, L-Ascorbic acid, NSW), funnels
(SteriHealth, VIC) and specimen collectors (Victoria Healthcare Products, VIC). Subjects
were given a urine collection protocol developed for this study and the procedure for
urine collection was explained to subjects at their first visit to the study venue (Appendix
E). On the day of collection, subjects discarded the first morning void and collected all
urine for the remainder of the day, completing the collection with the first morning void
on the next day. The candidate provided the subjects with advice on how to store the
collected samples and agreed on an appropriate storage method during the urine
collection period. An insulated cooler bag and three freezer blocks was provided to assist
each subject with samples storage prior to delivery to the study venue. To verify the
completeness of urine samples, subjects were asked to record on the bottle label whether
each sample was either complete or incomplete, with the time of missed samples noted in
a space provided (Murakami et al., 2008). Collections were repeated on the next two
consecutive days.
Subjects delivered the three 24-hour urine collection to the study venue on completion.
The samples were refrigerated and processed at the chemistry laboratory at Edith Cowan
University within 48 hours of receipt. The total volume and total weight of each 24-hour
urine sample was measured with graduated cylinders and a top pan balance (Appendix F).
A set of five aliquots was prepared from each sample, and to each aliquot 10µL of 30%
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sodium azide solution (0.3g/ml) was added as a bacteriostat (Appendix G). Each aliquot
was labeled and stored at -80°C until analysis.
Protocols for urine sample preparation and working with chemicals, and the Risk
Assessment and Management Plan (RAMP) was developed with the Analytical Chemist
to ensure the consistency of laboratory work, to assess the risk of the protocols and to
outline any emergency response. The RAMP was assessed and approved by the School of
Natural Sciences Safety Officer.

3.3. Subject recruitment
3.3.1 Selection criteria
3.3.1.1 Inclusion criteria
Subjects of both genders, aged between 18-70 years, from different cultural and social
backgrounds were eligible to participate. These inclusion criteria were designed to
capture the dietary diversity of phytoestrogen intake.

3.3.1.2 Exclusion criteria
Subjects were excluded from participating in the study if they were using or have used
regular doses of antibiotics for at least one month over the past 6 to 12 months, have
made substantial changes to their usual diet during the past month, have current
gastrointestinal problems such as ulcerative colitis and Crohn’s disease, or have
undergone gastrointestinal surgery involving removal of the large intestine, or have had
chronic or acute renal or liver disease in the previous 6-12 months (Appendix H).
3.3.2 Determination of an adequate sample size
The a priori estimated sample size to detect the significance was determined with a
statistician using G*power (Version 3.1.3 for Mac OS X, Institut für Experimentelle
Psychologie, Düsseldorf, Germany) for assessing the association between phytoestrogen
intake and status measured by dietary methods and urinary biomarkers. The sample size
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calculation indicated that 80 individuals were required to achieve a suggested moderate
effect size (R2 of 68%), based on correlations between the FFQ and reference methods
from previous validation studies, and correlations between dietary methods and
biomarkers (R2 of 30%), with 80% power and a 5% significance level. This sample was
within the range of the sample size recruited from previous validation studies (Bhakta et
al., 2005; Hanna et al., 2005). The anticipated dropout rate was 10% resulting in a
required sample size of 88 subjects.

3.3.3 Advertisement
A flyer was designed to advertise the study throughout the Edith Cowan University
Joondalup campus across various facilities, including the library, student village and
student guild, and online via the Graduate Research School Google group, Health and
Wellness flyer, and Research news on Edith Cowan University portal (Appendix I).

3.3.4 Ethics
The study was granted ethical approval by the Human Research Ethics Committee, Edith
Cowan University (Project number: 10415). All subjects provided informed written
consent prior to starting the study and were given the contact details of the principal
investigators and Ethics Officer in case of any concerns. Confidentiality of the data was
strictly enforced. All questionnaires, food records and urine samples collected were stored
securely. All data collected were entered into the candidate’s computer and stored
securely. Individual subjects were identified by study codes that matched his or her
questionnaire, food record and urine samples. This study involved human subjects and
was conducted following the principles in the National Statement on Ethical Conduct in
Human Research, Edith Cowan University Policy for the Conduct of Ethical Human
Research, and The Declaration of Helsinki.
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3.3.5 Subjects
The subjects consisted of staff and students recruited at Edith Cowan University.
Recruitment techniques included word of mouth and snowballing. Subjects who were in
the study were asked to suggest the study to other interested individuals. Figure 6
illustrates the process of subject recruitment from the start of the recruitment, screening,
commencement and undertaking of the study, to the completion of the study.
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Figure 6. The process of subject recruitment from commencement, screening and
selection, and participation, to the completion of the study
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3.4. Data collection and analysis
Dietary intake was collected using the phytoestrogen FFQ and the 3-day WFR.
Biomarkers of phytoestrogen metabolites were measured in the 24-hour urine samples,
collected over three days to reflect subjects’ habitual urinary excretion. Assuming that
biomarker excretion was delayed after consumption of phytoestrogens in the diet, due to
possible metabolic conversions in the colon prior to absorption, urinary excretion would
more likely reflect intake on the previous day (King & Bursill, 1998; Kuijsten et al., 2005;
Watanabe et al., 1998). Therefore urine collections were timed to start one day after
commencement of the WFR.

The collection of the FFQ, 3-day WFR and urine samples is illustrated in Figure 7. In the
first session, subjects completed the pre-study FFQ that reflected habitual diet over the
past month, and the demographic and lifestyle questionnaire. They received instructions
and the equipment for conducting a 3-day WFR and 3-day 24-hour urine collection
(Figure 8). For the current research, the minimum 3 days, including a weekend day, was
required for the food record as it is sufficient to obtain usual dietary intake, and practical
and feasible within the short data collection timeline (Buzzard, 1998; Lee & Nieman,
2010).
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Figure 7. Data collection protocol
The study extended over a 7 day period with a 3 day WFR collected on days 1 to 3 and 24
hour urine samples on day 2 to 4. The FFQ was completed on two occasions at the
beginning and end of the study period, coinciding with subject visits to the study venue.

Figure 8. Equipment provided to subjects to conduct the 3-day WFR and three
24-hour urine collections
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Subjects returned the completed 3-day WFR and 3-day urine collection at the second visit
to the study venue. The candidate reviewed all food records with the subjects to verify
completeness and clarify ambiguous information. Subjects then completed the same FFQ
(post-study FFQ).

3.4.1 Quality assurance and subject compliance
To ensure the quality of data collection, subjects were required to attend the first session
at the study venue. The candidate explained each step of the data collection procedure and
demonstrated the use of equipment. Subjects were encouraged to ask any questions that
they had during the session to make sure they understood the process. The candidate
discussed with the subjects their anticipated commence and finish date so a second
session could be scheduled for collection of equipment, weighed food record and urine
samples. Subjects were encouraged to contact the candidate anytime if they wished to
have any questions answered or would like advice when they had events that affected
their food recording and urine collection. A study calendar was provided to subjects as an
outline of the steps they needed to complete during the study. Spaces were available on
the calendar for subjects to record relevant information, for example, any events that
affected the dietary recording and urine collection, e.g. sickness, menstruation for female
subjects, travelling (Appendix J). Subjects who missed their urine sample or WFR
recording were advised to immediately contact and discuss with the candidate to resolve
the issue.

3.4.2 Assessment of energy and nutrient intake
The subjects’ food intake from the WFRs was analysed for intake of energy,
macronutrients and micronutrients using the AUSNUT (2007) database (FoodWorks®
Professional Edition version 7, Xryis Software, QLD). Details of the type or brand and
the preparation method were taken into account when choosing appropriate food items.
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For food items not available in the AUSNUT database, a new food was constructed based
on nutrient values of an existing similar food from other databases in FoodWorks®, or a
new food was entered or edited with nutrient values from external sources, for example,
the food label of the product or the USDA National Nutrient Database (U.S. Department
of Agriculture, 2014). For subjects who provided detailed recipes in their WFRs, each
ingredient and the quantity used for cooking the dish was entered into FoodWorks® to
construct a new item.

3.4.3 Assessment of phytoestrogen intake
3.4.3.1 Analysis of phytoestrogen intake derived from food frequency questionnaire
A template based on the FFQ was constructed using a Microsoft Excel spreadsheet to
calculate the phytoestrogen intake of usual diet over the past month. Values of
phytoestrogen content (based on wet weight and edible portion) were selected from the
dietary lignan and isoflavone databases and assigned to the listed 277 food and beverage
items. The portion size in grams and the number of times (how often) this item was
consumed was entered into portion size and frequency columns corresponding to that
particular food item. The first step was to calculate the weight of the item consumed per
day = portion of item consumed (g) x (number of times consumed per month/30) +
portion of item consumed (g) x (number of times consumed per week/7) + portion of item
consumed (g) x (number of times consumed per day). The second step was to measure
each lignan, enterolignan and isoflavone intake, for example, SECO (µg) consumed =
weight of item consumed per day (g) x SECO content (µg/100g). Total lignan intake (µg)
was calculated as the sum of intake of SECO, MAT, PINO, LARI; total enterolignan
intake (µg) was calculated as the sum of END and ENL; and total isoflavone intake (µg)
was calculated as the sum of daidzein, genistein, glycitein, formononetin and biochanin A
intakes.
Subjects recorded foods and beverages that were regularly consumed, but not listed, at the
end of the questionnaire. These items were flagged and grouped together on a separate
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spreadsheet and the foods were assigned with phytoestrogen content and added in to the
totals.

3.4.3.2 Analysis of phytoestrogen intake derived from weighed food records
The data from the 3-day WFR analysed by FoodWorks®, were managed with Microsoft
Access and exported to a Microsoft Excel spreadsheet to calculate phytoestrogen intake.
Intake data were sorted by alphabetical order of food names to streamline the assigning
process by giving the same phytoestrogen content values to all the same items at once.
Phytoestrogen intake (µg) was calculated as: phytoestrogen content (µg/100g) x weight of
item consumed (g). For recipes, the calculation of phytoestrogen content took into
account the weight of the recipe consumed and content of phytoestrogen per serve.

For items where no phytoestrogen values were available from the database, the values
were based on those from an appropriate item available within the same food group
Phytoestrogen content of mixed foods (foods and dishes composed of two or more
different components) was estimated based on the proportion of each ingredient specified
by the subjects or common recipes. Where appropriate, the water content of the food item,
particularly those with high water content e.g. fruits juice, and water-based recipes, soup,
was identified with NUTTAB 2010 and the proportion of the solid content calculated,
assuming phytoestrogens are only present in the solid part of the food matrices. Food
items with no available values and no appropriate substitution were left unassigned and a
phytoestrogen content of zero was assumed, for example, sugar, salt, confectionary, soft
drinks, vodka, seafood like crab and octopus, spices like cinnamon and cumin.

3.4.4 Assessment of food sources contributing to lignan and isoflavone intake
Food items from the FFQ were listed according to food groups specified in the Australian
Dietary Guidelines with nuts and seeds, and legumes and beans, as two separate groups,
(NHMRC, 2013a) and two additional groups, non-alcoholic beverages including coffee,
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tea and juices, and alcoholic beverages.

Using the Australian Dietary Guidelines

assured the food sources identified reflected the Australian dietary patterns.

Total and

individual phytoestrogen intake from each food group and from all foods was calculated,
and the percentage food contribution was calculated by dividing total phytoestrogen
intake of each food group with the total intake of all foods.

3.4.5 Assessment of urinary excretion of lignans and isoflavonoids

Chemicals
Methanol, acetonitrile and water were all LC-MS grade and supplied by Fisher Scientific.
Pinoresinol, lariciresinol, secoisolariciresinol, enterodiol were supplied by PhytoLab
(Vestenbergsgreuth, Germany). Matairesinol, enterolactone, daidzein, genistein, glycitein
and equol were supplied by Cayman Chemical (Michigan, U.S.). LKT Laboratories
(Minnesota, U.S.) supplied biochanin A and formononetin. Taxifolin was supplied by
Sigma Aldrich (Castle Hill, NSW, Australia) and glucuronidase (activity > 100,000
U/mL) /sulfatase (> 20,000 U/mL) enzyme extracted from red abalone (Haliotis
rufescens) was sourced from Kura Biotech (Puerto Varas, Chile). Formic acid and acetic
acid were supplied by Fluka and Ajax Finechem Pty Ltd. respectively.

Sample preparation
The urine was thawed to room temperature and then centrifuged (10 min at 13.2 rpm,
23°C) (Eppendorf Centrifuge 5415R, Eppendorf, Germany). A 200 µL aliquot of the
supernatant was transferred to a 2 mL Eppendorf tube before adding 240 µL of
glucuronidase/sulfatase enzymes from Kura Biotec (Puerto Varas, Chile), 10 % (v/v) in
sodium acetate (140 mM pH 4.8). Taxifolin (20 ng) was added as the internal standard
(Fluka, Sigma Aldrich, Castle Hill, NSW, Australia).

Enzyme and internal standard

were mixed thoroughly with the supernatant (Boeco Vortex V1 Plus, Boeco, Germany).
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The sample was then mixed gently and heated at 37 oC overnight (approximately 16 hrs)
(Eppendorf thermomixer comfort, Eppendorf, Germany).
Methanol (20 µL) was added to each sample.

The sample was then passed through a

preconditioned solid phase extraction cartridge (Alltech 100 mg, C18). The loaded

cartridge was washed with 90:10:0.1 water:methanol:acetic acid (1.0 mL) followed by
acetonitrile (1.0 mL) to elute the lignans. The lignan extract was freeze dried and stored at
-80 oC until analysed (Labconco FreeZone 2.5, Labconco, United States). The freeze
dried sample was reconstituted in 90:10:0.1 water:methanol:formic acid (400 µL).
Chloramphenicol (20 ng) was added to each sample and standard as an instrument check
(Valentin-Blasini, Blount, Schurz Rogers, & Needham, 2000).

Liquid chromatography-mass spectrometry (LC-MS) analysis
Concentration of urinary phytoestrogen metabolites (ng/ml) was measured by an
Analytical Chemist with a high resolution Time of Flight Mass Spectrometer (ABSCIEX
5600, AB SCIEX, Framingham, MA, United States) using electrospray ionisation in
negative mode.

This instrument was interfaced to a Shimadzu Nexera LC system (LC

30AD pump, SIL30AC autosampler and a CTO-20A column oven). The LC separation
was carried out using a Grace Smart RP 18 column (50 mm x 2.1 mm x 3 mm) with a 10
µL injection loop. The flow rate was 0.5 mL/min. The mobile phase consisted of 0.1%
v/v formic acid in water (A) and 0.1% v/v formic acid in acetonitrile (B) in a gradient
starting with 10% B to reach 50% B after 7 min, 100% B after 9 min, held for 5 minutes
and returning to 10% B for 5 min to equilibrate. The mass spectrometer was run in
independent data acquisition (IDA) mode with enhancement to the precursor ions for the
target analytes (secoisolariciresinol, matairesinol, pinoresinol, lariciresinol, enterodiol,
enterolactone, daidzein, genistein, glycitein, equol, biochanin A and formononetin). The
nebulizer gas, heater gas and curtain gas were run at 30, 45 and 50 psi respectively. The
ion source voltage was 4500 V and the probe temperature was 550°C. Collected mass
range was m/z 50-1000. MSMS data was collected with a collision energy of -35 V with a
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spread of 15 V (Grace, Mistry, Carter, Leathem, & Teale, 2007).

Creatinine analysis
Twenty four-hour urinary creatinine concentrations were determined with Jaffé Creatinine
method (Husdan & Rapoport, 1968) to assess completeness of the urine collection. Two
ml urine samples without added sodium azide were centrifuged for 90 seconds at 130rpm
(Eppendorf MiniSpin) and 200µL of sample was pipetted into a sample cup. The urine
sample was diluted 1/20 on board the analyser for analysis (Abbott Architect c16000,
Analytical Imprecision 5.4 mmol/L:CVA: 2.0%, 12.2 mmol/L:CVA:1.8 %). Creatinine
reacts with picric acid in an alkaline medium to produce a coloured creatinine-picrate
complex. The rate of formation of this complex, measured over a selected time interval at
a primary wavelength of 500nm and secondary wavelength of 572 nm, is proportional to
the concentration of creatinine in the sample (uncertainty of measurement, 0.22 mmol /L at
5.4 mmol/L ± 0.42 mmol/L at 12.2 mmol/L).

Day-to-day variation in creatinine

excretion of the three 24 hour urine samples of each subject was examined and compared
with expected urinary creatinine excretion (creatinine index) to determine possible
incompleteness of the 24 hour urine sample (Barr et al., 2005; De Keyzer et al., 2012;
Dugdale, 2011).

3.4.6 Assessment of phytoestrogen status and social and lifestyle characteristics
Social and lifestyle characteristics data were collected with the demographic and lifestyle
questionnaire. Height and weight were measured with subjects wearing light clothing and
no shoes. Height was measured to the nearest 0.01cm and weight to the nearest 0.1kg
with a digital measuring and weighing station (Seca 763, Seca GmbH & Co. KG.,
Hamburg, Germany) (Stewart, Marfell-Jones, Olds, & de Ridder, 2011). The height and
weight were used to calculate body mass index (BMI): weight (kg)/square of height (m)
(Diehl, 2011).
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Subjects stated their occupation. All responses for the occupation were classified into one
of the eight major groups according to the Australian and New Zealand Standard
Classification of Occupation (ABS, 2013a). There were six categories of education level:
University postgraduate, University undergraduate, Certificate or diploma, Year 12 Senior
secondary school, Year 10 Junior secondary school and Other (e.g. primary education)
(ABS, 2001). Subjects selected ethnic group that best described their and their biological
parents ancestry/ethnicity and the language they speak the most at home. They indicated
their country of birth and all responses were listed and classified into one of nine regions
according to the Standard Australian Classification of Countries (ABS, 2011).
Physical activity was categorised at four different levels and subject selected the level that
best described them: 1) Sedentary, move only for necessary chores/walking/other
activities 1-2/week; 2) Light, walking/other activities >3/week; 3) Moderate, exercise to
perspire 1-2 times/week, or moderate labour or physically demanding work; 4) High,
heavy exercise or sport several times/week, heavy labour or physically demanding work
(ABS, 2013b; Hanna et al., 2010). Subjects were asked to select the best option to
describe his or her usual physical activity over the past month.

Smoking status was categorised as: never smoked, current smoker (daily, weekly or other
frequency) and past smoker. Subjects described their bowel habits using frequency such
as how many times per week and the movement such as ‘hard to pass’, ‘smooth and soft’
or ‘mushy and watery’ according to the Bristol stool chart (Lewis & Heaton, 1997).
Subjects stated whether they used any commercial dietary supplements (yes or no), and
provided the details of regular supplements they were taking.

3.4.7 Statistical analysis
Data entry and cleaning
Quality assurance procedures were implemented in data entry and analysis. All
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questionnaires and WFRs were reviewed by the candidate to check for completeness and
ensure that food weights and ingredients were recorded. Subjects were contacted by the
candidate to clarify any missing or ambiguous details in the dietary, and demographic and
lifestyle data.
The WFR data were checked for consistency. All WFRs and recipes were visually
checked for accuracy by the candidate. All quantity and frequency numbers entered into
the FFQ template were crosschecked with the hard copy of the FFQ. The candidate
examined the nutrient analysis of 3-day WFR for extreme values that were not feasible
and corrected for any errors. Data of phytoestrogen excretion were checked by the
Analytical Chemist responsible for the LC-MS analysis. High and low outliers were
identified by boxplots and histogram and checked they were correctly assessed for
phytoestrogen intake and excretion. To calculate the average daily urinary excretion of
phytoestrogens over the three days, the weighted average was calculated based on the
relative urine volume for each day: average weighted phytoestrogen excretion (µg/day) =
(volume (L) of day 1 /Total volume (L) of all 3 days) x (phytoestrogen in µg/day 1) +
(Volume (L) of day 2 /Total volume (L) of all 3 days) x (phytoestrogen in µg/day 2) +
(Volume (L) of day 3 /Total volume (L) of all 3 days) x (phytoestrogen in µg/day 3). The
weighted averages for urinary excretion data were used in the statistical analysis.
The Mann-Whitney U test and Pearson’s Chi-Square test of contingencies were
conducted to test if the demographic and lifestyle characteristics of subjects who
completed significantly differed from that of those who withdrew from the study.
Statistical analysis was conducted using Statistical Package for Social Sciences (SPSS for
Windows, Version 22, 2014, Chicago, Illinois, USA).

Analysis for estimating dietary phytoestrogen intake
The normality of the phytoestrogen intakes from the FFQ and 3-day WFR were tested
with the Shapiro-Wilk test. Transformation of natural log was applied to the data but the
normality test indicated that not all data became normally distributed. Therefore, all data
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were treated as non-normal distributions and non-parametric statistical tests were used
throughout for median comparisons and correlations. For values of ENL, END and total
enterolignan intake that were zero, a natural log transformation plus a constant was
applied. Data were expressed as the mean±SD, median (IQR), and the minimum and
maximum.

Analysis for assessing validity and reliability of FFQ
Non-parametric tests were applied to compare the median of FFQ with 3-day WFR for
validity, and the median of pre FFQ and post FFQ for reliability. Comparison between
phytoestrogen intake from the pre-FFQ and post-FFQ, the FFQ and 3-day WFR, and the
FFQ or WFR and urinary biomarkers were conducted as follows. Associations were
assessed

with

the

Spearman’s

rank

correlation

coefficient

on

raw

data.

Cross-classifications (quartile agreements) were calculated by establishing the percentage
of subjects in the same/exact, adjacent (±1 and/or ±2 quartiles) or extreme/opposite
quartile; each set of intake and excretion data were divided into four equal groups with
the three quartile points as the boundaries (Bhakta et al., 2005).
Bland Altman plots were used to assess the degree of agreement between methods and
provide a graphical means to assess whether the two techniques or points of measure at
different occasions were comparable for measuring phytoestrogens. Raw phytoestrogen
intake data were used to construct Bland Altman plots (Altman & Bland, 1983; Myles &
Cui, 2007).

Associations between phytoestrogen status and social and lifestyle characteristics
Social and lifestyle factors were organised in an Excel spreadsheet and imported to SPSS.
As there were only one or two subjects in some categories, these factors were
recategorised as follows. Occupation was coded into four categories: level 1 - Family
duties and Students, level 2 - Clerical and administrative workers, level 3 - Community
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and personal service workers and Technical and trade workers, level 4 - Professionals and
Managers. Education was coded into two categories: level 1- Below university level
(Other and Secondary education, and Certificate or diploma), level 2 – University level
(University undergraduate and university postgraduate). Ancestry was coded into two
categories: Caucasian and other ethnic groups which included South East Asian, South
Asian, North East Asian, Middle Eastern, North Africa and Somalia Peninsular,
Central/South America and Other and Mixed ancestry. Language spoken at home was
coded into two categories with English and Other languages, including Cantonese, Arabic,
Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonia and
Bahasa Indonesian. Country of birth was coded into four categories: group 1 - Oceania
and Antarctica, group 2 - Europe, group 3 - North Africa and the Middle East,
Sub-Saharan Africa and Americans, group 4 - Asia (South-East, North-East Asia, and
Southern and Central Asia).

Physical activity level (PAL) was coded into four

(sedentary, light, moderate and high) and smoking status into three (never smoked, past
and current smoker) categories, respectively. Bowel frequency was coded into two levels
(1-7/week and >7/week) and two categories, mushy and watery/liquidy and smooth and
easy to pass, and lumpy and hard to pass, for bowel movement (Lewis & Heaton, 1997).

The median ± IQR intake of total lignan, total enterolignan, total isoflavone and total
phytoestrogens with respect to different categories of social and lifestyle characteristics
were presented. The Mann Whitney U test was used to compare the difference in median
intake with two levels or categories of the characteristic, namely, gender (male or female),
education (below university or university level), ancestry (Caucasian or other ethnic
groups) languages spoken at home (English or other languages), bowel frequency
(1-7/week or >7/week), bowel movement (mushy/liquidy to smooth and easy to pass or
hard to pass) and supplement use (yes or no). The median intake for the other
characteristics with three or more levels or categories was assessed with Kruskal-Wallis
One-way ANOVA.
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Analysis of contributing food sources of phytoestrogens
Food items from the FFQ were listed in food groups specified in the Australian Dietary
Guidelines with Nuts and seeds, and Legumes and beans as two separate groups. Three
additional groups, Nonalcoholic beverages including coffee, tea and juices, Alcoholic
beverages and Mixed food was added to reflect consumption of beverages and food
composed of ingredients from two or more food groups. The FFQ template constructed
for measuring phytoestrogen intake was used to evaluate the contributing food sources to
dietary total lignans, total enterolignans and total isoflavones. Individual phytoestrogen
intakes from each food group were calculated from the pre-FFQs. Total phytoestrogen
intakes of all subjects were then calculated by summing individual phytoestrogens. The
percentage contributions of each food group were calculated by dividing total
phytoestrogen intake from that food group by total phytoestrogen intake in the whole
group. The pre-study FFQ was selected to conduct this analysis to reduce possible bias
and influence from completing the other dietary assessment tools.

Analysis for triangular comparison between FFQ, WFR, and urinary biomarker for
phytoestrogen status
The Method of Triads (MOT) was used for the triangular comparison between the FFQ
(Q), WFR (R) and urinary biomarkers (M) for assessing phytoestrogen status (Figure 9)
(Kaaks, 1997). The analysis was conducted using software R (version 3.1.2, R Core Team,
Vienna, Austria).
Scripts for performing analysis of correlations between the measurement methods (r QR,
r QM, r RM), validity coefficients (VCs) between each measurement method and the true
but unknown intake (VC QT, VC RT, VC MT), and the confidence intervals (CIs) for
VCs using the bootstrapping method, were written by the Statistician on the R script
interface. Bootstrapping is a random sampling technique with replacement from the
research population; the data from the current research population were randomly
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sampled for 1000 times (Kaaks, 1997; Ocké & Kaaks, 1997).

A template that contained

the dataset for intake and excretion measurements of Q, R and M from each subject, was
constructed and linked to the scripts. Demographic and lifestyle continuous variables,
such as age and BMI, and categorical variables, such as physical activity level, bowel
movement, and language spoken at home were included in the MOT model.

Figure 9. Graphical interpretation of the method of triads
(Adapted from (Ocké & Kaaks, 1997; Shai et al., 2005))
The method of triads is the triangular comparison between FFQ, reference method and
biomarker. VCs are the associations between the measurement derived from the method
and the unknown true intake. VCs are mathematically derived from correlations between
the measurements from the two methods.
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CHAPTER FOUR: RESULTS

4.1 Subjects
There were 131 individuals who expressed interest in the study during the four-month
recruitment, of which 48 did not respond to the candidate’s invitation, 10 declined, 2 were
ineligible, and 71 consented to participate. Of these, 12 subjects withdrew and 59 completed
the study (Figure 10). The study was powered for a minimum of 80 subjects but due to the
time constraints of subject recruitment, only 59 completed the study.

Figure 10. Flow chart of subject recruitment

The study population consisted of 40 females and 19 males aged 18 to 67 years who ranged in
BMI from 17.9 to 54.0 kg/m2. Almost half of the population (48%) were of normal weight
(20.0-25.0 kg/m2) and 44% were in the overweight/obese range (>25.01 kg/m2). The
demographic and lifestyle characteristics of recruited subjects according to their completed or
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withdrawn status are outlined in Table 4.

The Mann-Whitney U test and Pearson’s

Chi-Square test of contingencies indicated that completers were more likely to speak more
than one language at home, be less physically active and less likely to use supplements than
those who withdrew.
Table 4. Demographic and lifestyle characteristics of recruited subjects (n=71) according
to completed or withdrew status
Variablesa

Gender
Male
Female
Education level achieved
University postgraduate
University undergraduate
Certificate/diploma
Secondary school
Occupation
Family duties
Students
Clerical and administrative workers
Community and personal service workers
Technician and trade workers
Managers
and
Professionals
(in
Education, Health, Legal and social
welfare,
and
Information
and
organisation)
Ancestry
Caucasian
South East Asian
South Asian
North East Asian
Middle Eastern, North Africa, Somalia
Peninsular
Central/South America
Other and Mixed ancestry (Caucasian &
Central and West Africa; Caucasian &
Indigenous Australian; Caucasian &
Central/South American; Caucasian &
Asian)

Number (%) of
Subjects who
completed (n=59)

Number (%) of
Subjects who
withdrew (n=12)

p-value

19 (32)
40 (68)

4 (33)
8 (67)

0.593

24 (40.7)
22 (37.3)
11 (18.6)
2(3.4)

5 (41.7)
5 (41.7)
0 (0)
2(16.7)

0.290

3(5.1)
34(57.6)
2(3.4)
5(8.5)
1(1.7)
14(23.7)

1(8.3)
5(41.7)
2(16.7)
0(0)
0(0)
4(33.3)

0.691

38(64.4)
6(10.2)
3(5.1)
5(8.5)
2(3.4)

9(75)
0(0)
0(0)
0(0)
0(0)

2(3.4)
3(5.1)

1(8.3)
2(16.7)

0.435
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Variablesa

Language spoken at home
English
Other languages (Cantonese, Arabic,
Mandarin, Spanish, German, Hindi,
Malay, Persian, Urdu, Afrikaans,
Macedonian, Bahasa Indonesian)

Number (%) of
Subjects who
completed (n=59)

Number (%) of
Subjects who
withdrew (n=12)

p-value

38(64.4)
21(35.6)

12(100)
0(0)

29(49.2)
10(16.9)

7(58.3)
4(33.3)

2(3.4)
14 (23.7)

0(0)
0(0)

2(3.4)
2(3.4)

1(8.3)
0(0)

0.330

6(10)
18(30)
21(35)
15(25)

1(8.3)
1(8.3)
3(25)
7(58.3)

0.047

38(64.4)
14(23.7)
7(11.9)

7(58.3)
3(25)
2(16.7)

0.884

Bowel frequency
1-3/week
4-7/week
>7/week

3(5.1)
21(35.6)
35(59.3)

1(8.3)
5(41.7)
6(50)

0.526

Bowel movement
Mushy and watery/liquidy
Smooth and easy to pass
Lumpy, Hard to pass

2(3.4)
53(89.8)
4(6.8)

0(0)
10(83.3)
2(16.7)

0.448

Commercial supplement use
No
Yes

32(54.2)
27(45.8)

2(16.7)
10(83.3)

0.018

Region of Country of birth
Oceania and Antarctica
Europe (North-West Europe, Southern
and Eastern Europe)
North Africa and the Middle East
Asia (South-East Asia, North-East Asia,
Southern and Central Asia)
Americans
Sub-Saharan Africa
Physical Activity Level (PAL)
Sedentary
Light
Moderate
High
Smoking status
Never smoked
Past smoker
Current smoker

a

0.014

Chi-square test of contingencies was used for Gender, Ancestry, Language spoken at home, Region of country of birth,

Smoking status, Bowel movement and Commercial supplement use. Mann-Whitney U test was used for Education level
achieved, Occupation, Physical activity level and Bowel frequency.
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4.2 Intake and excretion of phytoestrogens
4.2.1 Intake and excretion of lignans and enterolignans
Median, range of intakes of lignans and enterolignans measured by the pre- and post-FFQ and
WFR, and excretion of corresponding urinary metabolites (biomarkers) are shown in Table 5.
Urinary PINO and LARI were not detected, as the mass spectrometer used was unable to
ionise the analytes.
There were wide inter-individual ranges of intake observed for lignans from all dietary
assessment methods, with smallest variation (20-fold) in LARI from the pre- and post-FFQs
and highest variation (500-fold) in PINO from the WFR. Similar wide inter-individual
variation was observed in urinary excretion of metabolites, with smallest variation (40-fold)
in SECO and highest variation (500-fold) in ENL. All data were markedly skewed towards
higher values.

The majority of total lignan intake was contributed by SECO, from 45% to 71% across
dietary assessment methods; followed by PINO (14% to 30%), LARI (10% to 20%), and
MAT (4% from all methods). SECO contributed to the majority of lignan excretion (53.5%)
followed by MAT (46.5%).
ENL consistently contributed more than 99% to total enterolignan intake with less than 1%
from END. The proportion of END increased to 15% in urinary excretion (Table 5).

4.2.2 Comparison of intake and excretion of lignans and enterolignans
Due to the non-normal distribution of these variables, non-parametric measures, the Wilcoxon
signed rank test to compare median intakes, and Spearman’s Rho correlations were used for
all comparisons.

The reliability of the FFQ for lignans and enterolignans was examined by comparing intakes
from the pre and post FFQ (Table 5).

Median intakes were significantly different for
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individual lignans (p<0.05 to 0.002), total lignans (p<0.001) and combined total lignans and
enterolignans (p<0.05); but not for ENL and END. There were highly significant associations
between individual lignans and enterolignans and combined total lignans and enterolignans (rs
=0.71 to 0.86, p<0.001 for all).

The convergent validity of the FFQ for lignans and enterolignans was examined by
comparing intakes from the pre FFQ and WFR (Table 5). The median intakes of individual
lignans and enterolignans and combined total lignan and enterolignan by pre FFQ and WFR
were not significantly different (p>0.05), except for LARI (p=0.03). Moderately significant
associations were observed between individual lignans and enterolignans, and total lignans
and enterolignans (rs =0.32-0.62, p<0.05), except for END.

The criterion validity of the FFQ was examined by comparing lignan and enterolignan intakes
from the pre-FFQ with urinary excretion of corresponding biomarkers; intake from the WFR
was also compared with biomarker excretion. Because of the known interconversions of
metabolites after ingestion in the diet, comparisons of intake and excretion were based on the
combined value for all lignans plus enterolignans; individual associations were not examined
(Table 5). There were no significant differences between median combined intake of total
lignans and enterolignans from the pre-FFQ or WFR and median biomarker excretion; there
were no significant associations between intake and excretion.
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Table 5. Median daily intake and excretion of lignans and enterolignans - comparisons between pre-FFQ, post-FFQ, 3-day WFR (n=59) and
urinary biomarkers (BM) (n=53)
Tools

Pre FFQ

Post FFQ

WFR

BM†

(µg/day)

Validity

Validity

Validity

(pre-post FFQ)

(pre FFQ-WFR)

(pre FFQ-BM‡

(WFR-BM)‡

Wilcoxon signed ranked test, Z statistics, (p-value) for median

Median (Q1-Q3)
SECO

Reliability

2625 (1166, 4806)

2204 (958,4157)

1813 (837,

809 (419, 991)

-2.57 (p=0.010)

-1.62 (p=0.105)

-

-

3903)
MAT

163 (84, 252)

125 (75, 229)

183 (77, 381)

336 (211, 540)

-3.09 (p=0.002)

1.37 (p=0.169)

-

-

PINO

431 (266, 929)

391 (214, 638)

562 (211, 1546)

-

-2.40 (p=0.017)

0.99 (p=0.324)

-

-

LARI

518 (320, 685)

466 (226, 658)

636 (283, 1234)

-

-1.98 (p=0.048)

2.21 (p=0.027)

-

-

3914 (1965, 7317)

3839 (1795, 5845)

4302 (1920, 6354)

1118 (776, 1530)

-3.53 (p<0.001)

0.09 (p=0.929)

5.17 (p<0.001) (a)

5.66 (p<0.001) (a)

ENL

54 (22, 104)

52 (21, 101)

64 (34, 82)

1583 (589, 3151)

-1.62 (p=0.106)

-0.24 (p=0.813)

-

-

END

0.31 (0.14, 0.60)

0.35 (0.18, 0.68)

0.32 (0.05, 0.83)

175 (81, 344)

1.36 (p=0.176)

0.75 (p=0.453)

-

-

54 (23, 104)

53 (22, 102)

65 (35, 83)

1837 (740, 3856)

-1.41 (p=0.158)

-0.24 (p=0.807)

-6.33 (p<0.001)

-6.33 (p<0.001)

4051 (1995, 7945)

3930 (1851, 6058)

4446 (1877, 6959)

3104 (1685, 5725)

-3.65 (p<0.001)

0.32 (p=0.751)

1.24 (p=0.217)

1.16 (p=0.244)

Total lignans

Total enterolignans
Total

lignans

and

enterolignans±
Spearman’s Rho correlation, (95% CI)

Min, Max
SECO

161, 43455

78, 15391

328, 14673

74, 3220

0.81** (0.69, 0.88)

0.45** (0.22, 0.64)

-

-

MAT

21, 1765

18, 1713

23, 1682

19, 5269

0.82** (0.71,0.89)

0.45** (0.21,0.63)

-

-

PINO

59, 6612

27, 3203

41, 22560

-

0.71** (0.56,0.82)

0.32* (0.07, 0.53)

-

-

LARI

96, 2248

72, 1688

112, 9014

-

0.79** (0.66,0.87)

0.39** (0.15,0.59)

-

-

377, 46919

195, 18426

587, 47213

93, 6884

0.85** (0.76,0.91)

0.42** (0.18,0.61)

0.15 (-0.13, 0.40)(a)

0.24 (-0.03, 0.48)(a)

ENL

0, 416

0, 237

0, 257

54, 25657

0.86** (0.79, 0.90)

0.63**(0.44,0.76)

-

-

END

0, 2.34

0, 3.73

0, 4.16

16, 6491

0.75** (0.62,0.85)

0.15 (-0.11,0.39)

-

-

389, 46963

203, 21618

670, 536273

480, 35549

0.86** (0.77, 0.91)

0.44** (0.21, 0.63)

0.16 (-0.12, 0.41)

0.14 (-0.14, 0.40)

Total lignans

Total

lignans

and

enterolignans±
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Table 5. continued
Median daily intake and excretion of lignans and enterolignans
Tools

Pre FFQ

Post FFQ

WFR

BM†

71.15% (1st)

69.92% (1st)

45.33% (1st)

(µg/day)
Percentage (%)
contribution
SECO
MAT
PINO

th

th

th

53.5%

3.73% (4 )

4.29% (4 )

4.46% (4 )

nd

nd

nd

-

rd

14.70% (2 )

13.78% (2 )

46.5%

30.35% (2 )

LARI

10.42% (3 )

12.01% (3 )

19.86% (3 )

-

ENL

99.42%

99.22%

99.10%

84.6%

END

0.58%

0.78%

0.90%

15.4%

**p<0.001*p=0.02

rd

rd

(a) comparison between intake of SECO, MAT, PINO, LARI and excretion of SECO, MAT

† the dash line’-‘ for the BM column indicated that PINO and LARI were not detected in the LC-MS and subsequent analysis was not applicable
‡ the dash line ‘-‘ indicated that the comparison was not reported for between individual lignan intake and excretion due to inter-conversion from individual to enterolignan
± combined total intake of lignans (SECO, MAT, PINO, LARI) and enterolignans (ENL, END)
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4.2.3 Intake and excretion of isoflavonoids
Median (IQR) and range of intakes of isoflavonoids measured by pre FFQ, post FFQ and
WFR, and excretion of corresponding urinary metabolites (biomarkers) are shown in Table 6.
Urinary biochanin A was not detected, as the mass spectrometer was unable to ionise the
analyte.
Inter-individual variation in isoflavonoid intakes were overall greater than those for lignans
and enterolignans, with 300- to 6,000-fold variation observed for major isoflavonoids,
daidzein and genistein, and up to 8,000-fold for glycitein, formononetin and biochanin A,
where intake from individual subjects was very low, less than 1 µg/d. Data were notably
skewed towards higher values.
The majority of total isoflavonoid intake was contributed by daidzein (37% across all dietary
intake methods) and genistein (3% to 47%), with smaller contributions from glycitein (5% to
9%), formononetin (0.3% to 3%) and biochanin A (1% to 7%). Daidzein contributed to the
majority of isoflavonoid excretion (61%), followed by genistein (33%).

4.2.4 Comparison of intake and excretion of isoflavonoids
Due to the non-normal distribution of these variables, non-parametric measures, the Wilcoxon
signed rank test to compare medians, and Spearman’s Rho correlations, were used for all
comparisons.
The reliability of the FFQ for isoflavonoids was examined by comparing intakes from the pre
and post FFQs. Median intakes were not significantly different for individual or total
isoflavonoids (Table 6). There were highly significant associations between individual
isoflavonoids and total isoflavonoids (rs =0.76 to0.87, p<0.001 for all).
The convergent validity of the FFQ for isoflavonoids was examined by comparing intakes
from the pre FFQ and WFR reference method (Table 6). The median intakes of individual and
total isoflavonoids were not significantly different.

Moderately significant associations were

observed between individual or total isoflavonoids (rs =0.36 to 0.46, p<0.001 for all, except
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formononetin rs =0.26, p<0.05).
The criterion validity of the FFQ was examined by comparing isoflavonoid intakes from the
pre-FFQ with urinary excretion of corresponding biomarkers; intake from the WFR was also
compared with biomarker excretion (Table 6).

Median intakes for individual and total

isoflavonoids from the FFQ and WFR were significantly different to median biomarker
excretion (p<0.001 for all). There were significant associations between intake from the WRF
and biomarker excretion for daidzein (rs =0.46, p<0.001), glycitein (rs =0.30, p<0.05) and
total isoflavonoids (rs =0.28, p<0.05) but not for genistein or formononetin; there were no
significant associations between intake from the FFQ and biomarker excretion.

4.2.5 Intake and excretion of total phytoestrogens
Total phytoestrogen intake varied from 150-fold in the post-FFQ to 400-fold in the WFR.
Total isoflavones contributed 45% to 69% of total phytoestrogen intake obtained from the
three dietary tools and to 80% of urinary biomarker excretion (Table 7).

4.2.6 Comparison of intake and excretion of total phytoestrogens
There were significant associations between phytoestrogen intakes from the pre- and post
FFQs (rs =0.78, p<0.001) and pre-FFQ and WFR (rs =0.33, p<0.05), but not between the FFQ
or WFR and urinary biomarker excretion. (Table 7)
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Table 6. Median daily intake and excretion of isoflavonoids (µg/day) -comparisons between pre-FFQ, post-FFQ, 3-day WFR, (n=59) and urinary
biomarkers (n=53) (BM)
Tools

Pre FFQ

Post FFQ

WFR

BM†

(µg/day)

Validity (WFR-BM)†

Reliability

Validity

Validity

(pre-post FFQ)

(pre FFQ-WFR)

(pre FFQ-BM)†

Wilcoxon signed ranked test, Z statistics, (p-value) for median

Median (Q1-Q3)
Daidzein

1213 (269,4673)

608 (200,5294)

695 (203,3558)

161 (40, 569)

-1.28 (p=0.199)

-0.16 (p=0.874)

4.81 (p<0.001)

4.37 (p<0.001)

Genistein

1321 (243,5245)

1006 (218,5429)

721(280,4424)

91 (35, 489)

-1.01 (p=0.312)

-0.41 (p=0.684)

5.62 (p<0.001)

5.39 (p<0.001)

Glycitein

198 (36,1046)

145 (31,1328)

87 (26,1060)

18 (5, 55)

-1.19 (p=0.233)

-0.15 (p=0.880)

5.38 (p<0.001)

5.23 (p<0.001)

Formononetin

108 (26,367)

67 (21,372)

55 (21,378)

1.9 (1.4, 2.5)

-1.18 (p=0.239)

-0.52 (p=0.602)

6.03 (p<0.001)

6.08 (p<0.001)

Biochanin A

97 (29,252)

103 (24,256)

57 (22,175)

-0.94 (p=0.345)

-0.78 (p=0.437)

Total

3851 (920,11857)

2667 (795,12823)

2287 (847,11129)

-0.69 (p=0.487)

0.42 (p=0.673)

268 (96, 1388)

-

-

5.75 (p<0.001)(b)

5.63 (p<0.001) (b)

isoflavonoids
Spearman’s Rho correlation, (95% CI)

Min, Max
Daidzein

41, 124990

36, 22508

40, 89183

8, 7780

0.77***(0.63,0.85)

0.46***(0.23,0.64)

0.18 (-0.10, 0.43)

0.46*** (0.22, 0.65)

Genistein

52,164962

41, 30551

60, 121264

10, 3554

0.76***(0.63,0.85)

0.44***(0.21,0.63)

0.03 (-0.24, 0.30)

0.23 (-0.04, 0.47)

Glycitein

9, 36727

6, 8669

2, 15807

0.9, 692.2

0.80***(0.69,0.88)

0.45***(0.22,0.63)

0.22 (-0.05, 0.46)

0.30* (0.03, 0.53)

Formononetin

5, 1994

1, 2661

2, 1981

0.5, 68.2

0.83***(0.73,0.90)

0.26*(0.01,0.49)

0.14 (-0.14, 0.40)

0.02 (-0.25, 0.29)

Biochanin A

6, 1098

1, 1200

2, 15918

-

0.87***(0.79,0.92)

0.38***(0.14,0.58)

-

-

Total

202, 326708

122, 57996

208, 226389

0.78***(0.66,0.86)

0.36***(0.12,0.57)

0.10 (-0.18, 0.36)(b)

0.28** (0.01, 0.51)(b)

20, 10293

isoflavonoids
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Table 6. continued
Median daily intake and excretion of isoflavonoids
Tools

Pre FFQ

Post FFQ

WFR

BM†

(µg/day)
Percentage

Reliability

Validity

Validity

(pre-post FFQ)

(pre FFQ-WFR)

(pre FFQ-BM)†

Validity (WFR-BM)†

(%)

contribution (a)
Daidzein

37.87% (2nd)

37.94% (2nd)

37.24% (2nd)

61.4% (1st)

Genistein

48.74% (1st)

47.16% (1st)

44.47% (1st)

33.3% (2nd)

Glycitein

9.85% (3rd)

9.33% (3rd)

8.77% (3rd)

5.0% (3rd)

Formononetin
Biochanin A

th

2.09% (4 )
th

1.46% (5 )

th

3.22% (4 )
th

2.35% (5 )

th

2.37% (5 )
th

7.15% (4 )

0.3% (4th)
-

***p<0.001 **p=0.044 *p=0.03

(a) total isoflavone biomarker = daidzein, genistein, glycitein and formononetin
(b) comparison between intake of daidzein, genistein, glycitein, formononetin and biochanin A and excretion (excluding biochanin A, not detected)
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Table 7. Median daily intake and excretion of total phytoestrogens (µg/day) - comparisons between the pre-FFQ, post-FFQ, 3-day WFR (n=59),
and urinary biomarker (n=53) (BM)
Tools

Pre FFQ

Post FFQ

WFR

BM

(µg/day)

Validity

Validity

Validity

(pre-post FFQ)

(pre FFQ-WFR)

(pre FFQ-BM

(WFR-BM)

Wilcoxon signed ranked test, Z statistics, (p-value) for median

Median (Q1-Q3)
Total

Reliability

9633 (4663, 21329)

8592 (3863, 19259)

7775 (4774, 28596)

3924 (2205, 7575)

-2.05 (p=0.041)

1.05 (p=0.294)

4.27 (p<0.001)

4.40 (p<0.001)

0.12 (-0.16, 0.38)

0.002 (-0.27, 0.27)

phytoestrogens
Spearman’s Rho Correlation, (95% CI)

Min, Max
Total

1331, 333011

440, 65893

1233, 543004

522, 38567

Total isoflavones

68.9%

65.6%

44.9%

20.8%

Total lignans and

31.1%

34.4%

55.1%

79.2%

0.78** (0.66, 0.87)

0.33* (0.08, 0.54)

phytoestrogens
Percentage (%)
contribution (a)

enterolignans
**p<0.001 *0.011
(a) contribution to total phytoestrogen
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4.3 Cross classification of phytoestrogen intake
Dietary intake and urinary excretion data for individual phytoestrogens were categorised into
quartiles and a comparison of ranks was conducted between tools to further evaluate the
validity and reliability of the modified FFQ (Table 8).

The reliability of the FFQ was examined by comparing intakes from the pre- and post- FFQ;
64% to 73% of total lignans, enterolignans or isoflavones were correctly classified into the
same quartiles, with 23.7% to 32.2%, correctly classified into adjacent quartiles.

The convergent validity was examined by comparing intakes from the pre-FFQ and WFR;
32% to 47% of total lignans, enterolignans or isoflavones were correctly classified into the
same quartile, with 45.8% to 52.5%, correctly classified into adjacent quartiles.

The criterion validity was examined by comparing intakes from the pre-FFQ with biomarker
excretion; 24.5% to 26.4% of total lignans, enterolignans or isoflavones were correctly
classified into the same quartile, with 47.2% to 54.7% correctly classified into adjacent
quartiles; cross classification of ranks between the WFR and biomarker excretion was
comparable.

More than 90% were ranked in either the same or adjacent quartile when comparing the
pre-FFQ and post-FFQ, indicating the FFQ was a highly reliable tool for ranking intake in the
same, ±1 or ±2 quartiles. More than 80% were ranked in either the same or adjacent quartile
when comparing the FFQ with WFR indicating that the FFQ was a highly valid tool for
ranking intake. More than 70% were ranked in either the same or adjacent quartile when
comparing the FFQ with the urinary biomarker indicating moderate criterion validity
(Fernandez et al., 2013).
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Table 8. Cross classification comparison between quartiles of phytoestrogen intake and excretion for pre FFQ, post FFQ, WFR (n=59) and
urinary biomarkers (n=46)
Pre FFQ and Post FFQ

Pre FFQ and WFR

Pre FFQ and Biomarker†

WFR and Biomarker†

Same

Adjacent

Opposite

Same

Adjacent

Opposite

Same

Adjacent

Opposite

Same

Adjacent

Opposite

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

quartiles

SECO

62.7%

33.9%

3.4%

32.2%

52.5%

15.3%

28.3%

54.7%

17.0%

26.4%

58.5%

15.1%

MAT

64.4%

28.8%

6.8%

33.9%

52.5%

13.6%

24.5%

54.7%

20.8%

24.5%

52.8%

22.6%

PINO

57.6%

39.0%

3.4%

23.7%

55.9%

20.3%

-

-

-

-

-

-

LARI

59.3%

37.3%

3.4%

35.6%

50.8%

13.6%

-

-

-

-

-

-

Total lignan

71.2%

23.7%

5.1&

32.2%

52.5%

15.3%

26.4%

54.7%

18.9%

30.2%

58.5%

11.3%

ENL

71.2%

27.1%

1.7%

50.8%

40.7%

8.5%

28.3%

47.2%

24.5%

26.4%

49.1%

24.5%

END

66.1%

30.5%

3.4%

25.4%

54.2%

20.3%

26.4%

43.4%

30.2%

22.6%

49.1%

28.3%

Total enterolignan

72.9%

25.4%

1.7%

47.5%

45.8%

6.8%

24.5%

47.2%

28.3%

28.3%

47.2%

24.5%

Daidzein

64.4%

32.2%

3.4%

39.0%

49.2%

11.9%

26.4%

52.8%

20.8%

41.5%

47.2%

11.3%

Genistein

66.1%

28.8%

5.1%

45.8%

42.4%

11.9%

22.6%

54.8%

22.6%

24.5%

58.5%

17.0%

Glycitein

72.9%

22.0%

5.1%

33.9%

54.2%

11.9%

43.4%

35.8%

20.8%

33.9%

47.2%

18.9%

Formononetin

64.4%

33.9%

1.7%

30.5%

55.9%

13.6%

35.8%

43.4%

20.8%

24.5%

49.1%

26.4%

Biochanin A

67.8%

28.8%

3.4%

39.0%

45.8%

15.3%

Total isoflavone

64.4%

32.2%

3.4%

37.3%

45.8%

16.9%

26.4%

52.8%

20.8%

37.7%

45.3%

17%

Total Lignan and Total

71.2%

23.7%

5.1%

33.9%

50.8%

15.3%

28.3%

49.1%

22.6%

24.5%

60.4%

15.1%

71.2%

25.4%

3.4%

35.6%

49.2%

15.3%

26.4%

54.7%

18.9%

26.4%

47.2%

26.4%

Phytoestrogens

-

-

-

-

-

-

Enterolignan
Total Phytoestrogens‡

†the dash line ‘-‘indicated that the PINO, LARI and biochanin A were not detected in the LC-MS and the analysis cannot be conducted
‡ total phytoestrogens = total lignans + total enterolignans + total isoflavonoids
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4.4 Bland Altman plots of assessing the validity of food frequency questionnaire with
weighed food record
Bland Altman plots for comparing consistency of individual and total phytoestrogen intakes
estimated by pre FFQ and WFR are shown in Figures 11-14.

The mean bias between intakes, and limits of agreement for phytoestrogen intakes measured
from the pre-FFQ and WFR are shown in Table 9. The mean bias for individual
phytoestrogens measured by the two tools, ranged from 1256 µg/day for SECO to –1075
µg/day for PINO; the FFQ overestimated intake compared to the WFR for all individual
phytoestrogens except SECO, ENL, daidzein and genistein.

The Bland Altman plots showed a similar trend towards greater bias at higher mean
phytoestrogen intakes (Figure 11-14), suggesting poorer consistency of intake between the
FFQ and reference method for those subjects reporting higher phytoestrogen intakes.
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Table 9. Bias and 95% limits of agreement for measures of phytoestrogen by pre FFQ
compared with the WFR
Phytoestrogens
n
Mean
95% CI
Limits of agreement†
difference/Bias
*
Lignans
SECO
58
1256
-383, 2895
-11212, 13724
MAT
58
-67
-161, 27
-784, 650
PINO
58
-1075
-2249, 98
-10001, 7850
LARI
58
-658
-1125, -190
-4217, 2902
Total lignan
58
-544
-3248, 2160
-21109, 20021
Enterolignans
ENL
59
4
-11, 19
-115, 123
END
59
-0.2
-0.4, 0
-2.1, 1.7
Total enterolignan
59
3.8
-11, 19
-115, 123
Isoflavones
Daidzein
59
522
-4505, 5550
-38061, 39105
Genistein
59
1106
-5498, 7710
-49578, 51790
Glycitein
59
-251
-1108, 1610
-10180, 10682
Formononetin
59
-10
-157, 137
-1142, 1122
Biochanin A
59
-697
-1396, 1.2
-6059, 4664
Total isoflavone
59
1172
-11811, 14154
-98460, 100803
Total lignan and
enterolignan
Total phytoestrogens

59

-9217

-26794, 8360

-178626, 125680

59

-8045

-30272, 14181

-178626, 162535

*Bias is the difference (pre FFQ -WFR) between the raw values of intake phytoestrogens estimated from the pre FFQ and
WFR. This is the absolute difference between the raw mean intakes estimated from the pre FFQ and WFR.
† 95% Limits of agreement (mean difference±2SD)
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Figure 11. Bland Altman plots of estimated intake of (a) SECO, (b) MAT, (c) PINO, (d) LARI, (e) total lignan
by pre FFQ and average of 3-day WFR.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference)
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Figure 12. Bland Altman plots of estimated intake of (a) ENL, (b) END, (c) total enterolignan by pre FFQ and
average of 3-day WFR.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference)
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Figure 13. Bland Altman plots of estimated intake of (a) daidzein, (b) genistein, (c) glycitein, (d)formononetin,
(e) biochanin A, (f) total isoflavone by pre FFQ and average of 3-day WFR.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference)
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Figure 14. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and
enterolignan (END, ENL) (b) Total phytoestrogen (total lignan, total enterolignan and total isoflavone) by pre
FFQ and average of 3-day WFR.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference)
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4.5 Bland Altman plots of assessing the validity of food frequency questionnaire with
biomarkers
Bland Altman plots for comparing consistency of intake and excretion of total lignans,
enterolignans and isoflavonoids estimated by pre FFQ, and urinary biomarker excretion are
shown in Figures 15-18.

The comparisons of individual phytoestrogens are not shown.

The mean bias between intake from the pre-FFQ and biomarker excretion, and limits of
agreement are shown in Table 10. The mean bias ranged from -3119 µg/day for total
enterolignans to 13179 µg/day for total isoflavonoids; the FFQ overestimated compared to
urinary excretion for all phytoestrogen classes except total enterolignans.

Bland Altman plots (Figures 15 to 18) demonstrated a trend towards larger bias at higher
mean estimates of intake and excretion of the phytoestrogen classes. This trend is similar to
those observed for individual phytoestrogens in Figures 11 to 14, indicating poorer
consistency of measurement between intake and excretion at higher intakes.

Table 10. Bias and 95% limits of agreement for measures of phytoestrogen by pre FFQ
compared with the Biomarker (BM)
Phytoestrogens
n
Mean
95% CI
Limits of
difference/Bias
agreement†
*
Total lignan
53
4188
2128, 6249
-10762, 19139
Total enterolignan
53
-3119
-4517, -1722
-13259, 7020
Total isoflavone
53
13179
761, 25598
-76926, 103285
Total lignan and
53
1069
-1421, 3559
-16999, 19136
enterolignan
Total phytoestrogens 53
14248
1513, 26983 -78156, 106652
*Bias is the difference (pre FFQ -BM) between the raw values of intake phytoestrogens estimated from the pre FFQ and
excretion estimated from BM. This is the absolute difference between the raw mean intakes estimated from the pre FFQ and
excretion from BM.
† 95% Limits of agreement (mean difference±2SD)
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Figure 15. Bland Altman plots of estimated intake of (a) total lignans by pre FFQ (SECO, MAT, PINO, LARI)
and average of urinary biomarkers (SECO, MAT).
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ± mean difference)

Figure 16. Bland Altman plots of estimated intake of (a) total enterolignan (END, ENL) by pre FFQ and average
of urinary biomarkers.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ± mean difference)
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Figure 17. Bland Altman plots of intake of (a) total isoflavone intake by pre FFQ (daidzein, genistein, glycitein,
formononetin, biochanin A) and average of urinary biomarkers (daidzein, genistein, glycitein, formononetin).
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ± mean difference)
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Figure 18. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and
enterolignan (END, ENL) (b) total phytoestrogen (lignan, enterolignans and isoflavones) by pre FFQ and
average of urinary biomarkers.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference).
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4.6 Bland Altman plots of assessing the reliability of FFQ
Bland Altman plots for comparing consistency of phytoestrogen intakes estimated by the pre
FFQ and post FFQ are shown in Figures 19 to 22. The mean bias between the intakes and
limits of agreement for phytoestrogen intake measured by the FFQ administered 1 to 2 weeks
apart are shown in Table 11. The mean bias for individual phytoestrogens ranged from -9.2
µg/day for biochanin A to 2496 µg/day for genistein.

The pre-FFQ overestimated intake

compared to the post-FFQ for all individual phytoestrogens except END and biochanin A.
The Bland Altman plots show a trend towards greater bias at higher mean phytoestrogen
intakes suggesting poorer consistency of intake between repeat FFQs for those subjects with
higher phytoestrogen intakes (Figures 19-22).
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Table 11. Bias and 95% limits of agreement for measures of
FFQ compared with the post FFQ
Phytoestrogens
n
Mean
95% CI
difference/Bias*
Lignans
SECO
58
1119
-294, 2552
MAT
58
32
12, 52
PINO
58
262
-34, 557
LARI
58
89
-8, 186
Total lignan
58
1512
112, 2911
Enterolignans
ENL
59
8.9
-3.2, 21.1
END
59
-0.1
-0.19, 0.04
Total enterolignan
59
8.9
-3.3, 21.1
Isoflavones
Daidzein
59
1823
-2212, 5858
Genistein
59
2496
-2788, 7780
Glycitein
59
522
-663, 1707
Formononetin
59
1.2
-98, 100
Biochanin A
59
-9.2
-51, 33
Total isoflavone
59
4833
-5670, 15336
Total lignan and
enterolignan
Total phytoestrogens

phytoestrogen by pre
Limits of
agreement†
-9693, 11951
-123, 187
-1985, 2508
-650, 828
-9136, 12159
-85, 103
-0.97, 0.81
-85, 103
-29142, 32789
-38057, 43048
-8573, 9617
-757, 759
-330, 311
-75774, 85439

59

1529

155, 2903

-9015, 12074

59

6362

-4371, 17095

-76008, 88732

*Bias is the difference (pre FFQ-post FFQ) between the raw values of intake phytoestrogens estimated from the pre
FFQ and post FFQ. This is the absolute difference between the raw mean intakes estimated from the pre FFQ and post
FFQ.

† 95% Limits of agreement (mean difference±2SD)
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Figure 19. Bland Altman plots of estimated intake of (a) SECO, (b) MAT, (c) PINO, (d) LARI, (e) total lignan
by pre FFQ and post FFQ.

The central dashed line represents the mean difference (bias). The upper and lower

dashed lines represent the 95% limits of agreement (2SD of the mean difference)
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Figure 20. Bland Altman plots of estimated intake of (a) ENL, (b) END, (c) total enterolignan by pre FFQ and
post FFQ.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference)
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Figure 21.Bland Altman plots of estimated intake of (a)daidzein (b)genistein (c)glycitein (d)formononetin
(e)biochanin A (f)total isoflavone by pre FFQ and post FFQ.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ±the mean difference)
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Figure 22. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and
enterolignan (END, ENL) (b) total phytoestrogen (total lignan, total enterolignan and total isoflavone) by pre
FFQ and post FFQ.

The central dashed line represents the mean difference (bias). The upper and lower dashed

lines represent the 95% limits of agreement (2SD of the mean difference)
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4.7 Bland Altman plots for weighed-food record and urinary biomarkers

Bland Altman plots for comparing consistency of total phytoestrogen intake and excretion for
total lignans, enterolignans and isoflavonoids, estimated by the WFR and urinary biomarkers
are shown in Figures 23-26. The mean bias between the intakes and excretion of
phytoestrogen classes ranged from -3120 µg/day, for total enterolignans, to 14230 µg/day for
total lignans (Table 12); dietary intake estimated by the WFR was greater than urinary
biomarker excretion for total lignans and isoflavonoids, but urinary excretion of total
enterolignans exceeded enterolignan intake.

The Bland Altman plots showed the bias of the

estimates between WFR and biomarkers, (Figure 23-26), was larger when the mean estimates
of intake and excretion were higher. This trend is similar to what was observed between FFQ
and biomarker in Figures 15-18 and between estimates of intake between FFQ and WFR in
Figures 11-14.

Table 12. Bias and 95% limits of agreement for
compared with the Biomarker
Phytoestrogens
n
Mean
difference/Bias*
Total lignans
53
14230
Total enterolignans
53
-3120
Total isoflavones
53
11703
Total lignans and
53
11110
enterolignans
Total phytoestrogens
53
22813

measures of phytoestrogen by WFR
95% CI
-5928, 34388
-4515, -1726
2922, 20485
-9021, 31240

Limits of
agreement†
-132037, 160497
-13239, 6999
-52016, 75423
-134958, 157177

1303, 44323

-133264, 178890

* Bias is the difference (WFR-BM) between the raw values of intake phytoestrogens estimated from the WFR and excretion
from BM. This is the absolute difference between the raw mean intakes estimated from the WFR and excretion from BM.
† 95% Limits of agreement (mean difference±2SD
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Figure 23. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) by average of
3-day WFR and average of urinary biomarker (SECO, MAT).
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ± mean difference)

Figure 24. Bland Altman plots of estimated intake of (a) total enterolignan (END, ENL) by average of 3-day
WFR and average of urinary biomarker (END, ENL).
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ± mean difference)

111

Figure 25. Bland Altman plots of estimated intake of (a) total isoflavone (daidzein, genistein, glycitein,
formononetin, biochanin A) by average of 3-day WFR and average of urinary biomarker (daidzein, genistein,
glycitein, formononetin).
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD ±the mean difference)
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Figure 26. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and
enterolignan (END, ENL) (b) total phytoestrogens (total lignans, total enterolignans and total isoflavones) by
average of 3-day WFR and average of urinary biomarkers.
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the
95% limits of agreement (2SD of the mean difference)

113

4.8 Intake and excretion of phytoestrogens and demographic and lifestyle characteristics
The associations between demographic and lifestyle characteristics and median intakes of
total lignans, enterolignans and isoflavones from the FFQ and WFR are shown in Tables 13
and 14, respectively. Associations with median biomarker excretion are shown in Table 15.
The Mann-Whitney U test and Kruskal-Wallis one-way ANOVA were used to compare the
median intakes across categories of these demographic and lifestyle factors. A Bonferroni
adjustment was made for multiple comparisons, with a probability of P<0.0125 taken as
statistically significant.

Based on the FFQ, total lignan intake was higher in subjects with Caucasian ancestry, who
spoke English at home and who used commercial supplements (all p=0.01); there was a trend
towards higher intakes in females compared to males (p=0.03) and those born in Oceania,
North Africa or Middle East (p=0.02). Total enterolignan intake was higher in subjects who
used commercial supplements (p=0.01); there was a trend to higher intakes in subjects with
university education (p=0.02) (Table 13).

Based on the WFR, there were trends towards

higher total lignan intake in subjects who spoke English at home and higher total enterolignan
intake in those who used commercial supplements (both p=0.03). Phytoestrogen intake was
significantly in subjects who were either sedentary or had high physical activity (both p=0.01)
(Table 14).

Based on the urinary biomarkers, there were no significant associations for total lignan or
total isoflavone intakes. There were trends towards higher enterolignan excretion in females
compared to males, in subjects with education to secondary school, certificate or diploma
(both p=0.03), and in subjects from Oceania (p=0.04) (Table 15). Commercial supplements
consumed by subjects included multivitamins, calcium, iron, fish oil, protein powder.
Isoflavonoid or lignan dietary supplements such as LSA (linseed, soy, almond) were coded as
food items.
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Table 13. Average intake of lignans, enterolignans, isoflavones (µg/day) from pre-food
frequency questionnaire (FFQ pre) according to subjects’ characteristics (n=59)
Subject characteristics
Total lignans Total
Total
Total
phytoestrogens
Median±IQR enterolignans isoflavones
Median±IQR Median±IQR Median+IQR
Gender
Male (n=19)
2356±2663
54±83
2453±8806
6678±10786
Female (n=40)
4660±6735
54±81
4684±12260 10828±17064
p-value†
0.75
0.48
0.12
0.03
BMI(kg/M2)
<20.00 (n=5)
20.00-25.00 (n=28)
25.01-30.01 (n=15)
>30.01 (n=11)
p-value‡

2942±4310
3895±3762
4148±8576
4108±11931
0.74

61±211
48±81
44±110
59±64
0.66

832±10582
2216±9109
7102±14858
6202±11771
0.45

6064±11713
8398±13686
12905±27614
12299±23708
0.49

Age (y)
18-28 (n=26)
29-39 (n=16)
40-50 (n=9)
>50 (n=8)
p-value‡

3102±4820
3895±4066
3984±4983
9809±9733
0.08

53±67
44±83
66±93
57±124
0.94

1971±7937
6257±5873
11857±27316
9540±27171
0.34

7325±13826
9842±7164
19921±28639
18596±33138
0.19

3894±6853

52±75

2453±10407

9553±14836

4894±5444

76±107

6656±10421

11845±14362

3941±2557

56±35

11602±20726 16165±22081

3143±13101

63±202

4273±15787

8914±40140

0.94

0.85

0.80

0.98

5254±9271

15±57

7102±25839

18365±36049

University (undergraduate (n=22, 3757±5195

59±82

2518±9002

9452±12740

0.02

0.49

0.42

Occupation
Family duties (n=3) and
Students (n=34)
Clerical and administrative
workers (n=12)
Community and personal
service (n=2) & Technician
and trade workers (n=2)
Professionals (n=5) &
Managers (n=1)
p-value‡
Education level achieved
Below university (Other (n=1),
Secondary school (n=1),
Certificate/diploma (n=11)
postgraduate (n=24)

p-value†

0.53
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Table 13 continued
Subject characteristic

Total lignans
Median±IQR

Total
enterolignans
Median±IQR

Total
isoflavones
Median±IQR

Total
phytoestrogens
Median+IQR

Ancestry
Caucasian (n=38)
Other ethnic groups (n=21)1
p-value†

5264±8158
2356±2608
0.01

55±83
37±91
0.73

2352±12354
5732±9600
0.67

10757±21450
7303±11404
0.23

Language spoken at home
English (n=38)
Other languages (n=21)2
p-value†

4156±8156
2345±3707
0.01

57±84
37±91
0.54

3217±12354
3853±9974
0.94

11811±21009
7303±13608
0.16

5640±8544

59±97

1992±10462

11322±19906

3939±6117

57±50

2299±16692

7936±27408

Region of country of birth
Oceania and Antarctica
(n=29)
North-West (n=9) &
Southern and Eastern Europe
(n=1)
North Africa and the Middle
East (n=2), Americans (n=2),
Sub-Saharan Africa (n=2)
Asia (n=14)3
p-value‡

5596±4623

69±160

7598±9613

11840±10843

2182±2229
0.02

29±49
0.44

5967±12533
0.74

7300±14059
0.91

Physical activity level
(PAL)
Sedentary (n=5)
Light (n=18）
Moderate (n=21)
High (n=15)
p-value‡

4108±9009
3884±5731
3897±3639
4164±9030
0.64

13±22
61±106
54±75
55±70
0.13

16263±17243
5624±6875
1950±8595
3853±10474
0.06

26918±16872
10477±11824
6678±11279
12368±31924
0.053

Smoking status
Never smoked (n=38)
Past smoker (n=14)
Current smoker (n=7)
p-value‡

3491±3736
7098±14890
4148±8705
0.08

52±78
49±108
71±102
0.54

4684±9940
8924±31712
1544±3358
0.17

8560±13680
22765±47001
9028±10146
0.08
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Table 13 continued
Subject characteristic

Total lignans
Median±IQR

Total
enterolignans
Median±IQR

Total
isoflavones
Median±IQR

Total
phytoestrogens
Median+IQR

Bowel frequency
1-7/week (n=24)
>7/week (n=35)
p-value†

3152±3762
4108±6889
0.06

36±61
55±92
0.15

4792±11015
2584±10937
0.88

7387±14220
12299±20687
0.17

Bowel movement
Mushy and watery (n=2) &
Smooth and soft to pass
(n=53)
Hard to pass (n=4)
P-value†

3897±5865

54±82

2584±11610

9633±18639

4652±8033
0.55

54±117
0.74

4683±4872
0.94

10175±11717
0.85

Commercial supplements
use
No (n=32)
Yes (n=27)
P-value†

2644±3434
5640±8595
0.01

36±51
71±120
0.01

2382±14764
5732±9229
0.52

7278±17800
12299±15973
0.10

*Mann-Whitney U test
** Kruskal-Wallis One-Way ANOVA
1

South East Asian (n=6), South Asian (n=3), North East Asian (n=5), Middle Eastern, North Africa, Somalia
Peninsular (n=2), Central/South America (n=2), Other (n=1) & Mixed ancestry (n=2)

2

Cantonese, Arabic, Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonian, Bahasa
Indonesian)

3

(South-East (n=6), North-East (n=5), Southern and Central (n=3)

117

Table 14. Average intake of lignans, enterolignans, isoflavones from 3-day weighed food
record (WFR) according to subjects’ characteristics (n=59)
Subject characteristics
Total lignans
Total
Total
Total
phytoestrogens
Median±IQR enterolignans isoflavones
Median+IQR
Median±IQR Median±IQR
Gender
Male (n=19)
4460±4547
65±43
3171±8770
7775±24986
Female (n=40)
4302±6228
62±59
2069±12438 8137±23522
p-value†
0.81
0.74
0.91
0.99
BMI(kg/M2)
<20.00 (n=5)
20.00-25.00 (n=28)
25.01-30.01 (n=15)
>30.01 (n=11)
p-value‡

4160±17955
4284±7337
4543±4185
3104±3555
0.99

79±139
69±50
65±93
53±40
0.65

931±4248
2809±12172
5277±27635
1251±7804
0.14

4630±21840
9009±31556
9860±24552
6341±8049
0.30

Age (y)
18-28 (n=26)
29-39 (n=16)
40-50 (n=9)
>50 (n=8)
p-value‡

3791±7231
4548±8956
3104±3674
5555±7353
0.49

62±51
66±69
78±61
55±81
0.92

2809±12524
2063±4836
1748±17001
1596±11030
0.44

8506±25734
8117±28086
8781±18157
7000±18830
0.97

4543±8953

53±50

2448±9476

8781±21185

2292±4074

60±96

1102±7507

4799±11979

3829±7729

79±30

15195±34408 23134±38137

Occupation
Family duties (n=3) and
Students (n=34)
Clerical & administrative
workers (n=12)
Community and personal
service (n=2) &Technician
and trade workers (n=2)
Professionals (n=5) &
Managers (n=1)
P-value‡

4831±4133

73±105

12966±30147 19242±28317

0.55

0.25

0.16

0.18

Education level achieved
Below university (Other

4554±8497

40±68

11129±34173

17647±36894

4134±4411

66±58

2284±8575

7603±16531

0.77

0.25

0.24

0.25

(n=1), Secondary school (n=1),
Certificate/diploma (n=11)

University (undergraduate
(n=22, postgraduate (n=24)

p-value†
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Table 14 continued
Subject characteristics

Total lignans
Median±IQR

Total
enterolignans
Median±IQR

Total
isoflavones
Median±IQR

Total
phytoestrogens
Median+IQR

Ancestry
Caucasian (n=38)
Other ethnic groups
(n=21)1
p-value†

4499±6149
3473±4587

69±57
58±55

3426±14968
2010±3963

11030±24919
7714±13114

0.25

0.37

0.18

0.13

Language spoken at
home
English (n=38)
Other languages (n=21)2
p-value†

4972±5878
2485±4003
0.03

53±63
39±61
0.15

3426±14971
1565±7322
0.23

8506±25475
5985±13203
0.08

4612±6262

58±71

2280±16827

7492±25384

4276±6285

73±45

4340±12950

14577±27402

2292±9863

74±38

1705±19509

8826±36564

4008±5365
0.46

39±60
0.37

1775±6225
0.72

8278±10988
0.71

Physical activity level
(PAL)
Sedentary (n=5)
Light (n=18）
Moderate (n=21)
High (n=15)
p-value‡

5510±10868
2898±3869
4160±5929
5502±15512
0.36

8±103
39±83
65±37
79±55
0.09

13670±31778
1221±1874
4236±11878
3596±23915
0.08

17647±31510
5971±4262
12822±23798
19278±37868
0.01

Smoking status
Never smoked (n=38)
Past smoker (n=14)
Current smoker (n=7)
p-value‡

4501±5019
4951±5314
1766±11815
0.36

65±44
53±75
82±69
0.47

2809±8851
1630±27454
14572±28859
0.85

9009±12930
6249±42342
27240±32199
0.99

Region of country of
birth
Oceania and Antarctica
(n=29)
North-West (n=9) &
Southern and Eastern
Europe (n=1)
North Africa and the
Middle East (n=2),
Americans (n=2),
Sub-Saharan Africa (n=2)
Asia (n=14)3
p-value‡
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Table 14 continued
Subject characteristics

Total lignans
Median±IQR

Total
enterolignans
Median±IQR

Total
isoflavones
Median±IQR

Total
phytoestrogens
Median+IQR

Bowel frequency
1-7/week (n=24)
>7/week (n=35)
p-value†

2875±4280
4554±9262
0.06

42±52
78±62
0.07

1934±11002
3171±10259
0.64

7874±12781
7775±23802
0.17

7492±14648

Bowel movement
Mushy and watery (n=2)
& Smooth and soft to pass
(n=53)
Hard to pass (n=4)
p-value†

4160±4053

58±48

2010±9283

13679±24396
0.10

111±52
0.07

15940±25020 33881±7626
0.09
0.03

Commercial supplements
use
No (n=32)
Yes (n=27)
p-value†

4493±6687
4160±3877
0.91

58±60
76±87
0.03

1976±12172
3171±10313
0.69

9009±23244
7492±26296
0.98

†Mann-Whitney U test
‡ Kruskal-Wallis One-Way ANOVA
1

South East Asian (n=6), South Asian (n=3), North East Asian (n=5), Middle Eastern, North Africa, Somalia
Peninsular (n=2), Central/South America (n=2), Other (n=1) & Mixed ancestry (n=2)

2

Cantonese, Arabic, Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonian, Bahasa
Indonesian)

3

(South-East (n=6), North-East (n=5), Southern and Central (n=3)
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Table 15. Average excretion of lignans, enterolignans and isoflavones
biomarkers according to subjects’ characteristics (n=53)
Subject characteristic
Total lignans Total
Total
Median±IQR enterolignans isoflavones
Median±IQR Median±IQR
Gender
Male (n=18)
1253±684
1178±1903
274±582
Female (n=35)
932±794
1952±3991
259±1569
p-value†
0.14
0.56
0.03

from urinary
Total
phytoestrogens
Median+IQR
3554±5091
4190±6828
0.24

BMI(kg/M2)
<20.00 (n=5)
20.00-25.00 (n=25)
25.01-30.01 (n=14)
>30.01 (n=9)
p-value‡

895±581
1228±1332
976±734
1318±586
0.42

1930±1752
2734±3668
642±1822
1837±1872
0.054

252±561
573±2007
152±517
208±391
0.12

2531±2221
6363±5555
2567±4497
3449±4099
0.07

Age (y)
18-28 (n=23)
29-39 (n=15)
40-50 (n=8)
>50 (n=7)
p-value‡

1052±887
1228±621
1313±1668
1019±674
0.93

1942±3083
1887±3489
1052±2722
1934±3706
0.49

392±2001
259±1139
454±4104
81±161
0.11

4606±4523
3540±5333
5320±8237
3449±6325
0.75

1028±767

1579±2556

226±313

3178±4698

1341±954

3279±3425

1203±1138

4606±4282

1461±4130

2219±10674

3722±4730

8427±15661

676±900

1002±2880

309±2968

3063±6264

0.09

0.47

0.06

0.12

3322±5824

416±2315

5710±8151

1170±738

1445±2361

259±1292

3782±4520

0.72

0.03

0.64

0.17

Occupation
Family duties (n=3) and
Students (n=29)
Clerical and administrative
workers (n=11)
Community and personal
service & (n=2), Technician
and trade workers (n=2)
Professionals (n=5) &
Managers (n=1)
p-value‡

Education level achieved
Below university (Other (n=1), 1036±902
Secondary school (n=1),
Certificate/diploma (n=10)

University (undergraduate
(n=19, postgraduate (n=22)

p-value†
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Table 15 continued
Subject characteristics

Total lignans
Median±IQR

Total
enterolignans
Median±IQR

Total
Total
isoflavones
phytoestrogens
Median±IQR Median+IQR

Ancestry
Caucasian (n=33)
Other ethnic groups (n=20)1
p-value†

1118±698
1122±973
0.66

1934±3116
1411±2419
0.19

273±1503
256±954
0.78

3897±5425
4123±5449
0.49

Language spoken at home
English (n=34)
Other languages (n=19)2
p-value†

1146±830
1036±696
0.53

1985±3341
1378±1191
0.34

321±1491
248±1107
0.74

4237±5539
3782±4546
0.45

1146±762

2966±2812

390±1506

4445±4520

1258±913

769±1952

266±3841

3220±8067

Region of country of birth
Oceania and Antarctica
(n=26)
North-West (n=7) &
Southern and Eastern
Europe (n=1)
North Africa and the
Middle East (n=2),
Americans (n=1),
Sub-Saharan Africa (n=2)
Asia (n=14)3
p-value‡

1118±1186

927±2330

268±1136

2181±4289

1045±752
0.96

1201±1528
0.04

213±1751
0.98

3227±6394
0.58

Physical activity level
(PAL)
Sedentary (n=4)
Light (n=17）
Moderate (n=19)
High (n=13)
p-value‡

1417±4968
932±587
1118±665
1464±1711
0.42

3274±5356
1887±2952
1332±2305
1952±3355
0.71

5691±6628
199±354
273±1574
413±1785
0.09

11406±8578
3449±3006
3540±6019
6314±5285
0.07

Smoking status
Never smoked (n=35)
Past smoker (n=12)
Current smoker (n=6)
p-value‡

1118±857
1220±889
850±1901
0.71

1942±3047
1828±3474
1631±13333
0.85

274±1462
146±470
918±1593
0.15

4285±5088
3317±7574
3490±16318
0.96
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Table 15 continued
Subject characteristics

Total lignans
Median±IQR

Total
enterolignans
Median±IQR

Total
Total
isoflavones
phytoestrogens
Median±IQR Median+IQR

Bowel frequency
1-7/week (n=21)
>7/week (n=32)
p-value†

903±914
1199±730
0.29

1445±3576
1862±2914
0.86

413±1338
260±1298
0.65

4284±4554
3910±5555
0.72

1123±753

1837±2820

261±1292

3924±4783

913±4472
0.81

4289±12713
0.71

450±1722
0.86

5453±18415
0.83

1087±924
1118±794
0.57

1824±3040
1837±3340
0.86

265±2035
274±749
0.47

4445±5529
3540±4637
0.46

Bowel movement
Mushy and watery (n=2) &
Smooth and soft to pass
(n=47)
Hard to pass (n=4)
p-value†
Commercial supplements
use
No (n=30)
Yes (n=23)
p-value†
†Mann-Whitney U test
‡Kruskal-Wallis One-Way ANOVA
1

South East Asian (n=6), South Asian (n=3), North East Asian (n=5), Middle Eastern, North Africa, Somalia
Peninsular (n=2), Central/South America (n=1), Other (n=1) & Mixed ancestry (n=2)

2

Cantonese, Arabic, Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonian, Bahasa
Indonesian)

3

(South-East (n=6), North-East (n=5), Southern and Central (n=3)
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4.9 Food sources contributing to lignans, enterolignans and isoflavones
The contributing food sources to dietary total lignans, enterolignans and isoflavones, are
shown in Figure 27 to 29.

They were based on usual dietary patterns over the previous

month as recorded in the pre FFQ.

The top three contributing food sources of lignans were from the nuts and seeds group (30%),
such as linseed and cashews; nonalcoholic beverages such as coffee, tea and plant-based
milk-like beverages (19%); and breads and cereals including multigrain bread (19%). The
least important contributing food group was meat, poultry, seafood and eggs (Figure 27).

The majority of dietary enterolignans (86%) were from dairy products, namely milk, yoghurt
and cheese from animal origin, followed by nonalcoholic beverages (11%). Dairy products,
e.g. milk, were used in coffee and tea, and specialty coffees, such as like latte and cappuccino,
were commonly consumed in this research population. Plant-based food groups, including
nuts and seeds, breads and cereals, vegetables, fruits, legumes, and alcoholic beverages do not
contain enterolignans and therefore contributed none to dietary intake (Figure 28).

Legumes, including soy and related food products and beans and related food products were
the major contributors (78%) to total isoflavones; breads and cereal products was the second
highest contributor (17%) (Figure 29).
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Figure 27. Contributing food sources to dietary lignans estimated in usual diet over 1 month from food frequency questionnaire (n=59)
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Figure

28. Contributing food sources to dietary enterolignans estimated in usual diet over 1 month from food frequency questionnaire

(n=59)
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Figure 29. Contributing food sources to dietary isoflavones estimated in usual diet over 1 month from food frequency questionnaire
(n=59)
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4.10 Triangular comparison of FFQ, WFR and biomarker
The triangular comparison between three measurement methods, namely the FFQ, WFR and
biomarkers for each phytoestrogen was conducted with the Method of Triads (Figure 9).
The validity coefficients (VC) between FFQ (Q) and true intake (T), between WFR (R) and
(T), and between the biomarker (M) and (T) are reported in Table 16.

Spearman

correlations were selected due to the non-parametric nature of the data.

All VCs were estimated based on intake and excretion of each measurement with adjustment
for demographic and lifestyle variables. These variables were selected based on results in
Section 4.8. Variables were included in the MOT model if the median measurements were
found to be significantly different across levels or categories of that variable for at least two
methods, for example, the intake classified by gender was found to be significantly different
in both FFQ and WFR. Comparison between enterolignan intake and excretion was not
conducted due to inter-conversion from dietary intake of lignans to excretion in the form of
enterolignans.
The correlations between FFQ and WFR (rQR) were moderate but between biomarker and
WFR (rRM) or FFQ (rQM) were low. Heywood cases, that is the value exceeding 1, appeared
on most VCs for (R) and (T) on each comparison except for that of total lignans and
enterolignans (VC=0.78) and total phytoestrogen (VC=0.33) (Table 16). VCs for (Q) and (T)
ranged between 0.10 and 0.79, and for (M) and (T) ranged between 0.13 and 0.56, except for
the two Heywood cases for MAT and total phytoestrogen. Total lignans and enterolignans had
the highest VC in the WFR (0.78) and FFQ (0.79), and daidzein in the biomarkers (0.56).
The VCs for formononetin and total phytoestrogen were based on Spearman’s correlations
unadjusted for demographic and lifestyle variables, since the VCs when adjusted could not be
calculated due to an odd number of negative correlations, i.e. one or all three negative
correlation coefficients.
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Table 16. Validity coefficients for triangular comparison between FFQ, WFR and biomarker adjusted for demographic and lifestyle
characteristics
Correlation coefficients†

Validity Coefficients (VC)‡ (95% CI)

rQR±

rRM±

rQM±

WFR (R) &True intake (T)±

FFQ (Q) & (T)±

Biomarker (M) & (T)±

SECO

0.44

0.21

0.05

2.07 (0.44, 12.80)

0.38 (0.13, 2.41)

0.13 (0.02, 0.55)

MAT

0.44

0.10

0.16

13.68 (0.41, 16.53)

0.10 (0.14, 4.54)

1.65 (0.02, 1.29)

Total Lignan

0.41

0.24

0.16

1.26 (0.51, 10.02)

0.57 (0.09, 2.03)

0.28 (0.05, 1.33)

Daidzein

0.52

0.45

0.24

2.50 (1.28, 19.09)

0.43 (0.08, 1.71)

0.56 (0.10, 2.37)

Genistein

0.51

0.22

0.07

3.34 (0.58, 21.39)

0.33 (0.07, 2.36)

0.23 (0.03, 1.61)

Glycitein

0.51

0.26

0.27

1.37 (0.63, 9.02)

0.58 (0.14, 2.58)

0.48 (0.07, 1.67)

Formononetin^

0.18

-0.11

-0.13

1.45 (0.16, 15.88)

0.33 (0.06, 4.03)

0.44 (0.02, 2.47)

Total Isoflavone

0.42

0.26

0.15

2.16 (0.65, 14.57)

0.42 (0.09, 2.18)

0.37 (0.05, 1.84)

Total Lignan and

0.41

0.10

0.13

0.78 (0.21, 4.07)

0.79 (0.15, 2.71)

0.16 (0.02, 0.58)

0.08

0.25

0.07

0.33 (0.03, 4.09)

0.26 (0.03, 2.97)

1.68 (0.23, 12.86)

Enterolignan
Total Phytoestrogen*
†Spearman correlation coefficients
‡VCs were based on Spearman correlation adjusted for demographic and lifestyle variables. Lignans, SECO, MAT, total lignan, and total lignan and enterolignan were adjusted for age, BMI and
language spoken at home (English or non-English), isoflavones, daidzein, genistein, glycitein, formononetin, total isoflavone were adjusted for age and BMI. Total phytoestrogens were adjusted
for physical activity level (sedentary, light, moderate, high) and bowel movement (mushy/watery and smooth to pass or hard to pass)
± Q=food frequency questionnaire (FFQ), R=weighed food record (WFR), M=biomarker, T=true intake
^ VCs were based on Spearman correlation unadjusted for demographic and lifestyle variables due to validity coefficients not calculated or adjusted for Spearman correlation when there is a
negative correlation between the two measures
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CHAPTER FIVE: DISCUSSION

5.1 Research findings
The current research focused on evaluation of the validity and reliability of a modified
FFQ specially designed to measure intake of phytoestrogens in a group of 59 men and
women living in Perth, Western Australia. Three classes of phytoestrogens were measured:
lignans, enterolignans and isoflavonoids.
An original 112-item FFQ was customised by expanding the food list to include 277
items, to align with food groups and items provided in the most recent Australian Dietary
Guidelines (NHMRC, 2013a); selected ethnic items commonly-available in the Australian
market, were also included. Estimation of the lignan content of foods from the FFQ was
also modified. There is currently no available comprehensive database for estimating
dietary lignans and in the original 112-item FFQ, lignan content was based on an indirect
in-vitro colonic fermentation method providing estimated availability from foods of two
plant lignans (Thompson, Robb, Serraino, & Cheung, 1991). For the current FFQ,
estimates were based on more recent data for direct measurement of four lignans in
plant-based foods, previously compiled by our research group from a range of
international published values. The FFQ was also expanded to include food sources of
enterolignans, which are obtained exclusively from animal products such as dairy foods;
these are derived from consumption of plant lignans by the animal and interconversion to
enterolignans that then are absorbed and secreted into milk. The purpose of modifying the
FFQ was an attempt to improve performance as a potential tool for measuring
phytoestrogen intake, especially lignans, which had been a limitation with the original
questionnaire. The modified FFQ was designed to capture phytoestrogen intake over the
previous month.
The validation involved the use of a reference dietary assessment tool, namely WFR, and
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urinary biomarkers of phytoestrogen excretion. The measurement derived from the FFQ
was compared with the WFR and biomarkers. The reliability of the FFQ was tested by
comparing the intake of pre FFQ with that of the post FFQ, administered one week apart.

5.1.1 Evaluation of the FFQ
Convergent validity and reliability
Convergent validity was evaluated by comparing usual daily intake of phytoestrogens
from the FFQ with usual intake from a 3-day WFR reference method collected over
consecutive days to include two weekdays and one weekend day. In support of our first
and third hypotheses, the FFQ had acceptable convergent validity for intake of total
lignans and enterolignans when compared to a WFR, in terms of median intakes (lignans:
3.91 versus 4.30 mg/day, p=0.09; and enterolignans: 0.054 versus 0.065 mg/day, p=0.81,
respectively); and associations between the two methods (lignans ρ=0.42, p<0.001; and
enterolignans ρ=0.62, p<0.001) (Table 5). Median intakes of total isoflavonoids from the
FFQ and WFR were also comparable (3.85 versus 2.29 mg/day, p=0.67) with a significant
association between the two tools (ρ=0.36, p<0.001), although weaker than for total
lignans (Table 6). In addition to validation as a continuous measure, the FFQ was
examined by cross-classifications to determine whether it could accurately rank subjects
into quartiles of intake assessed by the WFR. With a total of 7% to 17% of subjects
misclassified into opposite quartiles for different phytoestrogen classes, the results further
indicate that the FFQ does accurately classify subjects assessed by the WFR (Table 8).
In support of our second hypothesis, the FFQ also had acceptable reliability when
compared to a repeat FFQ, for all classes of phytoestrogens, with strong correlations
between intakes (ρ=0.78 to ρ=0.85, p<0.001 for all) (Tables 5, 6) and minor
misclassifications into opposite quartiles, between 2% to 5% (Table 8).
Contrary to our fourth hypothesis, when the FFQ was assessed for agreement between
individual values in the WFR, the mean bias was moderately high for all phytoestrogen
classes (-0.54 mg/day for total lignans, +0.004 mg/day for enterolignans and +1.17
131

mg/day for isoflavonoids); and visual inspection of the Bland Altman graphs showed
trends towards greater inconsistency at higher median intakes (Figures 11e, 12c, 13f).

Criterion validity
Criterion validity was evaluated by comparing usual intake of four lignans and five
isoflavonoids from the FFQ with usual excretion of their biomarkers in three 24-hour
urine samples. Extensive interconversions of dietary lignans occur in the colon, with the
majority of dietary lignans converted to enterolignans prior to absorption and excretion
(Figure 3). For example in the current study, intake of enterolignans was low at 0.054
mg/day while urinary excretion was 30-fold higher at 1.84 mg/day. For this reason the
assessment of criterion validity was conducted using one combined value for lignans plus
enterolignans. Although median intake and excretion were not significantly different
(4.05 versus 3.10 mg/day, p=0.22, respectively), there was no significant correlation
between intake and excretion (ρ=0.16, NS) (Table 5). For total isoflavonoids, excretion
was 10-fold lower than intake from the FFQ (0.27 versus 3.85 mg/day, respectively
p<0.001) and there was no significant correlation between the two tools (ρ=0.10, NS).
Misclassification into the opposite quartile was also relatively high for both
phytoestrogen classes (21% to 23%) (Table 8). When usual intake from the 3-day WFR
was compared with 3-day urinary excretion collected over the same time period, the
associations became stronger and significant for isoflavonoids (ρ=0.28, p<0.05) but not
for lignans and enterolignans (ρ=0.14, NS). Despite previous studies reporting significant
dose-dependent relationships between intake and excretion of phytoestrogens and their
respective metabolites (French et al., 2007; Hanna et al., 2005; Huang et al., 2000;
Yamamoto et al., 2001), there were no significant associations in the current data,
indicating poor validity for the modified FFQ in relation to biomarkers of phytoestrogen
excretion.

Based on these findings, we conclude that the modified phytoestrogen FFQ is highly
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reliable. It would be a useful assessment tool for example to rank usual intake of
phytoestrogen classes for individuals within a group, or quantify mean intakes between
different population groups. It is not acceptably valid or accurate for estimation of
individual phytoestrogen status, for example for use in experimental studies or to
investigate associations with chronic diseases.

Reliability and validity data for individual phytoestrogens showed similar trends to data
for phytoestrogen classes with highly significant positive associations between intakes
from the repeat FFQs, moderately significant associations between intakes from the FFQ
and WFR, but weak and non-significant associations between intake from the FFQ and
excretion of respective urinary biomarkers.

Comparison of results with previous studies
Previous reliability studies using repeat FFQs administered from 1 month to 10 months
apart, have found moderate to strong associations between intake of isoflavones (r=0.60
to r=0.77) and lignans (r=0.36 to r=0.80) (French et al., 2007; Hanna et al., 2005;
Horn-Ross et al., 2006). Our associations of between ρ= 0.69 to 0.85 are comparable or
higher, possibly due to the shorter time frame of 1 week between repeat questionnaires,
which would have avoided possible seasonal changes that could contribute to variability
in previous studies with longer time intervals.

Contrary to the current findings of weak non-significant associations between intake from
the FFQ and excretion of urinary isoflavonoids (ρ=0.10) or lignans (ρ=0.16), previous
studies have reported significant moderate associations for isoflavonoids (r=0.21 to 0.54)
but smaller or non-significant associations for lignans (r=0.14 to 0.40) (French et al.,
2007; Hanna et al., 2005; Horn-Ross et al., 2006). Reasons for the discrepancy in our
study could be the lack of excretion data for PINO and LARI, due to failure of ionisation
of metabolites during the LC-MS analysis procedure (Grace et al., 2007; Valentin-Blasini
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et al., 2000), which would have resulted in underestimation of total lignan excretion, and
potential recall bias when subjects were recalling frequency and portion size in
completing the FFQ.

Previous studies did not attempt to measure intake or excretion of

these two lignans yet they were significant dietary contributors in our study, providing
about 25% of total lignan intake. Other factors that could affect bioavailability and hence
excretion of the phytoestrogens, include variations in individual gastrointestinal transit
time, efficiency of conversion of metabolites in the colon, and the degree of enterohepatic
recycling (Clavel et al., 2005; Lampe, 2003; Lampe et al., 2006; Landete, 2012).
Collection of faecal samples and measurement of faecal losses in future studies could
help identify these sources of variability.

Cross classification analyses
In the current study, cross classification analyses using quartiles of intake, indicated that
58-73% between the two repeat FFQs, 24-51% of intakes between the FFQ and WFR,
and 25-43% between the FFQ and urinary biomarkers, were classified into the same
quartiles.
Ideally a large proportion of subjects classified in the same quartile affirms the tool’s
accuracy to rank individuals according to their phytoestrogen intake, but the proportion
classified in the adjacent quartiles also suggests that the tool is effective in ranking
intakes. Bhakta et al. (2005) conducted a validation study with 58 English women and
compared dietary intake obtained by a FFQ with intake from twelve 24h dietary recalls
collected over a year as the reference standard.

Their results showed that 53% of

subjects were classified into adjacent quartiles for total lignans and isoflavones, which is
comparable to the 51% and 46% for total lignans and isoflavones, respectively, reported
in our validation study. This proportion of cases should be included in considering the
effectiveness of the tool in ranking intake. Eighty percent of cases or more in the same
and adjacent quartiles is considered an excellent tool, and between 60-70% is a good tool
(Fernandez et al., 2013). Using these criteria, the current FFQ is regarded as an excellent
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tool in ranking intake against the reference method; and a good tool for ranking intake
against biomarkers, with above 70% classified in the same or adjacent quartiles.

Individual agreement from Bland Altman plots
The Bland Altman plot is a method to assess the degree of agreement between two tools.
The plots provide a graphical means to observe for systematic differences, including
mean difference, limits of agreement and proportional bias between the two methods.
The mean difference between the measurements of the FFQ and WFR represents the
systematic error or bias of the tools, the limits of agreement show how far apart the
measurements are by the two tools, and the proportional bias at low and high intake levels
informs the trends in variation of phytoestrogen intake within the sample.
In the current study, the limits of agreement were relatively wide in all classes of
phytoestrogens for evaluation of both reliability and validity of the FFQ, and proportional
bias existed with greater inconsistency at higher than lower mean phytoestrogen intakes.
Bland Altman analyses conducted by previous studies that examined intake of isoflavones
have shown similar results, with the bias increasing with increasing intake between a FFQ
and 24h dietary recalls (Chan et al., 2008) and between repeat measures of a FFQ
administered 1 week apart (Frankenfeld et al., 2003).

In order to evaluate the clinical relevance of this variation, it is important to identify what
this difference and variation represent with regard to dietary intake. The mean bias
between the FFQ and WFR was 0.54 mg/day for total lignans, 0.004 mg/day for total
enterolignans and 1.17 mg/day for total isoflavones, and is equivalent to consuming 0.16g
of flaxseed, 17g or 1 tablespoon of milk and 4g or a teaspoon of tofu per day, respectively.
The median intakes of 4.23 mg/day for total lignans, 0.062 mg/day for total enterolignans
and 4.36 mg/day for total isoflavones that differentiates low intakes from high intakes, are
equivalent to having 1.2 g or ¼ of teaspoon of flaxseed, 1 cup of milk, and 15 g or 1
tablespoon of tofu per day, respectively. Phytoestrogens, especially lignans, are present
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in a wide range of foods but are concentrated in only limited food groups, namely nuts
and seeds (especially flaxseeds) for lignans, dairy products of animal origin for
enterolignans, and soy and related products for isoflavones. These food groups aligned to
the top contributing food sources of the sample in the current study (Figure 27-29). The
consumption or non-consumption of foods from these food groups, both between subjects
or day-to day within subjects, would result in sporadic intakes of the phytoestrogen
classes and contribute to the observed high variation in the current study.

Triangular comparison with Method of Triads
The current research is only the second study to conduct a triangular comparison of three
methods, the FFQ, WFR reference method, and biomarkers using the Method of Triads
(MOT) to evaluate the performance of each method for determining phytoestrogen status
(Bhakta et al., 2005). The validity coefficient (VC) indicates the correlation of the intake
by one method with the true but unknown intake, and therefore is an indication of the
degree of agreement between the methods in assessing phytoestrogen status in the
research population.

Since the introduction of MOT by Kaaks (1997), validation studies have widely adopted
this method when assessing three or more methods for nutrient status. To date, only
Bhakta et al. (2005) has utilised the MOT for phytoestrogen status in a study comparing
an FFQ, 24h recalls and plasma biomarkers in South Asian women in the UK. They
reported the highest VC for 24h recalls in measuring genistein (0.95) and daidzein (0.83),
the highest VC for the FFQ in measuring total lignans (0.91), and the poorest VC
(0.11-0.45) for biomarkers in measuring genistein, daidzein and total lignans. This
supports the current research in which higher VCs were observed for the FFQ in
measuring total lignans (VC=0.57) or the FFQ and WFR for measuring combined lignans
plus enterolignans (VC=0.79, 0.78, respectively) (Table 16). In addition, the VCs for the
current research were adjusted for demographic and lifestyle variables and the VCs
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improved slightly (data not shown).
The results for individual phytoestrogens were complicated by Heywood cases, defined
as VCs or CIs exceeding 1. For example, VCs and CIs exceeded 1 for all variables
measured by the WFR except combined total lignans and enterolignans (Table 16). VCs
are mathematically based on the correlation coefficients (Figure 9 in Methods). To have a
high VC, that is within the acceptable range of 0 to 1, values of all correlation coefficients
between the methods are required to be at a relatively equal level. In Table 16,
coefficients were moderate for FFQ and WFR, but low for the urinary biomarkers. This
suggests that the biomarker is not a good indicator of the true intake. The appearance of
Heywood cases could be the result of random sampling variation or may result from the
violation of the assumption of MOT, that the errors of the three methods are uncorrelated
and that a linear relationship of measurements exists between the methods. In this regard,
the WFR was chosen because it shared uncorrelated sources of error with FFQ (Table 1).
For the WFR, consumption was recorded for two weekdays and one weekend day using
precise kitchen scales and measuring cups and spoons to assist in portion size estimation;
the FFQ required a recall of past consumption on a regular frequency basis over the
previous month. As the FFQ and WFR are two distinct tools requiring responses in
different ways, the errors from each tool are likely to be unrelated.

Yokota et al. (2010) suggested that a larger sample size could reduce the chances of
Heywood cases for the VCs. They also highlighted recent guidelines for consideration of
sample sizes with at least 50 subjects for studies with a biomarker as a reference methods.
There were 53 subjects with complete data for the FFQ, WFR and biomarkers. Therefore
a further increase in the sample size could potentially improve the VCs.

5.1.2 Phytoestrogen intake and excretion
In comparison to previous studies conducted in Western countries, median intake of
lignans in the current study (3.91mg/day) was three times higher than that by Lahmann et
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al. (2012) in Australia, but similar to that found by Hedelin, Klint, Chang, Bellocco,
Johansson, Andersson, Heinonen, Adlercreutz, Adami, Gronberg, et al. (2006) in Sweden
(3.05mg/day), and considerably lower than that consumed in Eastern countries by
Bangladeshi women (7.32 mg/day) (Saleh et al., 2011). Enterolignan intakes in the
current study (0.056 mg/day) were also three fold higher than intakes reported by
Lahmann et al. (2012) (0.022 mg/day). Isoflavones in the current study (3.85 mg/day)
were considerably lower than amounts consumed in a Chinese population (11.5 mg/day)
(Wong, Lau, Leung, Leung, & Woo, 2007).

Median urinary excretion in the current study of lignans (-0.12mg/day), enterolignans
(1.84mg/day), and isoflavones (0.27mg/day) was consistently higher than the median
excretion in an Australian group

(lignans 0.01mg/day, enterolignans 0.22mg/day,

isoflavones 0.07mg/day) (Hanna et al., 2005) and in Canada (enterolignans 837µg/day,
isoflavones 759µg/day) (French et al., 2007).

Differences may be explained by the design of the FFQ, for example, the number of items
included in the food list was longer in the current study than previous study by Hanna et
al. (2005); use of different sources of published phytoestrogen databases for measuring
intake; as well as different dietary preferences, for example high isoflavone intake related
to high consumption of soy products as staple items in the Chinese population (Table 3).

5.1.3 Contributing food sources to phytoestrogen intake
The major contributing food sources to lignans in the current research were similar to
other previous studies conducted in Western countries, with flaxseed, breads and cereals,
beverages such as tea and coffee, vegetables, and fruits being the most common sources
in the current research (Figure 27). Other ethnic groups such as Chinese populations,
consumed more legumes and beans, vegetables, and tea, than bread and cereals (Hu et al.,
2014).
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Enterolignan intake is more likely to be measured in Western countries because of
frequent consumption of dairy products and other foods of animal origin. Foods of dairy
origin, as expected, contributed to 80-90% of enterolignan intake in both the current
research (Figure 28) and previous research (Zamora-Ros, Knaze, et al., 2012). Specialty
milk beverages such as latte and cappuccino were included in the current FFQ, and
subjects consumed these non-alcoholic beverages on a frequent basis.
Food sources contributing to isoflavone intake were soybeans, legumes and soy products
including soymilk and tofu.

Bread and cereals was the second highest contributor to

isoflavones in the current research since manufacturers in Australia use soy flour as an
ingredient in bread making (Lahmann et al., 2012). Popular items advertised for health,
such as soy and linseed bread, are available in the consumer market and were consumed
by subjects in the current research (Figure 29). In other ethnic groups, isoflavone intake
was derived from less refined sources, legumes and beans, vegetables such as soybean
sprouts and cabbage, and fruits (Bhakta et al., 2006; Huang et al., 2012; Saleh et al.,
2011).

5.1.4 Intake of phytoestrogen and demographic and lifestyle characteristics
In the current study, an attempt was made to recruit subjects from diverse backgrounds to
capture cultural diversity in an Australian group. While 64% of subjects were of
Caucasian ancestry and spoke English at home, 36% spoke another language at home,
including subjects from South East, South and North Asia, North Africa and South
America; 68% of subjects were females and 32% were males. The majority was recruited
from around the university and were university educated (78%); and 46% used
commercial dietary supplements.

Female subjects who were Caucasian, were at, or had achieved university education level
and took regular commercial dietary supplements, were more likely to have a higher
lignan and enterolignan intake than subjects with different characteristics (Table 13). This
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was also reflected in the urinary excretion of enterolignan metabolites in those subjects
with the same characteristics (Table 15). The food choices were plausibly the reason for
the higher intakes of lignans and enterolignans in these groups.

For example, subjects

who were of other ethnic background, spoke languages other than English at home and
were born outside of Australia had varying intake level and variety of food choices from
vegetables, fruit and cereal products, such as white rice and noodles, which contain low to
moderate lignan content (Section 2.9). Use of commercial supplements could be an
attribute of those subjects who were health conscious, and hence more inclined to select
foods that were nutrient dense such as wholegrain cereals and specialty seed breads,
promoted for health benefits and also rich in lignans. Subjects did not consume
isoflavonoid and lignan dietary supplements. Our findings support those in a previous
study conducted by Hanna et al. (2010), who investigated the intake of phytoesetrogens
and associated lifestyle factors in Australian older women (aged 40-80 years), and
reported higher education level and supplement use in the group of soy and linseed
consumers with at least one serve of soy and/or linseed item.

5.2 Limitations
One limitation of the current research is that urinary biomarker excretion was not
corrected for creatinine concentration, to indicate possible incompleteness of the 24-h
urine collections. Although creatinine concentrations were analysed, the correction of
phytoestrogen concentration was not conducted due to time constraints of thesis
submission. In the current research, subjects were encouraged to state the completeness of
the collection in a designated area on each urine bottle for any collection they had missed.
Twenty-three out of the 59 subjects stated that they had incomplete urine samples at some
time during their 3-day 24-hour collections. This could have added to the variability in
the urinary biomarker data and indicates the need for a follow up analysis of data, after
assessing samples for completeness and excluding any samples with implausibly low
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creatinine concentrations.

Another limitation is related to the intrinsic properties of phytoestrogens. Phytoestrogen
content naturally varies in foods as a result of genetic factors and the growing
environment, and effects of harvesting and processing (Kuhnle, Dell'Aquila, Runswick, et
al., 2009). Therefore the estimated intake may not be reflected in what was actually
present in the food consumed. Possible hidden sources of soy isoflavones in the food
supply, especially in processed foods, and foods with no database content of lignan,
would result in underestimation of the intake of lignans and isoflavones. This would
impact on the assessment of the FFQ validity with respect to the urinary biomarkers. For
the current research, phytoestrogen contents reported across multiple databases for the
same food item were averaged to minimise the effect of the natural variability of
phytoestrogens. Food items with missing lignan content were substituted with the content
of an appropriate food item in the phytoestrogen intake calculation. Other limitations that
could impact on the assessment of FFQ validity, include subjects’ day-to-day variation in
intake, particularly when subjects had sporadic intake of phytoestrogen rich food on one
day but not on the other day (See Bland Altman plots 4.4 and 4.7). Potential recall or
social desirability bias when subjects were completing the FFQ, inaccuracies in
estimation of frequency of intake or portion sizes and inter-individual variation in
phytoestrogen absorption, metabolism and excretion could also have contributed to the
variation in intake and excretion, and hence the evaluation of the FFQ.

While the current research included males and females from a range of cultural
backgrounds, it is not widely representative as subjects were recruited from a university
community rather than the general population. The anticipated number of subjects in the
current study was not achieved, due to time constraints of subject recruitment, which
could have reduced the likelihood of observing significant associations within the dataset.
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5.3 Recommendations and conclusions
The evaluation of the phytoestrogen food frequency questionnaire assisted in establishing
a valid and reliable dietary tool in measuring phytoestrogen status. The database used for
the current study to estimate intake was updated with content for lignans and
enterolignans from international published data. Even with actual estimates of
phytoestrogen content in food from the database and a FFQ well designed for capturing
the dietary intake, the bioavailability would be affected by natural variability of
phytoestrogens in foods. Therefore analyses are required for the phytoestrogen content of
foods grown and consumed in Australia, collated to develop a database culturally specific
to the Australian context.

The purpose of the FFQ in the current research was to quantify intake at the individual
and population level. While the FFQ was acceptably valid for measuring intake at the
group or population level, Bland Altman plots indicated wide individual variability and
greater variation of individual measurements between two methods at higher median
intakes. One reason for the variability is the sporadic nature of phytoestrogens, which are
concentrated in a few very rich food sources.

Consuming as little as 1.2g of flaxseed, 1

cup of milk or 15g of tofu a day would significantly increase the variation in the intake.
Using this as a reference, future researchers could screen consumers and non-consumers
of phytoestrogen rich foods with preliminary questions about regular consumption of
these typical foods before completing the dietary assessment tool.

The 3-day WFR was chosen as a reference method to evaluate convergent validity of the
FFQ. However, the WFR only represented a snapshot of dietary consumption over 3 days
and the observed sporadic nature of phytoestrogen intake over this relatively short time
period, both between and within subjects, impacted considerably on the estimate of
average daily intake. The FFQ was designed to survey usual diet over the past month and
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hence average daily intake would be less impacted by these sporadic intakes. Therefore
based on the study design and the interpretation of the results for the current research, it is
more appropriate to use the FFQ for status of usual phytoestrogen intake.

Food metabolomics is a branch of the nutrition research that focuses on the digestion and
biotransformation of foods and constituents and the identification of associated
metabolites. These metabolites include biomarkers that measure dietary exposure. The
current research involved the use of biomarkers to exemplify the exposure and
bioavailability of phytoestrogens. The excretion of metabolites and the population intake
level are of particular importance as these could relate food consumption over time with
development of diseases. An optimal intake level and metabolomics profile could be
derived from epidemiological studies of phytoestrogen status in relation to the status of
disease or health and wellbeing.

Metabolites acquire a range of routes for their excretion, and after absorption, they can
circulate in the plasma, and be secreted into bodily fluids, such as breast milk, and finally
excreted in urine and faeces. Urinary biomarkers were adopted in the current research and
although dose-dependent relationships have been observed between intake and excretion
in previous studies after phytoestrogen supplementation (Hutchins et al., 2000; Morimoto,
Beckford, et al., 2014), our cross-sectional data do not support a strong association. The
complexity of metabolic pathways is an obstacle in nutrition research involving the use of
biomarkers. A recommendation for future research is that the urinary biomarkers alone
are not sufficient to indicate phytoestrogen status, and additional use of faecal and plasma
collections would provide a more complete profile of phytoestrogen status. The effect of
lifestyle factors and dietary components on the gastrointestinal environment should also
be explored to address the inter- and intra-individual variation in biomarker excretion.

In conclusion, the results of the current research suggest that the modified phytoestrogen
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FFQ is valid with respect to WFR and reliable for the majority of the phytoestrogens.
The lack of associations between measurement of the FFQ and biomarkers, suggest that
urinary biomarkers alone are not sufficient for estimation of phytoestrogen status.
Addition of other biomarkers utilising faecal and plasma samples should be considered
for a more complete assessment of phytoestrogen status.
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Appendix A. Modified food frequency questionnaire (compete version is available on request)
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Appendix B. Pilot study questions
Name:_________________________

Face validity and pilot test questions for the food frequency questionnaire
Please spend some time to answer the following questions and express your opinion
about the food frequency questionnaire after you have completed it.
Your response and opinion will be considered to make the food frequency questionnaire
a better tool for everyone else to complete within a reasonable time.
1. How long did it take you to complete this questionnaire?

2. Do you find the format of the questionnaire easy to understand, i.e. portion size
estimation, frequency of consumption? If not, please be specific of how it can be
improved.
3. Do you require visual aids for any Standard serve size to assist your portion size
estimation? i.e. a photo of how a medium apple looks like, a photo of a tablespoon.
4. Are there any food items that you normally consume but were not included in the
questionnaire? Please name them to be considered in the questionnaire.

5. Are there any comments in regards to improving the questionnaire?
6. Would you prefer to do the questionnaire online? i.e. Qualtrics, PDF version with
fillable space or Microsoft Word version ?

Thank you so much for your time to test this questionnaire and your comments!
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Appendix C. Demographic and lifestyle questionnaire

Demographic and lifestyle
questionnaire
Date:(DD/MM/YY)_____________________________

Subject ID # _____________________________________
Contact details:__________________________________

Date of birth:(DD/MM/YYYY)__________________
1. Gender
Male

Female

2. What is your age: __________________
3. Weight:_________________________
BMI:________________________

Height:_______________________

4. What is your occupation, please specify:

__________________________________________

5. What is your highest achieved or current level of education or qualification
University postgraduate (Master degree, PhD)
University undergraduate (Bachelor degree)
Certificate/Diploma (TAFE/technical college/business college)
Secondary school, Year 12
Secondary school, Year 10
Other, please specify: _____________________________________
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6. Ancestry/ethnicity
Please describe which group(s) best defines the ancestry/ethnicity (based on a
mixture of culture, religion, skin colour and language) of you and your biological
parents. You may choose more than one group for each person.
A. Caucasian – Australian/NZ (Anglo European), Europe (includes Russia Central
and West Asia) & North Mediterranean, America, Canada, South Africa &
Zimbabwe
B. Indigenous Australian – Aboriginal, Torres Strait Islands
C. Pacific Islander – New Zealand Maori or Pacific Islands, Hawaii, New Guinea
D. South-East Asia – Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar/Burma,
Philippines, Singapore, Thailand, Vietnam
E. South Asian – Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan,
Sri Lanka
F. North East Asia – China, Hong Kong, Japan, Korea, Macau, Taiwan
G. North Asia – Mongolia, Siberia
H. Middle Eastern, North Africa, Somalia Peninsular – Algeria, Bahrain, Djibouti,
Eritrea, Ethiopia, Egypt, Israel, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Oman,
Palestinian Territories turkey, Turkish Cypriots, Qatar Saudi Arabia, Somalia, Syria,
Tunisia, United Arab Emirates, Yemen
I. Sub-Saharan Africa – indigenous African, African American
J. Central/South America – Central/South America
K. Other
L. Don’t know
Your biological Your biological
father
mother
A.
B.
C.
D.
E.
F.
G.
H.
I.
J.
K.
L.

Caucasian
Indigenous Australian
Pacific Islander
South-East Asian
South Asian
North East Asian
North Asian
Middle Eastern, North Africa,
Somali Peninsular
Sub-Saharan African
Central/South American
Other (please specify below)
Don’t know

You
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If Other, please specify for each:
Your Biological father:
______________________________________________________________________________
Your Biological mother:
____________________________________________________________________________
You: _______________________________________________________________________
7. Which language do you mainly speak at home (if more than one language, indicate
the one that is spoken most often)
English
Italian
Greek
Cantonese
Arabic
Mandarin
Vietnamese
Spanish
German
Hindi
Other, please specify: _________________________________
8. What is your country of birth, please specify:
____________________________________________________
If you were not born in Australia, please specify your date of arrival to Australia:
____________________________________________DD/MM/YYYY
9. What is your physical activity level
Sedentary, move only for necessary chores/walking/other activities
1-2/week
Light, walking/other activities >3/week
Moderate, exercise to perspire 1-2 times/week, or moderate labour or
physically demanding work
High, heavy exercise or sport several times/week, heavy labour or
physically demanding work
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10. Your smoking status:
Never smoked
Current smoker, daily, please specify how many times you smoke daily: ___
Current smoker, weekly, please specify how many times you smoke weekly:
Current smoker, other, please specify the frequency you smoke: _______
Past smoker
11. Your bowel habits:
11.1How often do you have bowel movement?
>7/week
4-7/week
1-3/week
<1/week
11.2 What is the best way to describe your bowel movement?
Hard to pass
Smooth and soft to pass
Mushy and watery
12. Supplemental use
12.1 Do you take any commercial supplement?
Yes
No
12.2 How many regular supplements do you take? E.g. vitamins, fish oil, flaxseed
etc.
None
1
2
≥3
Regular: supplements taken consistently in the past month, e.g. 1 times per week,
daily
12. 3 Please specify the type, brand name, dosage and frequency of each
supplement you take: (For the Frequency, please respond on either ‘times per
week ‘ or ‘times per day’)
(TURN to the back page)
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Type of
supplement
Example:
Fish oil

Frequency (how often)
Times per

Times per

week

day

3 times

Description (e.g. brand

Dose (e.g. 500mg, 2

name)

capsules or 2
teaspoons)

Blackmores Omega Daily

concentrated fish oil, double
strength

1034mg omega -3
triglycerides-fish
1 capsule

195

Appendix D. Three-day weighed food record

3-Day Weighed Food Record
Subject ID # _____________________________________________________

Contact details: _________________________________________________

PLEASE write food record on two weekdays and one
weekend

Instruction to Complete the Food Record
Food records allow detailed description of all food and beverages consumed over a period
of multiple days. The food records provide a way to validate the data supplied from the
Food Frequency Questionnaire. Data from the food records will be analysed statistically. It
is very important that as much detail regarding the food and drinks you consumed,
including the meal you consumed for, the amount you consumed, the place of
consumption and preparation is written down.
• Please eat as you usually eat
• Record everything you eat and drink, including snacks
• Complete the Meal, time, and place prepared and consumed columns for each
meal or snack. Please write in name of restaurant if you know it.
• Start each new day on a new page
• You do not have to use the whole booklet; just record what you eat and drink on
the day of recording.
• Please write clearly
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How to Record Each Food
• Describe each food and beverages in detail, as best you can. See example below

INCLUDE
How prepared
Added fat
Brand name and
type
Portion size

FOR EXAMPLE
Fried, grilled, stir fried, roast, barbeque, pam fry
Cook with oil, butter
Wheatbelt Bakehouse Magnificent Multigrain with added Chia
and quinoa
1/2 cup, 2 slices, 1tbsp

• Describe each ingredient in a mixed dish in the food record, or use Recipes
section on page 34. See example below

Spaghetti Bolognese

Pizza

•

11/2 cups cooked spaghetti, 125g lean beef
mince, 1/4 large onion, sliced, 1 clove garlic,
100g crushed tomato, sliced mushrooms,
2tbsp salt reduced tomato paste
3/4 cup flour, 1tbsp vegetable oil, 40g
cheese, 38g tomato, 20g mushroom,
capsicum and onion, 75g pineapple, 40g
chicken

Ideally weigh the amount of food before eating and record any leftovers with the
provided kitchen scale. Estimate the amount of each ingredient with measuring
tools. Demonstration on how to weigh food and drinks with the scale will be
provided. Weights of food can be calculated by weighing total and subtracting
utensil weight

Accuracy and detail is essential. This includes obtaining information such as:
•
•
•
•
•
•

Dairy foods – varying fat contents, calcium enriched
Bread – type, e.g. white, multigrain, wholemeal, fruit/raisin, sour dough
Method of preparing food = e.g. boiled, baked, pan fried, stir fried, steamed, roast
Amount and type of fat used in cooking – olive, canola, sesame, butter
Use of fortified foods – e.g. calcium enriched, fortified cereals wit nuts and seeds
Brand names whatever possible – for bread, cereals
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An Example:

Food Record:
Day: _________1________

Date: __21 (DD)_ /__8 (MM)__ / _2013_(YYYY)_

Scale and measuring tools used?
Meal

Time

B=Breakfast

Place
prepared
and
consumed

S=Snacks

H=Home

L=Lunch

D=Dinner

B

R=Restaurant

8am

O=Other, please
specify

H

Yes

No

Food and Beverages (Please
describe Brand name,
cooking method used, type
i.e. low fat, and any additional
information)
Homemade breakfast cereal:
Milk, reduced fat, Harvey
Fresh
Corn flakes, Freedom
Foods
Wheat germ powder
Almonds

Pistachio

Dried cranberry

White chocolate chips

Oat, minute, McKenzie’s

All microwaved

Amount and unit
of consumption,
(e.g. Tbsp, Tsp, Oz.,

Pieces, Slice, Cup, gram,
handful, glass, etc.)

1 bowl
200ml

1/4 cup
2 tsp

6 nuts
4 nuts

5 berries
8 chips

3/4 cup
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Food Record:
Day: _______________________________
Scale and measuring tools used?
Meal
B=Breakfast
L=Lunch

D=Dinner
S=Snacks

Time

Place prepared
and consumed
H=Home

R=Restaurant

O=Other, please
specify

Date: _____ /_____ / ______
Yes

No

Food and Beverages
(Please describe Brand
name, cooking method
used, type i.e. low fat, and
any additional information)

Amount and
unit of
consumption,
(e.g. Tbsp, Tsp, Oz.,

Pieces, Slice, Cup,

gram, handful, glass,
etc.)
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Appendix E. Urine collection protocol
Urine collection protocol for subjects
- It is important that you drink normally during the day. This means do not drink
more or less fluids than you usually would during a normal day.
- For accurate evaluation of tests of how much metabolites are excreted on your
24-hour urine samples, it is important that you make the effort to collect every
drop of urine during each 24-hour period.
- It is important that you will need to produce at least 100ml of urine per 24 hour

You will need:
• 3x3-litre urine collection bottles, with vitamin C added as preservative (supplied in 1st
session)
• A pen, pencil or marker
• Funnel and Collection ‘hat’ (supplied in 1st session)
• Cooler bag, ice pack (supplied in 1st session)
• Watch/clock

1. You will be given equipment, 3x3-litre urine collection bottles, funnel, collection
container/hat, cooler bag and ice pack for urine collection in the 1st session. Discuss
with Winnie if you think you will need more collection bottles.

2. RECORD information, such as the start and complete date and time of urine collection,
and sample complete or incomplete on the label of the bottles. If any sample is missed,
record the time of the missed sample on the calendar provided.
3. BEGIN the urine collection, after you have DISCARDED the first urine sample you
made in the morning or day after you wake up for the day ONE only. Record the time
on the front of your bottle. You will collect all samples for the day TWO and day
THREE.
4. COLLECT all urine for the remainder of the day, finishing with the last sample before
rest. Write the finished time on the bottle.

5. Use the collection hat to assist the collection. Place the clean collection hat between
the toilets bowl top and lid to hold it in place. Make sure the curved part of the hat is
lined up with the front edge of the toilet bowl. You should urinate in the collection hat.
If it is convenient, you can instead urinate directly into the bottles with the funnel.
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6. Remove the red cap off the bottle; insert the funnel into the bottle. Transfer the urine
to the bottle through the funnel without splashing or spilling. The collection ‘hat’ has
a pour spout which makes it easy to pour the urine into the collection bottles. Close
the cap when you finish transferring the urine sample into the bottle.
Note: It is best to do the transferring immediately after urinating. If you get up
during the night but do not pour the urine into the bottle immediately, please do so as
soon as possible the next morning.

7. Please store the bottles in a cool place. If it is okay for you, you may store in the
fridge. If not, for example, in bathroom or air conditioned environment, during the
day of collection or in the cooler bag provided with ice pack. Remember to cap the
bottle and close it tightly.
8. When you finish all 3x24-hour urine samples, put them all in the cooler bag with ice
pack, along with other given equipment and ready to return them to Winnie. If you
know you will be on ECU Joondalup campus after you have finished one 24-hour
urine collection, you may bring the completed 24-hour urine bottle from the
previous day to Winnie at the time of your convenience. Please contact Winnie to do
so. Alternatively, you may choose to bring all the bottles along with other
equipment and paperwork, i.e. Food record, calendar, food frequency questionnaire,
to the 2nd session.

Note:
If you need to have a bowel movement, any urine passed with the bowel movement
should be collected. Try not to include faeces with the urine collection. If faeces does get
mixed in, do not try to remove the faeces from the urine collection bottle.
For female subject, please do not collect samples during menstrual cycle.

The vitamin C powder inside the bottles is added as preservative. You will not be in
direct contact with the powder. Please leave them as it is and the powder is not harmful.
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Appendix F. Laboratory protocol for measuring weight and volume of urine
Protocol for measuring total weight and volume of urine samples
You will need:
-24 hour urine sample
-top pan balance
-graduated cylinder, beaker


Record subject name and subject ID in the 24-hour urine sample page of the Lignan
project laboratory manual



To obtain the weight of the 24-hour urine sample, weigh the urine bottle and the urine
sample with the top pan balance, record the total weight (g) of bottle and urine in the
laboratory manual



Decant the urine into the graduated cylinder to measure the total volume (L) for each day
sample and record its volume in the laboratory manual



Weigh the empty bottle and subtract its weight from the total weight of the bottle and
urine to obtain the weight of the urine



Record the weight (g) and volume (L) of each sample in the 24-hour urine samples page
of the manual (Day 1, 2 or 3), indicate the completeness of each sample, the date of
sample return and the date of sodium azide added



Rinse out the graduated cylinder after measurement of each day sample to minimise cross
contamination
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Appendix G. Laboratory protocol for urine sample aliquoting
Protocol for sample aliquoting and aliquot storage
You will need:
-24 hour urine samples
-sodium azide solution
-pipette that measure 10ml, 10µL and pipette tip
-dropper
-10ml centrifuge tubes, 2ml eppendorf
-beaker
-label, pen and plastic bag


Create new entries of the urine aliquots in the Aliquot page of the Lignan project
laboratory manual. Assign a subject ID to new subject. Assign a sample ID to each
aliquot, record the content of each aliquot and create comment and note columns about
what these samples, how they will be used for and how they will be treated



Rinse all glassware with water and urine sample before use



After measuring the total volume for each 24-hour urine sample with the graduated
cylinder, decant urine into a 100ml beaker



Adjust the pipette to measure 10ml. Insert the appropriate pipette tip that can transfer the
volume of 10ml. Use this 10ml pipette to measure one 10ml aliquot from each day
sample and transfer into 10ml polypropylene centrifuge tubes. Label them with their
subject and sample IDs (refer to Lignan project laboratory manual). These aliquots are
sent to PathWest for creatinine analysis



Use a dropper or the pipette to measure two approximately 2ml urine into 2ml centrifuge
tube from each day sample, you will have a total of six 2ml centrifuge tubes per subject.
Close the lid. Label them with their unique sample IDs. These centrifuge tubes are
reserved for Dr. Mary Boyce to develop urinary creatinine analysis method using
capillary electrophoresis.



Top up the beaker with urine if necessary
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Prepare a sodium azide solution as per the Protocol for preparing the sodium azide
solution.



Use the 10ml pipette to measure three 10ml aliquots from each day sample into 10ml
polypropylene centrifuge tubes. You will have a total of twelve aliquots per subject, plus
the first one prepared without sodium azide added for each day sample. Each tube is to
be labeled with the type of sample (i.e. 24-hour urine), subject and sample ID, initial of
person and the date of aliquoting



Adjust a different pipette that can measure 10µL and insert a pipette tip that can transfer
this volume. Use this pipette to measure 10µL sodium azide solution and add to the other
three 10ml aliquots (Except for the ones that will be sent to PathWest for creatinine
analysis).



Mix the sodium azide by slowly inverting each tube 4 to 5 times.



Pour the unused volume of urine from the cylinder to the sink or decant back to the urine
bottles (if needed), rinse the sink with shower, and clean the cylinder after aliquoting
each day sample. Dispose the pipette tip and dropper after aliquoting each day sample
and change to a new one before pipetting new day sample



You will have a total of twelve 10ml aliquots (four per each of three days sample) and six
2ml centrifuge tubes (two per each of three days sample) per subject. Ensure the lids are
closed firmly



Place the tubes for each subject in the rack. Put the rack with sample tubes in the plastic
bag, with a paper label in the bag. The label should contain information of the name of
the study (LIGNAN study), name of supervisor (Dr. Mary Boyce), date to discard (2018)



Store the plastic bag with rack of sample tubes in the -80°C freezer (19.206)
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Appendix H. Screening questions
Screening questions
These questions will be asked to screen potential participants.
All answer must be No in order for a participant to be eligible to participate
1.
2.
3.

Are you currently taking any antibiotics?
Yes, exclude the subject.
No, ask Question 2

Have you taken any antibiotics for the past 6 to 12 months?
Yes, exclude the subject
No, ask Question 3

Did you make substantial changes to your usual diet for the past 3 months?
Yes, exclude the subject
No, ask Question 4

4. Do you have any currently diagnosed gastrointestinal problems, such as ulcerative
colitis, or Crohn’s disease?
Yes, exclude the subject
No, ask Question 5
5. Have you had gastric surgery that remove all or part of your large intestine?
Yes, exclude the subject
No, ask Question 6

6. Do you have chronic renal or liver diseases? Or have had acute renal or liver diseases
in the previous 6 to 12 months?
Yes, exclude the subject.
No, subject is eligible to participate
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Appendix I. Study flyer
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Appendix J. Study calendar
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